Mineral supplement | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Multivitamin with Minerals Capsules | Each Hard Gelatin Capsule contains: | IP | 10 mg | Mineral supplement |
Thiamine Mononitrate | IP | 10 mg | ||
Riboflavin | IP | 3.0 mg | ||
Pyridoxin Hydrochloride | IP | 15 mcg | ||
Vitamin B12 | IP | 100mg | ||
Niacinamide | IP | 50 mg | ||
Calcium Pantothenate | IP | 1.5 mg | ||
Folic Acid | USP | 100 mcg | ||
Biotin | IP | 150 mg | ||
Ascorbic Acid (as Coated ) | q.s. | |||
Excipients | ||||
Approved colored used in Hard Gelatin Capsule shell | ||||
Multivitamin and Multimineral capsules. | Each Hard Gelatin Capsule contains: | IP | 5000 IU | Mineral supplement |
Vitamin A concentrate ( powder form) | IP | 5 mg | ||
Vitamin B1 | IP | 5 mg | ||
Vitamin B2 | IP | 2 mg | ||
Vitamin B6 | IP | 25 mcg | ||
Methylcobalamin | IP | 75 mg | ||
Vitamin c (coated) | IP | 400 IU | ||
Vitamin D3 | IP | 15 mg | ||
Vitamin E acetate | IP | 50 mg | ||
Nicotinamide | IP | 5 mg | ||
Calcium D-Pantothenate | IP | 1 mg | ||
Folic Acid | BP | 0.5 mg | ||
Copper sulphate | ||||
Equ. to Copper | USP | 2 mg | ||
Potassium( as Potassium Sulphate) | USP | 0.5 mg | ||
Manganese sulphate Monohydrate | IP | |||
Magnesium sulphate | 3 mg | |||
Equ. to Magnesium | IP | 75 mg | ||
Calcium dibasic phosphate equ. to Calcium | IP | 25 mg | ||
Zinc Sulphate monohydrate | IP | 0.1 mg | ||
Potassium iodide equ. to Iodine. | q.s. | |||
Excipients | ||||
Approved colored used in Hard Gelatin Capsule shell | ||||
Antibaterial | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Prebiotic and Probiotic Capsules | Each Hard Gelatin Capsule contains: | 0.48 billion | Antibaterial | |
Lactobacillus acidophillus | 0.48 billion | |||
Lactobacillus rhamnosus | 0.48 billion | |||
Bifidobacterium Longum | 0.48 billion | |||
Bifidobacterium Bifidum | 0.1 billion | |||
Saccharomyces noulardii | 0.48 billion | |||
Streptococcus thermophilus | 300 mg | |||
Fructo oligo saccharide | q.s. | |||
Excipients | ||||
Approved colored used in Hard Gelatin Capsule shell | ||||
Ciprofloxacin, Metronidazole, Terbinafine HCl & Clobetasol Propionate Cream | Composition : | IP | 1.0% w/w | Antibaterial |
Ciprofloxacin Hydrochloride | IP | 1.0% w/w | ||
Eq. to. Ciprofloxacin | IP | 1.0% w/w | ||
Metronidazole benzoate | IP | 0.05% w/w | ||
Eq. to. Metronidazole | ||||
Terbinafine Hydrochloride | ||||
Clobetasol Propionate | IP | 0.16% w/w | ||
Preservative | IP | 0.033% w/w | ||
Methyl Paraben | q.s. | |||
Propyl Paraben | ||||
Cream Base | ||||
Clobetasol Propionate, Gentamicin, Miconazole Nitrate &Chlorcresol Cream | Composition: | IP | 0.05% | Antibaterial |
Clobetasol Propionate | IP | 0.10% | ||
Gentamicin | ||||
(As Gentamicin Sulphate) | IP | 2.00% | ||
Miconazole Nitrate | IP | 0.10% | ||
Chlorcresol | q.s. | |||
Cream Base | ||||
Clotrimazole, Beclomethasone & Neomycin cream | Composition : | IP | 1 % w/w | Antibaterial |
Clotrimazole | IP | 0.025 %w/w | ||
Beclomethasone | ||||
Dipropionate | IP | |||
Neomycin Sulphate | 0.5 %w/w | |||
Eq. to Neomycin | ||||
Chlorocresol | IP | 0.1%w/w | ||
( as preservative) | q.s. | |||
Cream base | ||||
Silver Sulfadiazine with chlorhexidine Cream | Composition : | IP | 1.0%w/w | Antibaterial |
Silver Sulfadiazine | IP | 5.0% w/w | ||
Chlorhexidine Gluconate solution Equivalent to Chlorhexidine Gluconate | q.s | |||
Cream Base | ||||
Fradiomycin Cream | Composition : | JP | 5.0 mg | Antibaterial |
Fradiomycin sulphate | IP | 0.01%w/w | ||
Chlorocresol | ||||
(as preservative) | q.s. | |||
In cream base | ||||
Mupirocin Cream USP | Composition :- | IP | 2.0%w/w | Antibaterial |
Mupirocin | q.s. | |||
Cream Base | ||||
Sodium fusidate ointment BP | Each gram contains : | IP | 20 mg | Antibacterial |
Sodium fusidate | q.s. | |||
Ointment Base | ||||
Clotrimazole, Menthol,Ichthammol, Boric AcidandzincoxideCream | Composition : | Antibaterial | ||
Clotrimazole IP0.5%w/w | ||||
Menthol IP1.0%w/w | ||||
Ichthammol USP0.2%w/w | ||||
BoricAcid IP 1.0%w/w | ||||
ZincOxide IP 5.0%w/w | ||||
Preservatives: | ||||
Phenoxyethanol IP0.2%w/w | ||||
Benzylalcohol IP1.0%w/w | ||||
CreamBase q.s | ||||
Pre probiotic Capsule | Each hard gelatin capsule contains: | 30Millions | Antibacterial | |
Sterptococcus Faecalis T-110 | 2 Millions | |||
Clostridium Butyeicum T0-A | 1 Millions | |||
Bacillus mesentericus T0-A | 50Millions | |||
Lactobacillus Sporogens | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Streptococcus Faecails, Clostridium Butyricum, Bacillus Mesentericus and Lactic Acid Bacillus Capsules | Each Hard Gelatin Capsule Contains: | 30 million | Antibacterial | |
Streptococcus Faecails | 2 million | |||
Clostridium Butyricum | 1 million | |||
Bacillus Mesentericus | 50 million | |||
Lactic Acid Bacillus | q.s. | |||
(Lactobacillus Sporogenes) | ||||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Pre & Probiotic Capsules | Each hard gelatin capsule contains:- | 30Million | Antibacterial | |
Streptococcus Faecalis | 2Million | |||
Clostridium Butyricum | 1Million | |||
Bacillus Mesentericus | 50Million | |||
Lactic Acid Bacillus | q.s. | |||
Excipients | ||||
Approved colours used in empty capsule shells. | ||||
Tetracycline HCl capsules IP | Each hard gelatin capsule contains:- | IP | 500mg | Antibacterial |
Tetracycline Hydrochloride | q.s. | |||
Excipients | ||||
Approved colours used in empty capsule shells. | ||||
Clindamycin Hydrochloride Capsule IP | Each hard gelatin capsule contain: | IP | 150 mg | Antibacterial |
Clindamycin Hydrochloride | ||||
Equivalent to Clindamycin | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule | ||||
Oxytetracycline HCl capsules IP | Each hard gelatin capsule contains: | IP | 500mg | Antibacterial |
Oxytetracycline Hydrochloride | q.s. | |||
Excipients | ||||
Approved colours used in empty capsule shells. | ||||
Micanazole Nitrate and Flucinolone Acetonide cream | Composition: | IP | 2.0%w/w | Antibacterial |
Micanazole Nitrate | IP | 0.01% w/w | ||
Flucinolone Acetonide | q.s. | |||
In a Cream base | ||||
Mupirocin ointment IP | Composition :- | IP | 2.0%w/w | Antibacterial |
Mupirocin | q.s. | |||
Ointment Base | ||||
Clotrimazole & Beclomethasone Dipropionate Cream | Composition : | IP | 1.0%w/w | Antibacterial |
Clotrimazole | IP | 0.025%w/w | ||
Beclomethasone Dipropionate | ||||
Preservatives: | IP | 1.0%w/w | ||
Benzyl Alcohol | IP | 0.15%w/w | ||
Methyl Paraben | q.s | |||
Cream base | ||||
Fusidic Acid Cream IP | Composition:- | IP | 2.00%w/w | Antibacterial |
Fusidic Acid | q.s. | |||
Cream Base | ||||
Sodium fusidate ointment BP | Each gram contains : | IP | 20 mg | Antibacterial |
Sodium fusidate | q.s. | |||
Ointment Base | ||||
Nanocrystalline Silver Gel | Composition: | 0.002%w/w | Antibacterial | |
Nanocrystalline Silver | q.s. | |||
Gel Base | ||||
Nadifloxacin Gel | Composition: | IP | 1.00% | Antibacterial |
Nadifloxacin | q.s. | |||
Cream base | ||||
Clarithromycin Tablets IP 500 mg | Each Film Coated Tablet Contains:- | IP | 500 mg | Antibacterial |
Clarithromycin | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Clotrimazole Vaginal Tablets IP 100 mg | Each Uncoated Vaginal Tablet Contains:- | IP | 100 mg | Antibacterial |
Clotrimazole | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Clotrimazole Vaginal Tablets IP 200 mg | Each Uncoated Vaginal Tablet Contains:- | IP | 200 mg | Antibacterial |
Clotrimazole | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Clotrimazole Vaginal Tablets IP 500 mg | Each Uncoated Vaginal Tablet Contains:- | IP | 500 mg | Antibacterial |
Clotrimazole | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Sertaconazole Nitrate Vaginal Tablets 500 mg | Each Uncoated vaginal Tablet Contains:- | BP | 500 mg | Antibacterial |
Sertaconazole Nitrate | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Azithromycin Tablets IP | Each Film Coated Tablet Contains:- | Antibacterial | ||
Azithromycin Dihydrate IP | ||||
Eq. to Azithromycin ——- 500 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Norfloxacin Tablets IP. | Each Film Coated Tablet Contains:- | Antibacterial | ||
Norfloxacin IP ——————-400mg | ||||
Excipients————————-q.s. | ||||
Colour-Approved colour used. | ||||
Norfloxacin Tablets IP. | Each Film Coated Tablet Contains:- | Antibacterial | ||
Norfloxacin IP 200mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Norfloxacin Tablets IP. | Each Film Coated Tablet Contains:- | Antibacterial | ||
Norfloxacin IP 800mg | ||||
Excipients—————–q.s. | ||||
Colour-Approved colour used. | ||||
Levofloxacin Tablets IP | Each Film Coated Tablet Contains:- | Antibacterial | ||
Levofloxacin Hemihydrate IP | ||||
Eq. to Levofloxacin ——–750 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Levofloxacin Tablets IP | Each Film Coated Tablet Contains:- | Antibacterial | ||
Levofloxacin Hemihydrate IP | ||||
Eq. to Levofloxacin ——–250 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Ciprofloxacin Tablets IP | Each Film Coated Tablet Contains:- | Antibacterial | ||
Ciprofloxacin Hydrochloride IP | ||||
Eq. to Ciprofloxacin ———500 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Azithromycin Tablets IP | Each Film Coated Tablet Contains:- | Antibacterial | ||
Azithromycin Dihydrate IP | ||||
Eq. to Azithromycin (Anhydrous)—250 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Ciprofloxacin and Tinidazole Tablets IP | Each Film Coated Tablet Contains:- | Antibacterial | ||
Ciprofloxacin Hydrochloride IP | ||||
Eq. to Ciprofloxacin ———500 mg | ||||
Tinidazole IP ————— 600 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Ofloxacin and Ornidazole Tablets | Each Film Coated Tablet Contains:- | Antibacterial | ||
Ofloxacin IP —————-200 mg | ||||
Ornidazole IP ————— 500 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Ciprofloxacin Tablets IP | Each Film Coated Tablet Contains:- | Antibacterial | ||
Ciprofloxacin Hydrochloride IP | ||||
Eq. to Ciprofloxacin ———250 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Ciprofloxacin Tablets IP | Each Film Coated Tablet Contains:- | Antibacterial | ||
Ciprofloxacin Hydrochloride IP | ||||
Eq. to Ciprofloxacin ———750 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Ofloxacin Tablets IP | Each Film Coated Tablet Contains:- | Antibacterial | ||
Ofloxacin IP ————– 400 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Ofloxacin Tablets IP | Each Film Coated Tablet Contains:- | Antibacterial | ||
Ofloxacin IP ————– 100 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Ofloxacin Tablets IP | Each Film Coated Tablet Contains:- | Antibacterial | ||
Ofloxacin IP ————– 300 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Ofloxacin and Tinidazole Tablets IP | Each Film Coated Tablet Contains:- | Antibacterial | ||
Ofloxacin IP ————– 200 mg | ||||
Tinidazole —————- 600 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Erythromycin Stearate Tablets IP | Each film Coated Tablet Contains: | Antibacterial | ||
Erythromycin Stearate IP | ||||
Eq. to Erythromycin —————– 125 mg | ||||
Excipients……………q.s. | ||||
Colour : Approved Colour Used | ||||
Azithromycin and Lactic Acid Bacillus Tablets | Each Film Coated Tablet Contains:- | Antibacterial | ||
Azithromycin Dihydrate IP | ||||
Eq. to Azithromycin ——- 250 mg | ||||
Lactic Acid Bacillus ————60 million Spores | ||||
Excipients——————q.s. | ||||
Colour-Approved colour used. | ||||
Azithromycin and Lactic Acid Bacillus Tablets | Each Film Coated Tablet Contains:- | Antibacterial | ||
Azithromycin Dihydrate IP | ||||
Eq. to Azithromycin ——- 500 mg | ||||
Lactic Acid Bacillus ————60 million Spores | ||||
Excipients——————q.s. | ||||
Colour-Approved colour used. | ||||
Clarithromycin Tablets | Each Film Coated Tablet Contains:- | Antibacterial | ||
Clarithromycin IP ————— 250 mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Norfloxacin &Tinidazole Tablets | Each Film Coated Tablet Contains:- | Antibacterial | ||
Norfloxacin IP ————— 400 mg | ||||
Tinidazole IP ————– 600 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Roxithromycin Tablets IP | Each Film Coated Tablet Contains:- | Antibacterial | ||
Roxithromycin IP ————— 150 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Erythromycin Stearate Tablets IP | Each film Coated Tablet Contains: | Antibacterial | ||
Erythromycin Stearate IP | ||||
Eq. to Erythromycin —————– 250 mg | ||||
Excipients……………q.s. | ||||
Colour : Approved Colour Used | ||||
Ciprofloxacin and Tinidazole Tablets IP | Each Film Coated Tablet Contains:- | Antibacterial | ||
Ciprofloxacin Hydrochloride IP | ||||
Eq. to Ciprofloxacin ——— 250 mg | ||||
Tinidazole IP ————— 300 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Ofloxacin TabletsIP | EachFilmCoatedTabletContains:- | Antibacterial | ||
Ofloxacin—— 200mg | ||||
Excipients————q.s. | ||||
Colour-Approvedcolour used. | ||||
Doxycycline HCl With Lactic Acid Bacillus Capsule | Each Hard gelatin capsule Contains: | Antibacterial | ||
Doxycycline Hydrochloride…………………IP100mg | ||||
Lactic Acid Bacillus ………………………………..100 Million | ||||
Excipients …………………………………….IP Spores | ||||
Approved colour used in empty hard gelatin capsule shell…….q.s | ||||
Doxylamine Succinate, Pyridoxine Hydrochloride & Folic Acid Tablet | Each Enteric Coated Tablet | Antibacterial | ||
Contains:- USP 20mg | ||||
Doxylamine Succinate……………………IP 20 mg | ||||
Pyridoxine Hydrochloride……………….IP 5 mg | ||||
Folic Acid………………………………………….q.S | ||||
Excipients | ||||
Colour-Approved colour used. | ||||
Riboflavin, Folic Acid, Niacinamide with lactic acid bacillus Tablets | Each Film Coated Tablet Contains:- | Antibacterial | ||
Riboflavin IP …………………… 10 mg | ||||
Folic Acid IP ……………………..1.5 mg | ||||
Niacinamide IP ………………… 50 mg | ||||
lactic acid bacillus 60 million Spores | ||||
Excipients……………………………..q.s. | ||||
Metronidazole, Sucralfate & Lignocaine Hcl ointment. | Composition: | IP | 1.0%w/w | Antibacterial |
Metronidazole | IP | 4.0% w/w | ||
Lignocaine Hydrochloride | IP | 7.0% w/w | ||
Sucralfate | q.s. | |||
Cream base | ||||
Vitamin E & Aloevera cream | Composition: | I.P. | 0.50% w/w | Antibacterial |
Vitamin E Acetate | ||||
Moisturizing cream base with Aloevera | q.s. | |||
Clarithromycin Gel 1.0%w/w | Composition: | I.P. | 1.0%w/w | Antibacterial |
Clarithromycin | I.P. | 1.0% w/w | ||
Phenoxyethanol | q.s. | |||
(As preservative) | ||||
Gel Base | ||||
Rifaximin Tablets BP | Each Film Coated Tablet Contains:- | B.P. | 400 mg | Antibacterial |
Rifaximin | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Rifaximin Tablets BP | Each Film Coated Tablet Contains:- | B.P. | 550 mg | Antibacterial |
Rifaximin | q.s. | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Levofloxacin and Ornidazole Tablets | Each Film Coated Tablet Contains:- | Antibacterial | ||
Levofloxacin Hemihydrate IP | ||||
Eq. to Levofloxacin ————–250 mg | ||||
Ornidazole IP ————— 500 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Moxifloxacin Tablets 400 mg | Each Uncoated Tablet Contains: | IP | 400 mg | Antibacterial |
Moxifloxacin Hydrochloride | q.s | |||
Eq. to Moxifloxacin | ||||
Excipients | ||||
Colour-Approved colour used. | ||||
Metronidazole Tablets IP | Each Film Coated Tablet Contains:- | Antibacterial | ||
Metronidazole IP—————250 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Levofloxacin Tablets IP | Each Film Coated Tablet Contains:- | Antibacterial | ||
Levofloxacin Hemihydrate IP | ||||
Eq. to Levofloxacin ——–500 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Ornidazole Tablets IP | Each Uncoated Tablet Contains:- | Antibacterial | ||
Ornidazole IP———–500 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Tetracycline HCl capsules IP | Each hard gelatin capsule contains: | IP | 250mg | Antibacterial |
Tetracycline Hydrochloride | q.s. | |||
Excipients | ||||
Approved colours used in empty capsule shells. | ||||
Oxytetracycline HCl capsules IP | Each hard gelatin capsule contains: | IP | 250mg | Antibacterial |
Oxytetracycline Hydrochloride | q.s. | |||
Excipients | ||||
Approved colours used in empty capsule shells. | ||||
Minocycline HCl capsules | Each hard gelatin capsule contains: | USP | 100mg | Antibacterial |
Minocycline Hydrochloride | q.s. | |||
Excipients | ||||
Approved colours used in empty capsule shells. | ||||
Antifungal | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Itraconazole capsule BP 100mg | Each hard gelatin capsule contains: | BP | 100 mg | Antifungal |
Itraconazole Pellets | q.s. | |||
Eq to Itraconazole | ||||
Excipients | ||||
Colour: Approved Colours Used. in Empty Shell & Pellet | ||||
Itraconazole capsule BP200mg | Each hard gelatin capsule contains: | BP | 200 mg | Antifungal |
Itraconazole Pellets | q.s. | |||
Eq to Itraconazole | ||||
Excipients | ||||
Colour: Approved Colours Used. in Empty Shell & Pellet | ||||
Fungal Diastase & Lactic acid Bacillus Capsules | Each hard gelatin capsule contains: | IP | 20 mg | Antifungal |
Fungal Diastase | 150×106Spores | |||
Lactic acid bacillus | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Fluconazole Capsules IP | Each Hard Gelatin Capsule Contains:- | IP | 50.0 mg | Antifungal |
Fluconazole | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Fluconazole Capsules IP | Each Hard Gelatin Capsule Contains:- | IP | 150.0 mg | Antifungal |
Fluconazole | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Fluconazole Capsules IP | Each Hard Gelatin Capsule Contains:- | IP | 200.0 mg | Antifungal |
Fluconazole | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Ketoconazole Cream | Composition: | IP | 2.0% w/w | Antifungal |
Ketoconazole | ||||
Preservation | IP | 0.1% w/w | ||
Methyl Paraben | IP | 0.05% w/w | ||
Phenoxyenthol | q.s. | |||
Cream Base | ||||
Ketoconazole Cream | Composition: | IP | 2.0% w/w | Antifungal |
Ketoconazole | ||||
Preservation | IP | 0.1% w/w | ||
Methyl Paraben | IP | 0.05% w/w | ||
Phenoxyethanol | q.s. | |||
Cream Base | ||||
Itraconazole, Ofloxacin, Ornidazole & Clobetasol propionate Cream | Composition: | IP | 1.0% w/w | Antifungal |
Itraconazole | IP | 0.75 % w/w | ||
Ofloxacin | IP | 2 0 w/w | ||
Ornidazole | IP | 0.05%w/w | ||
Clobetasol Propionate | ||||
Preservation | IP | 16% | ||
Methyl Paraben | IP | 0.03% | ||
Propyl Paraben | q.s. | |||
Cream base | ||||
Clobetasol Propionate , Miconazole Nitrate, Neomycin Sulphate Cream | Composition : | IP | 0.05%w/w | Antifungal |
Clobetasol Propionate | IP | 2%w/w | ||
Miconazole Nitrate | IP | |||
Neomycin Sulphate | 0.1%w/w | |||
Equ. to Neomycin Base | IP | 0.1%w/w | ||
Chlorocresol | ||||
(as preservative) | q.s. | |||
Cream base | ||||
Itraconazole & Terbinafine Cream 1% w/w | Composition | BP | 1 % w/w | Antifungal |
Itraconazole | IP | 1 % w/w | ||
Terbinafine hydrochloride | ||||
Preservative: | IP | 0.16% w/w | ||
Methyl Paraben | IP | 0.05% w/w | ||
Propyl Paraben | q.s. | |||
Cream base | ||||
Miconazole Nitrate Gel | Composition : | IP | 2.0 %w/w | Antifungal |
Miconazole Nitrate | q.s | |||
Gel Base | ||||
Clotrimazole Cream IP | Composition : | IP | 2.0 %w/w | Antifungal |
Clotrimazole | IP | 0.10% w/w | ||
Chlorocresol | ||||
( as preservative) | q.s | |||
Cream Base | ||||
Miconazole Nitrate, Nadifloxacin & Mometasone Furoate & Cream | Composition:- | IP | 2% w/w | Antifungal |
Miconazole Nitrate | USP | 1% w/w | ||
Nadifloxacin | IP | 0.1%w/w | ||
Mometasone Furoate | q.s. | |||
Cream Base | ||||
Terbinafine Hydrochloride Cream IP | Composition:- | IP | 1% w/w | Antifungal |
Terbinafine Hydrochloride | q.s. | |||
Cream Base | ||||
Ketoconazole with Beclomethasone Dipropionate Cream | Composition : | IP | 2.0% w/w | Antifungal |
Ketoconazole | IP | 0025% w/w | ||
Beclomethasone dipropionate | ||||
Preservatives: | IP | 0.15% w/w | ||
Methyl Paraben | IP | 0.05% w/w | ||
Propyl Paraben | q.s. | |||
Cream Base | ||||
Voriconazole Tablet IP 50 mg | Each Film coated Tablet Contains:- | IP | 50 mg | Antifungal |
Voriconazole | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Voriconazole Tablet IP 200 mg | Each Film coated Tablet Contains:- | IP | 200 mg | Antifungal |
Voriconazole | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Trimethoprim And Sulphamethoxazole Tablets IP. (Co-trimoxazole Tablets I.P.) | Each Uncoated Tablet Contains:- | Antifungal | ||
Trimethoprim IP———————40mg | ||||
Sulphamethoxazole IP————-200mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Trimethoprim And Sulphamethoxazole Tablets IP. (Co-trimoxazole Tablets I.P.) | Each Uncoated Tablet Contains:- | Antifungal | ||
Trimethoprim IP———————80mg | ||||
Sulphamethoxazole IP————-400mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Metronidazole Tablets IP | Each Film Coated Tablet Contains:- | Antifungal | ||
Metronidazole IP————— 400 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Metronidazole Tablets IP | Each Film Coated Tablet Contains:- | Antifungal | ||
Metronidazole IP—————200 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Fluconazole Tablet IP | Each Uncoated Tablet Contains:- | Antifungal | ||
Fluconazole IP———–50 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Fluconazole Tablet IP | Each Uncoated Tablet Contains:- | Antifungal | ||
Fluconazole IP———–100 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Fluconazole Tablet IP | Each Uncoated Tablet Contains:- | Antifungal | ||
Fluconazole IP———–150 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Fluconazole Tablet IP | Each Uncoated Tablet Contains:- | Antifungal | ||
Fluconazole IP———–200 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Ketoconazole Tablet IP | Each Uncoated tablet contains : | Antifungal | ||
Ketoconazole IP—————200.0 mg | ||||
Excipients ————————-q.s. | ||||
Colour :- Approved colour used. | ||||
Terbinafine Tablets I.P. | Each Uncoated Tablet Contains:- | Antifungal | ||
Terbinafine Hydrochloride IP | ||||
Eq.to Terbinafine 500 mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Fluconazole & Tinidazole Tablets | Each Film Coated Tablet Contains:- | Antifungal | ||
Fluconazole IP —————75 mg | ||||
Tinidazole IP —————- 1000 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Ketoconazole,Clobetasol Propionate &Neomycin SulphateCream | Composition: | Antifungal | ||
Ketoconazole IP1.0%w/w | ||||
ClobetasolPropionate IP0.025%w/w | ||||
Neomycin Sulphate IP 5000IU | ||||
CreamBase q.s | ||||
Itraconazole Gel 1 %w/w | Composition: | Antifungal | ||
Itraconazole B.P1.0%w/w | ||||
Preservatives: | ||||
MethylParaben IP0.1%w/w | ||||
PropylParaben IP0.05%w/w | ||||
CreamBase q.s | ||||
Itraconazole capsule | Each hard gelatin capsule Contains: | USP | 200 mg | Antifungal |
Itraconazole | q.s. | |||
Approved colored used in empty capsule shells. | ||||
Excipients | ||||
Metronidazole Benzoate and Chlorhexidine Gluconate Gel | Composition: | IP | 1.0%w/w | Antifungal |
Metronidazole Benzoate | 0.5 %w/w | |||
Eq to Metronidazole | IP | qs | ||
Chlorhexidine Gluconate Solution | ||||
(as preservative) | ||||
Gel Base | ||||
Itraconazole capsule | Each hard gelatin capsule Contains: | USP | 100 mg | Antifungal |
Itraconazole | q.s. | |||
Approved colored used in empty capsule shells. | ||||
Excipients | ||||
Ketoconazole with ZPTO Sampoo | Composition: | IP | 2.0%w/w | Antifungal |
Ketoconazole | 1.0%w/w | |||
Zinc pyrithone (ZPTO) | qs | |||
Sampoo base | ||||
Eberconazole cream1.0%w/w | Composition: | IP | 1.0% w/w | Antifungal |
Eberconazole Nitrate | IP | |||
Eq. to Eberconazole | 0.1% w/w | |||
preservative | 0.025% w/w | |||
Methyl paraben | qs | |||
Propyl paraben | ||||
Cream base | ||||
Clindamycin Phosphate Gel | Composition: | IP | 1.0% w/w | Antifungal |
Clindamycin Phosphate | 0.1%w/w | |||
Eq. to Clindamycin | IP | 0.05%w/w | ||
Sodium methyl paraben | IP | q.s. | ||
Sodium Propyl paraben | ||||
Allanton base | ||||
Metronidazole, & sucralfate cream. | Composition: | IP | 1.0% w/w | Antifungal |
Metronidazole | IP | 7.0 % w/w | ||
Sucralfate | q.s. | |||
Cream Base | ||||
Ofloxacin and Ornidazole Tablets I.P. | Each Film Coated Tablet Contains:- | I.P. | 200 mg | Antifungal |
Ofloxacin | I.P. | 500 mg | ||
Ornidazole | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Itraconazole capsule BP 100mg | Each hard gelatin capsule contains: | BP | 100 mg | Antifungal |
Itraconazole | q.s. | |||
Excipients | ||||
Colour: Approved colours used in empty Shell & Pellets | ||||
Ornidazole Tablets I.P. 500 mg | Each Film Coated Tablet | I.P. | 500 mg | Antifungal |
Contains :- | q.s. | |||
Ornidazole | ||||
Excipients | ||||
Colour-Approved colour used | ||||
Calamine Lotion IP | Calamine | I.P. | 15.0% w/v | Antifungal |
Zinc oxide | I.P. | 5.0% w/v | ||
Bentonite | I.P. | 3.0%w/v | ||
Sodium citrate | I.P. | 0.5% w/v | ||
Liquefied phenol, | I.P. | 0.5% w/v | ||
Glycerin | I.P. | 5.0% w/v | ||
Purified water | q.s. | |||
Clotrimazole Topical Solution USP. | Composition: | I.P. | 1.0 %w/v | Antifungal |
Clotrimazole | q.s. | |||
Non aqueous Base | ||||
Metronidazole and Benzocaine Gel | Composition: | IP | 0.01%w/w | Antifungal |
Metronidazole | IP | 0.2 %w/w | ||
Benzocaine | q.s. | |||
Gel Base | ||||
Micanazole Nitrate and FlucinoloneAcetanide cream | Composition: | IP | 2.0%w/w | Antifingal |
Micanazole Nitrate | IP | 0.01% w/w | ||
FlucinoloneAcetanide | q.s. | |||
In a Cream base | ||||
Ciprofloxacin Hcl, Fluocinolone acetonde, Chlorocresol & Clotrimazole & Clotrimazole & Clotrimazole Cream | Composition: | IP | 0.5% w/w | Antibaterial , Antifugal |
Ciprofloxacin Hydrochloride | IP | 0.01%w/w | ||
Eq. to. Ciprofloxacin | IP | 1.0% w/w | ||
Fluocinolone acetonide | IP | 0.1% w/w | ||
Clotrimazole | q.s | |||
Chlorocresol ( as preservative) | ||||
Cream Base | ||||
Antibiotics, Antiviral & Antifungal | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Doxycycline HCl With Lactic Acid Bacillus Capsule | Each Hard gelatin capsule Contains: | IP | 100 mg | Antibiotics, Antiviral & Antifungal |
Doxycycline Hydrochloride | IP | 5 Billion Spores | ||
Lactic Acid Bacillus | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Chloramphenicol Capsule IP 500 mg | Each Hard Gelatin Capsule Contains: Chloramphenicol | IP | 500 mg | Antibiotics, Antiviral & Antifungal |
Excipients | q.s. | |||
Approved colour used in empty hard gelatin capsule shell | ||||
Racecadotril Capsules IP | Each Hard Gelatin Capsules Contains: | IP | 100 mg | Antibiotics, Antiviral & Antifungal |
Racecadotril | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Chloramphenicol Capsule IP 500 mg | Each Hard Gelatin Capsule Contains: | IP | 500 mg | Antibiotics, Antiviral & Antifungal |
Chloramphenicol | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Oseltamivir Capsules IP | Each hard gelatin capsule contains: | IP | 30.0 mg | Antibiotics, Antiviral & Antifungal |
Oseltamivir Phosphate | q.s. | |||
eq. to Oseltamivir | ||||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Oseltamivir Capsules IP | Each hard gelatin capsule contains: | IP | 45.0 mg | Antibiotics, Antiviral & Antifungal |
Oseltamivir Phosphate | q.s. | |||
equ. to Oseltamivir | ||||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Oseltamivir Capsules IP | Each hard gelatin capsule contains: | IP | 75.0 mg | Antibiotics, Antiviral & Antifungal |
Oseltamivir Phosphate | q.s. | |||
equ. to Oseltamivir | ||||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Linezolid Tablets IP | Each Film Coated Tablet Contains:- | Antibacterial & Antiviral | ||
Linezolid IP—————600 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Doxycycline capsules IP | Each hard gelatin capsule contains: | IP | 50mg | Antibiotics, Antiviral |
Doxycycline Hydrochloride | q.s. | |||
eq. to Doxycycline | ||||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Doxycycline capsules IP | Each hard gelatin capsule contains: | IP | 100mg | Antibiotics, Antiviral |
Doxycycline Hydrochloride | q.s. | |||
eq. to Doxycycline | ||||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Doxycycline capsules IP | Each hard gelatin capsule contains: | IP | 200mg | Antibiotics, Antiviral |
Doxycycline Hydrochloride | q.s. | |||
eq. to Doxycycline | ||||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Doxycycline and Ambroxol capsule | Each hard gelatin capsule contains: | IP | 100mg | Antibiotics & Antiviral |
Doxycycline Hydrochloride | 7.5mg | |||
eq. to Doxycycline | IP | q.s. | ||
Ambroxol Hydrochloride | ||||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Acyclovir & Hydrocortisone Cream | Compositions | IP | 5% w/w | Antibiotics & Antiviral |
Acyclovir | IP | 1 % w/w | ||
Hydrocortisone acetate | q.s. | |||
In a cream base | ||||
Antifungal, Antiseptic | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Povidone Iodine & Metronidazole Ointment | Composition: | IP | 5.0 % w/w | Antifungal, Antiseptic |
Povidone Iodine | IP | 1 % w/w | ||
Metronidazole | q.s. | |||
Ointment base | ||||
Povidone Iodine & Metronidazole Ointment | Composition: | IP | 10.0 % w/w | Antifungal, Antiseptic |
Povidone Iodine | IP | 1 % w/w | ||
Metronidazole | q.s. | |||
Ointment base | ||||
Povidone Iodine, Metronidazole &Dexapanthanol | Composition: | IP | 5.0 % w/w | Antiseptic, Antifungal |
Ointment | Povidone Iodine | IP | 1 % w/w | |
Metronidazole | IP | 5.0 % w/w | ||
Dexapanthanol | q.s. | |||
Ointment base | ||||
Povidone-Iodine & Ornidazole Ointment. | Composition: | IP | 1.0%w/w | Antifungal& Antiseptic |
Ornidazole | IP | 5.0%w/w | ||
Povidone-Iodine (available iodine 0.5% w/w) | ||||
Ointment base | qs | |||
Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Betamethasone Dipropionate & Neomycin Cream | Composition: | IP | 0.025% w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Betamethasone Dipropionate | IP | 0.5% w/w | ||
Neomycin sulphate | qs | |||
Cream Base | ||||
Econazole Betamethasone Dipropionate & Neomycin cream . | Composition: | IP | 0.025% w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Betamethasone Dipropionate | IP | 0.5% w/w | ||
Neomycin sulphate | 1.0%w/w | |||
Econazole | qs | |||
In Cream Base | ||||
Clindamycin Phosphate & Nicotinamide Gel | Composition: | IP | 1.0% w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Clindamycin Phosphate | 4.0%w/w | |||
eq. to Clindamycin | IP | q.s. | ||
Nicotinamide | ||||
Aloe Allantoin Gel Base with ethyl lactate | ||||
Clobetasol Propionate with salicylic Acid Ointment | Composition: | IP | 0.05% w/w | antifungal, corticosteroid, antibacterial & anti-inflammatory |
Clobetasol Propionate | IP | 3.00% | ||
Salicyclic Acid | q.s. | |||
Ointment base | ||||
Betamethasone & Neomycin Cream | Composition: | IP | 0.05 % w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Betamethasone propionate eq. to. Betamethasone | 0.5 % w/w | |||
Neomycin sulphate | IP | |||
Eq. to Neomycin | q.s. | |||
In a cream base | ||||
Beclomethasone Dipropionate with salicyclic Acid Cream | Composition: | IP | 0.025%w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Beclomethasone Dipropionate | IP | 3.00% | ||
Salicylic Acid | q.s. | |||
Cream base | ||||
Clobetasol Propionate with salicyclic Acid Ointment | Composition: | IP | 0.05% w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Clobetasol Propionate | IP | 3.00% | ||
Salicyclic Acid | q.s. | |||
Ointment base | ||||
Mometasone Cream IP | Composition:- | IP | 0.10%w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Mometasone Furoate | ||||
Preservatives: | IP | 0.20%w/w | ||
Methyl Paraben | IP | 0.20%w/w | ||
Propyl Paraben | q.s. | |||
Cream Base | ||||
Neomycin and Polymyxin B Sulfate and Bacitracin Zinc Ointment USP | Composition : | USP | 5000 units | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Each gm Contains : | ||||
Polymyxin B Sulfate | IP | |||
Equ. to Polymyxin | 400units | |||
Bacitracin Zinc | IP | |||
Equ. to Bacitracin | 3400units | |||
Neomycin Sulphate | ||||
Equ. to Neomycin | IP | 0.1%w/w | ||
Preservative: | q.s | |||
Benzyl Alcohol | ||||
Ointment Base | ||||
Mometasone &Fusidic Acid Cream | Composition:- | IP | 0.10%w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Mometasone furoate | IP | 2.00%w/w | ||
Fusidic Acid | q.s. | |||
Cream Base | ||||
Beclomethasone Dipropionate, Phenylephrine Hydrochloride & Lignocaine Hydrochloride Cream | Composition: | IP | 0.020%w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Beclomethasone Dipropionate | IP | 0.10% w/w | ||
Phenylephrine Hydrochloride | IP | 2.50% w/w | ||
Lignocaine Hydrochloride | IP | 0.1% w/w | ||
Chlorocresol | ||||
(as Preservative) | q.s. | |||
Cream base | ||||
Betamethasone Dipropionate Cream IP | Composition | 0.05 % w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory | |
Betamethasone propionate | q.s. | |||
eq. to. Betamethasone | ||||
In a cream base | ||||
Mometasone Furoate Ointment | Composition: | IP | 0.1% w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Mometasone Furoate | q.s. | |||
Excipients | ||||
Fluticasone Propionate Ointment | Composition: | IP | 0.05% w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Fluticasone Propionate | q.s | |||
Ointment Base | ||||
Fluticasone Propionate cream IP | Composition: | IP | 0.05% w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Fluticasone Propionate | q.s | |||
Cream Base | ||||
Mometasone & Salicylic Acid Cream | Composition:- | IP | 0.10%w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory , Analgesic |
Mometasone furoate | IP | 5.00%w/w | ||
Salicylic Acid | q.s. | |||
Cream Base | ||||
Clobetasol Propionate with salicyclic Acid cream | Composition: | IP | 0.05% w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory , Analgesic |
Clobetasol Propionate | IP | 6.0% w/w | ||
Salicyclic Acid | q.s. | |||
Cream base | ||||
Halobetasol Cream | Composition : | USP | 0.05%w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Halobetasol Propionate | q.s | |||
Equivalent to Halobetasol | ||||
Cream Base | ||||
Fluticasone Cream IP | Composition : | IP | 0.05 %w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Fluticasone Propionate | q.s | |||
Cream Base | ||||
Clobetasol Propionate with salicyclic Acid Ointment | Composition: | IP | 0.05% w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Clobetasol Propionate | IP | 6.00% | ||
Salicyclic Acid | q.s. | |||
Ointment base | ||||
Clobetasol Propionate& Miconazole Cream | Composition: | IP | 0.05 % w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Clobetasol Propionate | IP | 2.0 % w/w | ||
Miconazole Nitrate | q.s. | |||
Cream Base | ||||
Clobetasol propionate and Ammonium lactate Gel | Composition: | IP | 0.05%w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Clobetasol propionate | 12.0%w/w | |||
Ammonium lactate | q.s. | |||
Gel Base | ||||
Clobetasol Cream IP | Composition: | IP | 0.05%w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Clobetasol propionate | q.s. | |||
Cream Base | ||||
Clobetasol Propionate, Neomycin sulphate, Miconazole &Chlorhexidine Gluconate, Cream | Composition : | IP | 0.05%w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Clobetasol Propionate | IP | 0.50%w/w | ||
Neomycin sulphate | IP | 2.0%w/w | ||
Miconazole Nitrate | IP | 0.2%w/w | ||
Chlorhexidine Gluconate Solution | q.s | |||
Cream Base | ||||
Halobetasol& Salicylic acid Cream | Composition : | USP | 0.05%w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Halobetasol Propionate Equivalent to Halobetasol | IP | 6.0 % w/w | ||
Salicylic Acid | q.s | |||
Cream Base | ||||
Beclomethasone dipropionate, Econazole & Neomycin cream | Composition : | IP | 0.025 %w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Beclomethasone | ||||
Dipropionate | IP | 1.0 %w/w | ||
Econazole Nitrate | IP | |||
Neomycin Sulphate | 0.5 %w/w | |||
Eq. to Neomycin | q.s. | |||
Cream base | ||||
Halobetasol&Salicylic acid Ointment | Composition : | USP | 0.05%w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Halobetasol Propionate | 6.0 % w/w | |||
Equivalent to Halobetasol | IP | q.s | ||
Salicylic Acid | ||||
Ointment Base | ||||
Clobetasol Propionate and Ammonium lactate Gel | Composition: | IP | 0.05% w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Clobetasol Propionate | ||||
Ammonium Lactate | 12.00% | |||
equ. to Lactic Acid | q.s. | |||
Gel base | ||||
Clobetasol Propionate, Gentamicin, Tolnaftate, Iodochlorhydroxyquinoline & Clotrimazole Cream | Composition: | IP | 0.05 % w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Clobetasol Propionate | IP | |||
Gentamicin Sulphate | 0.1 % w/w | |||
equ. to Gentamicin | IP | 1.0% w/w | ||
Tolnaftate | IP | 1.0% w/w | ||
Iodochlorhydroxyquinoline | IP | 1.0% w/w | ||
Clotrimazole | IP | 0.1%w/w | ||
Chlorocresol | ||||
(as preservative) | q.s. | |||
In a cream base | ||||
Diphenhydramine HCl, Clotrimazole, Lignocaine HCl, Menthol &Aloe Vera cream | Composition: | IP | 2.0%w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Diphenhydramine HCl | IP | 1.0%w/w | ||
Clotrimazole | IP | 0.5%w/w | ||
Lignocaine HCl | IP | 1.0%w/w | ||
Menthol | 0.5%w/w | |||
Aloe Vera | q.s. | |||
Cream Base | ||||
Diclofenac Diethylamine , Oleum Lini,Methyl Salicylate & Menthol gel | Composition: | IP | 1.16% w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Diclofenac Diethylamine | ||||
eq. to Diclofenac sodium | IP | 1.0% w/w | ||
Oleum Lini (containing predominantly alpha linolenic acid) | BP | 3.0% w/w | ||
Methyl Salicylate | ||||
Menthol | IP | 10.0% w/w | ||
IP | 5.0%w/w | |||
Gel Base | q.s. | |||
Chlorhexidine, Metronidazole & Lignocaine Gel | Composition: | IP | 1.0% w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Chlorhexidine Gluconate solution | 1.0 %w/w | |||
equ. to Chlorhexidine | IP | 2.0%w/w | ||
Metronidazole | IP | q.s. | ||
Lignocaine Hydrochloride | ||||
Gel Base | ||||
Clobetasol Propionate& Gentamicin Cream | Composition: | IP | 0.05 % w/w | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Clobetasol Propionate | IP | |||
Gentamicin Sulphate | 0.1 % w/w | |||
Equ. to Gentamicin | IP | 0.1 % w/w | ||
Chlorcresol | q.s. | |||
Cream Base | ||||
Nicotinamide Tablets IP | Each Film Coated Tablet Contains:- | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory | ||
Nicotinamide IP ———— 50 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Betamethasone Tablets IP | Each Uncoated Tablet Contains: – | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory | ||
Betamethasone IP ————– 0.5 mg | ||||
Excipients……………q.s. | ||||
Colour : Approved Colour Used | ||||
Clobetasol Propionate,Salicylic acid,Urea,Lactic acid &Sodium Lactate Ointment | Composition: | Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory | ||
ClobetasolPropionate USP0.05%w/w | ||||
SalicylicAcid IP3.0%w/w | ||||
Urea IP10.0%w/w | ||||
LacticAcid IP3.0%w/w | ||||
SodiumLactatesolution USP | ||||
Equ.toLactic Acid 2.0%w/w | ||||
OintmentBase q.s | ||||
Antiacne & Antifungal | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Isotretinoin Capsule IP. | Each Hard gelatin capsule Contains: | IP | 10 mg | Antiacne |
Isotretinoin | qs | |||
Excipients | ||||
Approved colour used | ||||
Isotretinoin Capsule IP | Each Hard Gelatin Capsule contains: | IP | 10 mg | Antiacne |
Isotretinoin | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Clindamycin Phosphate & Nicotinamide Gel | Composition: | IP | 1.0% w/w | Antiacne |
Clindamycin Phosphate | 4.0%w/w | |||
eq. to Clindamycin | IP | q.s. | ||
Nicotinamide | ||||
Aloe Allantoin Gel Base with ethyl lactate | ||||
Luliconazole Cream | Composition: | IP | 1 % w/w | Antiacne & Antifungal |
Luliconazole | ||||
Preservative: | IP | 1% w/w | ||
Benzyl Alcohol | q.s. | |||
Cream Base | ||||
Ofloxacin, Fluocinolone Acetonide & Clotrimazole Cream IP | Composition : | IP | 0.5 %w/w | Antibaterial, Antifungal |
Ofloxacin | IP | 0.01%w/w | ||
Fluocinolone | IP | 1.0%w/w | ||
Acetonide | 0.12%w/w | |||
Clotrimazole | q.s | |||
Cream Base | ||||
Adapalene and clindamycin Gel | Composition: | BP | 0.1%w/w | Antiacne & Antifungal |
Adapalene | IP | 1.0 %w/w | ||
Clindamycin Phosphate | q.s. | |||
equivalent to Clindamycin | ||||
Gel Base | ||||
Hydroquinone, | Composition: | USP | 2.0% w/w | Antiacne & Antifungal |
Tretinoin & | Hydroquinone | USP | 0.05%w/w | |
Hydrocortisone Acetate Cream | Tretinoin | IP | 1.0% w/w | |
Hydrocortisone Acetate | q.s. | |||
In a Cream Base | ||||
Adapalene and Benzoyl Peroxide Gel | Composition: | BP | 0.1%w/w | Antiacne & Antifungal |
Adapalene | USP | 2.5 %w/w | ||
Benzoyl Peroxide | q.s | |||
Gel Base | ||||
Tretinoin Gel USP | Composition : | USP | 0.05 %w/w | Antiacne & Antifungal |
Tretinoin | q.s | |||
Gel Base | ||||
ClobetasolPropionate,GentamicinSulphate,Miconazole Nitrate &ZincOxide Cream | Composition: | Antiacne & antifungal | ||
ClobetasolPropionate IP 0.05%w/w | ||||
GentamicinSulphate IP0.2%w/w | ||||
Eq.toGentamicin | ||||
MiconazoleNitrate IP2.0%w/w | ||||
ZincOxide IP0.1% w/w | ||||
CreamBase q.s | ||||
Clindamycin Phosphate&TretinointopicalGel | Composition: | Antiacne & antifungal | ||
ClindamycinPhosphate eq.to IP1.0%w/w | ||||
Clindamycin | ||||
Tretinoin USP0.025%w/w | ||||
Gelbase q.s | ||||
Hydroquinone, Tretinoin & Mometasone Furoate Cream | Composition: | USP | 2.0% w/w | Anti Acne & Anti Fungal |
Hydroquinone | USP | 0.025%w/w | ||
Tretinoin | IP | 0.10%w/w | ||
Mometasone Furoate | IP | 0.1% w/w | ||
Chlorocresol (as preservative) | q.s. | |||
In a Cream Base | ||||
Amorolfine Hydrochloride cream | Composition: | IP | 0.25%w/w | Anti Acne & Anti Fungal |
Amorolfine Hydrochloride | IP | 1.0%w/w | ||
Phenoxyethanol | ||||
Cream base | ||||
Clindamycin Phosphate & Isotretinoin topical Gel | Composition: | IP | 1.0% w/w | Anti Acne & Anti Fungal |
Clindamycin Phosphate | 0.05%w/w. | |||
eq. to Clindamycin | IP | q.s. | ||
Isotretinoin | ||||
Gel base | ||||
Tretinoin Cream USP | Composition : | USP | 0.05 %w/w | Anti Acne & Anti Fungal |
Tretinoin | q.s | |||
Cream Base | ||||
Sertaconazole Nitrate Cream | Composition: | IP | 2.00% | Anti Acne & Anti Fungal |
Sertaconazole | q.s. | |||
Cream Base | ||||
Tretinoin Cream USP | Composition : | USP | 0.025 %w/w | Anti Acne & Anti Fungal |
Tretinoin | q.s | |||
Cream Base | ||||
Hydroquinone, Tretinoin & Fluocinolone Acetonide Cream | Composition: | USP | 2.0% w/w | Anti Acne & Anti Fungal |
Hydroquinone | USP | 0.025%w/w | ||
Tretinoin | IP | 0.01%w/w | ||
Fluocinolone Acetonide | q.s. | |||
Cream Base | ||||
Antihypertensive | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Rosuvastatin &Clopidogrel Capsules | Each hard gelatin capsule contains: | IP | 5.0 mg | Antihypertensive |
Rosuvastatin Calcium | ||||
Eq.to Rosuvastatin | ||||
(As pellets) | 75 mg | |||
Clopidogrel Bisulphate | IP | |||
Eq. to Clopidogrel | q.s. | |||
(As pellets) | ||||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Rosuvastatin &Clopidogrel Capsules | Each hard gelatin capsule contains: | IP | 10 mg | Antihypertensive |
Rosuvastatin Calcium | ||||
Eq.to Rosuvastatin | 75 mg | |||
(As pellets) | IP | |||
Clopidogrel Bisulphate | ||||
Eq. to Clopidogrel | q.s. | |||
(As pellets) | ||||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Rosuvastatin &Clopidogrel Capsules | Each hard gelatin capsule contains: | IP | 20 mg | Antihypertensive |
Rosuvastatin Calcium | ||||
Eq.to Rosuvastatin | ||||
(As pellets) | 75 mg | |||
Clopidogrel Bisulphate | IP | |||
Eq. to Clopidogrel | q.s. | |||
(As pellets) | ||||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Atorvastatin Tablets IP 10 mg | Each Film coated Tablets contains: | IP | 10 mg | Antihypertensive |
Atorvastatin Calcium | q.s. | |||
eq. to. Atorvastatin | ||||
Excipients | ||||
Colour: Approved ColourUsed | ||||
Atorvastatin Tablets IP 20 mg | Each Film coated Tablets contains: | 20 mg | Antihypertensive | |
Atorvastatin Calcium | IP | q.s. | ||
eq. to. Atorvastatin | ||||
Excipients | ||||
Colour: Approved ColourUsed | ||||
Atorvastatin Tablets IP 40 mg | Each Film coated Tablets contains: | IP | 40 mg | Antihypertensive |
Atorvastatin Calcium | q.s. | |||
eq. to. Atorvastatin | ||||
Excipients | ||||
Colour: Approved ColourUsed | ||||
Atorvastatin Tablets IP 80 mg | Each Film coated Tablets contains: | IP | 80 mg | Antihypertensive |
Atorvastatin Calcium | q.s. | |||
eq. to. Atorvastatin | ||||
Excipients | ||||
Colour: Approved ColourUsed | ||||
Ramipril and Hydrochlorothiazide Tablets | Each Uncoated Sustained release Tablet Contains:- | IP | 2.5 mg | Antihypertensive |
Ramipril | IP | 12.5mg | ||
Hydrochlorothiazide | q.s | |||
Excipients. | ||||
Colour-Approved colour used. | ||||
Tofacitinib Tablets 5 mg | Each Film coated Tablet Contains:- | 5 mg | Antihypertensive | |
Tofacitinib Citrate | q.s | |||
Eq. to Tofacitinib | ||||
Excipients | ||||
Colour-Approved colour used. | ||||
Telmisartan & Atorvastatin Tablets | Each Film coated Tablets contains: | IP | 40 mg | Antihypertensive |
Telmisartan | IP | |||
Atorvastatin Calcium | 10 mg | |||
eq. to. Atorvastatin | ||||
Excipients | q.s | |||
Colour: Approved Colour Used | ||||
Losartan Potassium and Hydrochlorothiazide Tablets I.P | Each film coated tablet contains: | Antihypertensive | ||
Losartan Potassium IP————50 mg | ||||
Hydrochlorothiazide IP————12.5 mg | ||||
Excipients————————–q.s | ||||
Colour-Approved colour used. | ||||
Aspirin Gastro- resistant Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Aspirin IP —————– 75 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Aspirin Gastro- resistant Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Aspirin IP —————– 150 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Lisinopril and Amlodipine Tablets | Each Uncoated Tablet Contains:- | Antihypertensive | ||
Lisinopril IP | ||||
Eq. to Anhydrous Lisinopril ———- 5 mg | ||||
Amlodipine Besylate IP | ||||
Eq. to Amlodipine ——————–5 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Olmesartan Medoxomil Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Olmesartan Medoxomil IP ———-40 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Olmesartan Medoxomil Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Olmesartan Medoxomil IP ———- 20 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Amlodipine, Telmisartan and Hydrochlorothiazide Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Amlodipine Besylate IP | ||||
Eq. to Amlodipine ———- 5.0 mg | ||||
Telmisartan IP ————–40 mg | ||||
Hydrochlorothiazide IP —— 12.5 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Amlodipine, and Indapamide Tablets | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Amlodipine Besylate IP | ||||
Eq. to Amlodipine ———- 10.0 mg | ||||
Indapamide (SR) IP —— 1.5 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Telmisartan and Amlodipine Tablets | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Telmisartan IP ————–40 mg | ||||
Amlodipine Besylate IP | ||||
Eq. to Amlodipine ———- 5 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Metoprolol Succinate Extended Release Tablets IP | Each Extended Release Film Coated Tablet Contains:- | Antihypertensive | ||
Metoprolol Succinate IP 23.75 mg | ||||
Eq. to Metoprolol Tartrate ———25 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Metoprolol Succinate Extended Release Tablets IP | Each Extended Release Film Coated Tablet Contains:- | Antihypertensive | ||
Metoprolol Succinate IP 47.50 mg | ||||
Eq. to Metoprolol Tartrate ———50 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Metoprolol Succinate Extended Release Tablets IP | Each Extended Release Film Coated Tablet Contains:- | Antihypertensive | ||
Metoprolol Succinate IP 11.875 mg | ||||
Eq. to Metoprolol Tartrate ——-12.50 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Rosuvastatin Calcium Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Rosuvastatin Calcium IP | ||||
Eq. to Rosuvastatin ———20 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Rosuvastatin Calcium Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Rosuvastatin Calcium IP | ||||
Eq. to Rosuvastatin ———10 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Rosuvastatin Calcium Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Rosuvastatin Calcium IP | ||||
Eq. to Rosuvastatin ———5 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Atenolol Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Atenolol IP ———– 50 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Atenolol Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Atenolol IP ———– 100 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Telmisartan and Hydrochlorothiazide Tablets IP | Each Uncoated Tablet Contains:- | Antihypertensive | ||
Telmisartan IP ————–40 mg | ||||
Hydrochlorothiazide IP —— 12.5 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Telmisartan Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Telmisartan IP ————– 20 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Telmisartan Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Telmisartan IP ————– 80 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Telmisartan Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Telmisartan IP ————– 40 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Telmisartan and Amlodipine Tablets | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Telmisartan IP ————–80 mg | ||||
Amlodipine Besylate IP | ||||
Eq. to Amlodipine ———- 5 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Amlodipine, Telmisartan and Hydrochlorothiazide Tablets | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Amlodipine Besylate IP | ||||
Eq. to Amlodipine ———-2.5 mg | ||||
Telmisartan IP ————–20 mg | ||||
Hydrochlorothiazide IP —— 6.25 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Valsartan Tablet IP | Each Film coated tablet contains: | Antihypertensive | ||
Valsartan IP———- 80.0 mg | ||||
Excipients ———-q.s. | ||||
Colour-Approved colour used. | ||||
Valsartan Tablet IP | Each Film coated tablet contains: | Antihypertensive | ||
Valsartan IP———- 160.0 mg | ||||
Excipients ———-q.s. | ||||
Colour-Approved colour used. | ||||
Valsartan & Hydrochlorothiazide Tablet IP | Each Film coated tablet contains: | Antihypertensive | ||
Valsartan IP——————–80.0 mg | ||||
Hydrochlorothiazide IP———12.5 mg | ||||
Excipients ———-q.s. | ||||
Colour-Approved colour used. | ||||
Valsartan & Amlodipine tablet | Each Film coated tablet contains: | Antihypertensive | ||
Valsartan IP ———————80.0 mg | ||||
Amlodipine (As besylate) IP ——– 5.0 mg | ||||
Excipients ———-q.s. | ||||
Colour-Approved colour used. | ||||
Valsartan, Amlodipine Hydrochlorothiazide tablet | Each Film coated tablet contains: | Antihypertensive | ||
Valsartan IP ——————— 160.0 mg | ||||
Amlodipine (As besylate) IP——– 5.0 mg | ||||
Hydrochlorothiazide IP———– 12.5 mg | ||||
Excipients ———-q.s. | ||||
Colour-Approved colour used. | ||||
Losartan Potassium & Hydrochlorothiazide Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Losartan Potassium IP ————— 25 mg | ||||
Hydrochlorothiazide IP —————-12.5 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Losartan Potassium Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Losartan Potassium IP ————— 50 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Losartan Potassium Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Losartan Potassium IP ————— 25 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Carvedilol Tablet IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Carvedilol IP————- 3.125 mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Carvedilol Tablet IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Carvedilol IP————- 6.25 mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Carvedilol Tablet IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Carvedilol IP————- 12.5 mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used | ||||
Telmisartan & Metoprolol Succinate tablets IP | Each uncoated Bilayer tablet contains: | Antihypertensive | ||
Metoprolol Succinate 47.5 mg | ||||
Eq. to Metoprolol Tartrate (SR)———50 mg | ||||
Telmisartan IP ——————40.0 mg | ||||
Excipients ——————-q.s. | ||||
Colour-Approved colour used. | ||||
Telmisartan & Metoprolol Succinate tablets IP | Each uncoated Bilayer tablet contains: | Antihypertensive | ||
Metoprolol Succinate 23.75 mg | ||||
Eq. to Metoprolol Tartrate (SR)———25 mg | ||||
Telmisartan IP ——————40.0 mg | ||||
Excipients ——————-q.s. | ||||
Colour-Approved colour used. | ||||
Telmisartan & Chlorthalidone Tablets | Each Uncoated Tablet contains: | Antihypertensive | ||
Telmisartan IP ————– 40 mg | ||||
Chlorthalidone IP————— 12.5 mg | ||||
Excipients ————— q.s. | ||||
Colour-Approved colour used. | ||||
Methyldopa Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Methyldopa IP —————500 mg | ||||
Excipients—————– q.s | ||||
Atorvastatin &Fenofibrate Tablets | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Atorvastatin Calcium IP | ||||
Eq. to Atorvastatin ———— 10 mg | ||||
Fenofibrate IP ————- 160 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Amlodipine Tablets IP | Each Uncoated Tablet Contains:- | Antihypertensive | ||
Amlodipine Besylate …………….IP | ||||
Eq. to Amlodipine ………………….10mg | ||||
Excipients ……………………………….q.s | ||||
Colour-Approved colour used. | ||||
Atenolol Tablets IP | Each Film coated Tablet contains: | IP | 50 mg | Antihypertensive |
Atenolol | q. s. | |||
Excipients | ||||
Atenolol Tablets IP | Each Film coated Tablet contains: | IP | 100 mg | Antihypertensive |
Atenolol | q. s. | |||
Excipients | ||||
Aspirin & Rosuvastatin Capsules. | Each Hard Gelatin capsule contains: | IP | 150mg | Antihypertensive |
Aspirin | ||||
(As Enteric coated pellets ) | IP | 10mg | ||
Rosuvastatin Calcium | ||||
Eq. to Rosuvastatin | q.s. | |||
(pellets) | ||||
Excipients | ||||
Approved colour used | ||||
Atorvastatin Calcium & Aspirin Capsules | Each Hard Gelatin Capsule contains: | IP | 10 mg | Antihypertensive |
Atorvastatin Calcium | ||||
eq. to Atorvastatin (As pellets) | ||||
Aspirin (As Enteric coated pellets) | IP | 150 mg | ||
Excipients | q.s | |||
Approved colour used | ||||
Rosuvastatin Calcium & Aspirin Capsules | Each Hard Gelatin Capsule contains: | IP | 10 mg | Antihypertensive |
Rosuvastatin Calcium | ||||
eq. to Rosuvastatin (As pellets) | IP | 75 mg | ||
Aspirin (As Enteric coated pellets) | q.s | |||
Excipients | ||||
Approved colour used | ||||
Rosuvastatin Calcium & Aspirin Capsules | Each Hard Gelatin Capsule contains: | IP | 20 mg | Antihypertensive |
Rosuvastatin Calcium | ||||
eq. to Rosuvastatin (As pellets) | IP | 75 mg | ||
Aspirin (As Enteric coated pellets) | q.s | |||
Excipients | ||||
Approved colour used | ||||
Aspirin & Clopidogrel Capsule. | Each hard gelatin capsule contain: | IP | 75mg | Antihypertensive |
Aspirin | ||||
( As enteric coated Pellets ) | IP | |||
Clopidogrel Bisulphate) | 75mg | |||
eq. to Clopidogrel | ||||
Excipients | qs | |||
Approved colour used | ||||
Aspirin & Clopidogrel capsule | Each hard gelatin capsule contain: | IP | 75mg | Antihypertensive |
Aspirin | ||||
( As enteric coated Pellets ) | IP | |||
Clopidogrel Bisulphate) | 150mg | |||
eq. to Clopidogrel | ||||
(As pellets) | qs | |||
Excipients | ||||
Approved colour used | ||||
Escitalopram Oxalate Tablets IP 10 mg | Each film coated Tablet Contains:- | IP | 10 mg | Antihypertensive |
Escitalopram Oxalate | q.s. | |||
Eq. to Escitalopram | ||||
Excipients | ||||
Colour- Approved colour used. | ||||
Escitalopram Oxalate Tablets IP 20 mg | Each film coated Tablet Contains:- | IP | 20 mg | Antihypertensive |
Escitalopram Oxalate | q.s. | |||
Eq. to Escitalopram | ||||
Excipients | ||||
Colour- Approved colour used. | ||||
Telmisartan and Hydrochlorothiazide Tablets I.P. | Each Uncoated Bilayered Tablet Contains:- | I.P. | 40 mg | Antihypertensive |
Telmisartan | I.P. | 12.5 mg | ||
Hydrochlorothiazide | q.s | |||
Excipients | ||||
Colour-Approved colour used | ||||
Telmisartan and Amlodipine Tablets I.P. | Each Uncoated Tablet Contains:- | I.P. | 40 mg | Antihypertensive |
Telmisartan | I.P. | |||
Amlodipine Besylate | 5 mg | |||
Eq. to Amlodipine | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Telmisartan and Hydrochlorothiazide Tablets IP | Each Uncoated Tablet Contains:- | Antihypertensive | ||
Telmisartan IP ————– 80 mg | ||||
Hydrochlorothiazide IP —— 12.5 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Atenolol Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Atenolol IP ———– 25 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Bisoprolol Fumarate tablet | Each Film Coated Tablet Contain: | Antihypertensive | ||
Bisoprolol Fumarate ———– 5.0 mg | ||||
Excipients—————– q.s | ||||
Colour: – Approved colour used | ||||
Bisoprolol Fumarate tablet | Each Film Coated Tablet Contain: | Antihypertensive | ||
Bisoprolol Fumarate ———– 10.0 mg | ||||
Excipients—————– q.s | ||||
Colour: – Approved colour used | ||||
Metoprolol Extended Release Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Metoprolol Succinate IP | ||||
Eq. to Metoprolol Tartrate ——–100 mg | ||||
Excipients—————– q.s | ||||
Colour: – Approved colour used | ||||
Metoprolol ER&Amlopdipine Tablets IP | Each Film Coated Tablet Contains:-: | Antihypertensive | ||
Metoprolol Succinate IP ———47.5 mg | ||||
Eq. to Metoprolol Tartrate ———50.0 mg | ||||
Amlopdipine Besylate IP | ||||
Eq. to Amlopdipine ——————5.0 mg | ||||
Excipients ——————-q.s. | ||||
Colour-Approved colour used. | ||||
Metoprolol ER& Amlodipine Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Metoprolol Succinate IP ———23.75 mg | ||||
Eq. to Metoprolol Tartrate ———25.0 mg | ||||
Amlopdipine Besylate IP | ||||
Eq. to Amlopdipine ——————5.0 mg | ||||
Excipients ——————-q.s. | ||||
Colour-Approved colour used. | ||||
Telmisartan & Atorvastatin Tablets | Each Film coated Tablets contains: | IP | 20 mg | Antihypertensive |
Telmisartan | IP | |||
Atorvastatin Calcium | 10 mg | |||
eq. to. Atorvastatin | q.s | |||
Excipients | ||||
Colour: Approved Colour Used | ||||
Telmisartan & Atorvastatin Tablets | Each Film coated Tablets contains: | IP | 40 mg | Antihypertensive |
Telmisartan | IP | |||
Atorvastatin Calcium | 5 mg | |||
eq. to. Atorvastatin | q.s | |||
Excipients | ||||
Colour: Approved Colour Used | ||||
Torsemide & Spironolactone Tablets | Each Uncoated Tablet Contains:- | IP | 20 mg | Antihypertensive |
Torsemide | IP | 50 mg | ||
Spironolactone | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Olmesartan Medoxomil, Hydrochlorothiazide & Amlodipine Tablets | Each Film Coated Tablet Contains:- | IP | 2.5 mg | Antihypertensive |
Amlodipine Besylate | 5 mg | |||
Eq. to Amlodipine | IP | 12.5 mg | ||
Olmesartan Medoxomil | IP | q.s | ||
Hydrochlorothiazide | ||||
Excipients | ||||
Colour-Approved colour used. | ||||
Atenolol Tablets IP 25 mg | Each Uncoated Tablet Contains:- | IP | 25 mg | Antihypertensive |
Atenolol | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Atenolol Tablets IP 50 mg | Each Uncoated Tablet Contains:- | IP | 50 mg | Antihypertensive |
Atenolol | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Atenolol Tablets IP 100 mg | Each Uncoated Tablet Contains:- | IP | 100 mg | Antihypertensive |
Atenolol | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Olmesartan Medoxomil, Hydrochlorothiazide & Amlodipine Tablets | Each Film Coated Tablet Contains:- | IP | 10 mg | Antihypertensive |
Amlodipine Besylate | 40 mg | |||
Eq. to Amlodipine | IP | 25 mg | ||
Olmesartan Medoxomil | IP | q.s | ||
Hydrochlorothiazide | ||||
Excipients | ||||
Colour-Approved colour used. | ||||
Olmesartan Medoxomil, Hydrochlorothiazide & Amlodipine Tablets | Each Film Coated Tablet Contains:- | IP | 5 mg | Antihypertensive |
Amlodipine Besylate | 40 mg | |||
Eq. to Amlodipine | IP | 12.5 mg | ||
Olmesartan Medoxomil | IP | q.s | ||
Hydrochlorothiazide | ||||
Excipients | ||||
Colour-Approved colour used. | ||||
Olmesartan Medoxomil, Hydrochlorothiazide & Amlodipine Tablets | Each Film Coated Tablet Contains:- | IP | 5 mg | Antihypertensive |
Amlodipine Besylate | 20 mg | |||
Eq. to Amlodipine | IP | 12.5 mg | ||
Olmesartan Medoxomil | IP | q.s | ||
Hydrochlorothiazide | ||||
Excipients | ||||
Colour-Approved colour used. | ||||
Olmesartan Medoxomil, Hydrochlorothiazide & Amlodipine Tablets | Each Film Coated Tablet Contains:- | IP | 5 mg | Antihypertensive |
Amlodipine Besylate | 5 mg | |||
Eq. to Amlodipine | IP | 12.5 mg | ||
Olmesartan Medoxomil | IP | q.s | ||
Hydrochlorothiazide | ||||
Excipients | ||||
Colour-Approved colour used. | ||||
Azelnidipine Tablets IP 8 mg | Each Uncoated Tablet Contains:- | IP | 8 mg | Antihypertensive |
Azelnidipine | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Azelnidipine Tablets IP 16 mg | Each Uncoated Tablet Contains:- | IP | 16 mg | Antihypertensive |
Azelnidipine | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Bosentan Tablets IP 62.5mg | Each Film Coated Tablet Contains:- | IP | 62.5 mg | Antihypertensive |
Bosentan Monohydrate | q.s | |||
Eq. to Bosentan | ||||
Excipients | ||||
Colour-Approved colour used. | ||||
Bosentan Tablets IP 125mg | Each Film Coated Tablet Contains:- | IP | 125 mg | Antihypertensive |
Bosentan Monohydrate | q.s | |||
Eq. to Bosentan | ||||
Excipients | ||||
Colour-Approved colour used. | ||||
Minoxidil Topical solution USP | Composition | IP | 5.0%w/v | Antihypertensive |
Minoxidil | IP | q.s. | ||
Iso propyl alcohol | ||||
Minoxidil Topical lotion USP 2% | Composition: | IP | 2.0%w/v | Antihypertensive |
Minoxidil | qs | |||
In Adhesive base | ||||
Lisinopril Tablets IP 5 mg | Each Uncoated Tablet Contains:- | IP | 5 mg | Antihypertensive |
Lisinopril | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Lisinopril Tablets IP 2.5 mg | Each Uncoated Tablet Contains:- | IP | 2.5 mg | Antihypertensive |
Lisinopril | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Losartan Potassium & Hydrochlorothiazide Tablets IP | Each Film Coated Tablet Contains:- | IP | 25 mg | Antihypertensive |
Losartan Potassium | IP | 5 mg | ||
Hydrochlorothiazide | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Fenofibrate and Rosuvastatin Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Fenofibrate IP ————- 160 mg | ||||
Rosuvastatin Calcium IP | ||||
Eq. to Rosuvastatin ———10 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Olmesartan & Ramipril Tablets. | Each uncoated tablet contains: | Antihypertensive | ||
Olmesartan IP ————- 20.0 mg | ||||
Ramipril IP ————–5.0 mg | ||||
Excipients —————– q.s | ||||
Colour: – Approved colour used | ||||
Telmisartan and Amlodipine Tablets I.P. | Each Uncoated Bilayered Tablet Contains:- | I.P. | 40 mg | Antihypertesnive |
Telmisartan | I.P. | 5 mg | ||
Amlodipine Besylate | ||||
Eq. to Amlodipine | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Atorvastatin Calcium & Clopidogrel Capsules | Each Hard Gelatin Capsule contains: | IP | 10 mg | Antihypertensive |
Atorvastatin Calcium | 75 mg | |||
eq. to Atorvastatin (As pellets) | IP | q.s | ||
Clopidogrel (as Bisulphate) (As pellets) | ||||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Atorvastatin Calcium & Clopidogrel Capsules | Each Hard Gelatin Capsule contains: | IP | 20 mg | Antihypertensive |
Atorvastatin Calcium | ||||
eq. to Atorvastatin | 75 mg | |||
(As pellets) | IP | |||
Clopidogrel (as Bisulphate) | q.s. | |||
(As pellets) | ||||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Propranolol Sustained Release Capsules IP | Each hard gelatin capsule contains: | IP | 40.0 mg | Antihypertensive |
Propranolol Hydrochloriode | ||||
( As sustained Release pellets) | q.s. | |||
Excipients | ||||
Approved Colors Used. in Empty Shell & Pellet | ||||
Propranolol Sustained Release Capsules IP | Each hard gelatin capsule contains: | IP | 60.0 mg | Antihypertensive |
Propranolol Hydrochloriode | ||||
( As sustained Release pellets) | q.s. | |||
Excipients | ||||
Approved Colors Used. in Empty Shell & Pellet | ||||
Propranolol Sustained Release Capsules IP | Each hard gelatin capsule contains: | IP | 80 | Antihypertensive |
Propranolol Hydrochloriode | ||||
( As sustained Release pellets) | q.s. | |||
Excipients | ||||
Approved Colors Used. in Empty Shell & Pellet | ||||
Prasugrel & Aspirin Capsules | Each Hard Gelatin Capsule contains: | USP | 10 mg | Antihypertensive |
Prasugrel Hydrochlorode | ||||
Equ. to Prasugrel | 75 mg | |||
(As pellets) | IP | q.s. | ||
Aspirin | ||||
(As enteric coated Pellets) | ||||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Prazosin Tablets IP 5 mg | Each Film Coated Tablet Contains:- | IP | 5 mg | Antihypertensive |
Prazosin Hydrochloride | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Chlorthalidone Tablets 6.25 mg | Each Uncoated Tablet contains: | IP | 6.25 mg | Antihypertensive |
Chlorthalidone | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Ramipril and Hydrochlorothiazide Tablets | Each Uncoated Sustained release Tablet Contains:- | IP | 5 mg | Antihypertensive |
Ramipril | IP | 12.5 mg | ||
Hydrochlorothiazide | q.s | |||
Excipients. | ||||
Colour-Approved colour used. | ||||
Enalapril Maleate Tablets IP. | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Enalapril Maleate IP.————–2.5mg | ||||
Excipients———————–q.s. | ||||
Colour-Approved colour used. | ||||
Enalapril Maleate Tablets I.P. | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Enalapril Maleate I.P ————5- mg | ||||
Excipients———————–q.s. | ||||
Colour-Approved colour used. | ||||
Enalapril Maleate Tablets IP. | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Enalapril Maleate IP———-10mg | ||||
Excipients———————q.s. | ||||
Colour-Approved colour used. | ||||
Enalapril Maleate Tablets I.P. | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Enalapril Maleate I.P———-20mg | ||||
Excipients———————-q.s. | ||||
Colour-Approved colour used. | ||||
Hydrochlorothiazide Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Hydrochlorothiazide IP———25 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Hydrochlorothiazide Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Hydrochlorothiazide IP———50 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Lisinopril Tablets I.P. | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Lisinopril IP——— 10 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Spironolactone Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Spironolactone IP——— 50 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Spironolactone Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Spironolactone IP——— 20 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Spironolactone Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Spironolactone IP——— 100 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Aspirin Tablet IP | Each Uncoated Tablet Contains:- | Antihypertensive | ||
Aspirin IP——— 75 mg | ||||
Excipients—————–q.s | ||||
Colour-Approved colour used. | ||||
Aspirin Tablet IP | Each Uncoated Tablet Contains:- | Antihypertensive | ||
Aspirin IP——— 150 mg | ||||
Excipients—————–q.s | ||||
Colour-Approved colour used. | ||||
Amlodipine Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Amlodipine Besylate IP | ||||
Eq. to Amlodipine ——— 5 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Amlodipine Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Amlodipine Besylate IP | ||||
Eq. to Amlodipine ——— 10 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Fenofibrate and Rosuvastatin Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Fenofibrate IP ————- 145 mg | ||||
Rosuvastatin Calcium IP | ||||
Eq. to Rosuvastatin ———5 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Methyldopa Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensives | ||
Methyldopa IP | ||||
(As Anhydrous) —————125 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Methyldopa Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensives | ||
Methyldopa IP | ||||
(As Anhydrous) —————250 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Torsemide Tablets IP | Each Uncoated Tablet Contains:- | Antihypertensive | ||
Torsemide IP ————– 5 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Torsemide Tablets IP | Each Uncoated Tablet Contains:- | Antihypertensive | ||
Torsemide IP ————– 10 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Torsemide Tablets IP | Each Uncoated Tablet Contains:- | Antihypertensive | ||
Torsemide IP ————– 20 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Torsemide Tablets IP | Each Uncoated Tablet Contains:- | Antihypertensive | ||
Torsemide IP ————– 100 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Propranolol Tablet IP | Each uncoated tablet contains: | Antihypertensive | ||
Propranolol HCl IP————–10.0 mg | ||||
Excipients —————-q.s. | ||||
Colour-Approved colour used. | ||||
Propranolol Tablet IP | Each uncoated tablet contains: | Antihypertensive | ||
Propranolol HCl IP————–40.0 mg | ||||
Excipients —————-q.s. | ||||
Colour-Approved colour used | ||||
Atorvastatin & Ezetimibe Tablet | Each Film Coated Tablet contain | Antihypertensive | ||
Atorvastatin IP————40.0 mg | ||||
Ezetimibe ——————–10.0 mg | ||||
Excipients —————-q.s. | ||||
Colour-Approved colour used | ||||
Atorvastatin & Ezetimibe Tablet | Each Film Coated Tablet contain | Antihypertensive | ||
Atorvastatin IP————10.0 mg | ||||
Ezetimibe ——————–10.0 mg | ||||
Excipients —————-q.s. | ||||
Colour-Approved colour used | ||||
Fenofibrate and Rosuvastatin Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Fenofibrate IP ————- 145 mg | ||||
Rosuvastatin Calcium IP | ||||
Eq. to Rosuvastatin ———20.0 mg | ||||
Excipients—————– q.s | ||||
Colour-approved colour used. | ||||
Olmesartan & Ramipril Tablets. | Each uncoated tablet contains: | Antihypertensive | ||
Olmesartan IP ————- 40.0 mg | ||||
Ramipril IP ————–5.0 mg | ||||
Excipients —————– q.s | ||||
Colour: – Approved colour used. | ||||
Spironolactone and Furosemide Tablets | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Spironolactone IP——— 25.0 mg | ||||
Furosemide IP ————40.0 mg | ||||
Excipients—————– q.s | ||||
Colour :- Approved colour used | ||||
Cilnidipine tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Clinidipine IP ————— 10 mg | ||||
Excipients—————– q.s | ||||
Colour: Approved colour used | ||||
Amitriptyline Hydrochloride Tablets | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Amitriptyline Hydrochloride IP ——— 10 mg | ||||
Excipients—————– q.s | ||||
Colour: Approved colour used | ||||
Amitriptyline Hydrochloride Tablets | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Amitriptyline Hydrochloride IP ——— 25 mg | ||||
Excipients—————– q.s | ||||
Colour: Approved colour use | ||||
Amitriptyline Hydrochloride Tablets | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Amitriptyline Hydrochloride IP ——— 50 mg | ||||
Excipients—————– q.s | ||||
Colour: Approved colour used | ||||
Escitalopram Oxalate Tablets IP | Each coated Tablet Contains:- | Antihypertensive | ||
Escitalopram Oxalate I.P. | ||||
Eq. to Escitalopram —————— 5 mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Ramipril & Metoprolol Succinate Tablets | Each Bilayered tablet contains: | Antihypertensive | ||
Ramipril IP ———————— 2.5 mg | ||||
Metoprolol Succinate IP ———–23.75 mg | ||||
Eq. to Metoprolol Tartrate ———-25 mg | ||||
(Extended Release) | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Cilnidipine & Telmisartan Tablets | Each Film Coated Tablet contains: | Antihypertensive | ||
Cilnidipine IP ————— 10.0 mg | ||||
Telmisartan IP ————– 40 mg | ||||
Excipients ——————- q.s. | ||||
Colour-Approved colour used. | ||||
Ramipril & Metoprolol Succinate Tablets | Each Bilayered tablet contains: | Antihypertensive | ||
Ramipril IP ———————— 5.0 mg | ||||
Metoprolol Succinate IP ———– 47.5 mg | ||||
Eq. to Metoprolol Tartrate ———-50 mg | ||||
(Extended Release) | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Metoprolol Succinate (ER) & Cilnidipine Tablets | Each Film Coated Tablet contains: | Antihypertensive | ||
Metoprolol Succinate USP | ||||
Eq. to Metoprolol Tartrate ——— 50 mg | ||||
Cilnidipine IH ————— 10.0 mg | ||||
Excipients ————— q.s. | ||||
Approved Colour Used. | ||||
Colour-Approved colour used. | ||||
Metoprolol Succinate (ER) & Cilnidipine Tablets | Each Film Coated Tablet contains: | Antihypertensive | ||
Metoprolol Succinate USP | ||||
Eq. to Metoprolol Tartrate ——— 25 mg | ||||
Cilnidipine IH ————— 10.0 mg | ||||
Excipients ————— q.s. | ||||
Colour-Approved colour used. | ||||
Azilsartan Medoximil Tablets | Each Uncoated Tablet Contains:- | Antihypertensive | ||
Azilsartan Medoximil —————– 40 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Azilsartan Medoximil Tablets | Each Uncoated Tablet Contains:- | Antihypertensive | ||
Azilsartan Medoximil —————– 80 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Clopidogrel Bisulphate and Aspirin Tablets | Each Film Coated Tablets Contains :- | Antihypertensive | ||
Clopidogrel Bisulphate | ||||
Eq. to Clopidogrel —————— 75 mg | ||||
Aspirin IP —————— 75 mg | ||||
(As Enteric coated Granules) | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Clopidogrel Bisulphate and Aspirin Tablets | Each Film Coated Tablets Contains :- | Antihypertensive | ||
Clopidogrel Bisulphate | ||||
Eq. to Clopidogrel —————— 75 mg | ||||
Aspirin IP —————— 150 mg | ||||
(As Enteric coated Granules) | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Amlodipine, Telmisartan and Hydrochlorothiazide Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Amlodipine Besylate IP | ||||
Eq. to Amlodipine ———- 10.0 mg | ||||
Telmisartan IP ————– 80 mg | ||||
Hydrochlorothiazide IP —— 25 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Amlodipine, Telmisartan and Hydrochlorothiazide Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Amlodipine Besylate IP | ||||
Eq. to Amlodipine ———- 2.5 mg | ||||
Telmisartan IP ————– 20 mg | ||||
Hydrochlorothiazide IP —— 12.5 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Rosuvastatin & Fenofibrate Tablets IP | Each Film Coated Tablet Contains:- | Antihypertensive | ||
Rosuvastatin Calcium IP | ||||
Eq. to Rosuvastatin ———5.0 mg | ||||
Fenofibrate IP ————- 67 mg | ||||
Excipients—————– q.s | ||||
Colour-approved colour used. | ||||
Atorvastatin Calcium & Aspirin Capsules | Each Hard Gelatin Capsule contains: | IP | 10 mg | Antihypertensive |
Atorvastatin Calcium | ||||
eq. to Atorvastatin (As pellets) | 75 mg | |||
Aspirin (As Enteric coated pellets) | IP | q.s | ||
Excipients | ||||
Approved colour used | ||||
Amlodipine & Atenolol Tablets IP | Each Uncoated Tablet Contains:- | Antihypertesnive | ||
Amlodipine Besylate IP | ||||
Eq. to Amlodipine ——— 5 mg | ||||
Atenolol IP —————- 50 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Nifedipine Sustained-Release Tablets I.P. | Each Film Coated Sustained-Release Tablets:- | Antihypertesive | ||
Nifedipine I.P————–10mg | ||||
Excipients——————-q.s. | ||||
Colour-Approved colour used. | ||||
Nifedipine Sustained-Release Tablets I.P. | Each Film Coated Sustained-Release Tablets:- | Antihypertesive | ||
Nifedipine I.P—————20mg | ||||
Excipients———————q.s. | ||||
Colour-Approved colour used. | ||||
Nicorandil Tablets I.P. | Each Uncoated Tablet Contains:- | Antihypertesive | ||
Nicorandil I.P.——– 5 mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Nicorandil Tablets I.P. | Each Uncoated Tablet Contains:- | Antihypertesive | ||
Nicorandil I.P.————– 10 mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Nicorandil Tablets I.P. | Each Uncoated Tablet Contains:- | Antihypertesive | ||
Nicorandil I.P.……………….. 20 mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Midodrine Hydrochloride Tablets USP 2.5 mg | Each Uncoated Tablet Contains:- | USP | 2.5 mg | Antihypotensive |
Midodrine Hydrochloride | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Anti acne & Anti fungal | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Clindamycin Hydrochloride Capsule IP | Each hard gelatin capsule contain: | IP | 300 mg | Anti acne & Anti fungal |
Clindamycin Hydrochloride | q.s. | |||
Equivalent to Clindamycin | ||||
Excipients | ||||
Approved colour used in empty hard gelatin capsule | ||||
Terbinafine Tablets I.P. | Each Uncoated Tablet Contains:- | Anti Acne & Anti Fungal | ||
Terbinafine Hydrochloride I.P. | ||||
Eq.to Terbinafine 250mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Analgesic & anti Inflammatory | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Diclofenac &thiocolchicoside Capsule | Each Hard Gelatin Capsule contain: | IP | 100 mg | Analgesic & anti Inflammatory |
Diclofenac Sodium (EC) | IP | 8 mg | ||
Thiocolchicoside | q.s. | |||
Excipients | ||||
Colour-Approved colour used in capsule shells. | ||||
Antihypertensive, Antithrombotic | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Rosuvastatin and Aspirin Capsules | Each Hard Gelatin Capsule contain: | IP | 5.0 mg | Antihypertensive, Antithrombotic |
Rosuvastatin calcium | ||||
Equivalent to Rosuvastatin | 75 mg | |||
(As pellets) | IP | |||
Aspirin | q.s. | |||
(As enteric coated pellets) | ||||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Rosuvastatin and Aspirin Capsules | Each Hard Gelatin Capsule contain: | IP | 10 mg | Antihypertensive, Antithrombotic |
Rosuvastatin calcium | ||||
Equivalent to Rosuvastatin | ||||
(As pellets) | IP | 150 mg | ||
Aspirin(As enteric coated pellets) | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Atorvastatin, Aspirin & Clopidogrel Capsules | Each Hard Gelatin Capsule contains: | IP | 10 mg | Antihypertensive, Antithrombotic |
Atorvastatin Calcium | 75 mg | |||
eq. to Atorvastatin (As pellets) | IP | |||
Aspirin | ||||
( As enteric coated Pellets ) | IP | 75 mg | ||
Clopidogrel Bisulphate) | q.s. | |||
equ. to Clopidogrel | ||||
(As pellets) | ||||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Atorvastatin, Aspirin & Clopidogrel Capsules | Each Hard Gelatin Capsule contains: | IP | 20 mg | Antihypertensive, Antithrombotic |
Atorvastatin Calcium | 75 mg | |||
eq. to Atorvastatin (As pellets) | IP | |||
Aspirin | ||||
( As enteric coated Pellets ) | IP | 75 mg | ||
Clopidogrel Bisulphate) | ||||
equ. to Clopidogrel | q.s. | |||
(As pellets) | ||||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Rosuvastatin, Clopidogrel & Aspirin Capsules | Each Hard Gelatin Capsule contains: | IP | 10 mg | Antihypertensive, Antithrombotic |
Rosuvastatin Calcium | ||||
eq. to Rosuvastatin | 75 mg | |||
(As pellets) | IP | |||
Aspirin | ||||
( As enteric coated Pellets ) | IP | 75 mg | ||
Clopidogrel Bisulphate) | q.s. | |||
equ. to Clopidogrel | ||||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Rosuvastatin and Aspi rin Capsules | Each Hard Gelatin Capsule contain: | IP | 10 mg | Antihypertensive, Antithrombotic |
Rosuvastatin calcium | ||||
Equivalent to Rosuvastatin | ||||
(As pellets) | IP | 75 mg | ||
Aspirin (As enteric coated pellets) | ||||
Excipients | q.s. | |||
Approved colour used in empty hard gelatin capsule shell | ||||
Clopidogrel Bisulphate Tablet IP | Each Film coated tablet contains: | Antihypertensive, antithrombotic | ||
Clopidogrel Bisulphate IP | ||||
eq. to. Clopidogrel ——– 75.0 mg | ||||
Excipients ———-q.s. | ||||
Colour-Approved colour used. | ||||
Clopidogrel Bisulphate Tablet IP | Each Film coated tablet contains: | Antihypertensive, antithrombotic | ||
Clopidogrel Bisulphate IP | ||||
eq. to. Clopidogrel ——– 150.0 mg | ||||
Excipients ———-q.s. | ||||
Colour-Approved colour used. | ||||
Ramipril Tablet IP | Each uncoated tablet contains: | Antihypertensive, antithrombotic | ||
Ramipril IP ————-5.0 mg | ||||
Excipients —————-q.s. | ||||
Colour-Approved colour used | ||||
Ramipril Tablet IP | Each uncoated tablet contains: | Antihypertensive, antithrombotic | ||
Ramipril IP ————-10.0 mg | ||||
Excipients —————-q.s. | ||||
Colour-Approved colour used | ||||
Ramipril Tablet IP 1.25 mg | Each uncoated | Antihypertensive, Antithrombotic | ||
tablet contains: | ||||
Ramipril IP ————-1.25 mg | ||||
Excipients —————-q.s. | ||||
Colour-Approved colour used | ||||
Ramipril Tablet IP 2.5 mg | Each uncoated | Antihypertensive, Antithrombotic | ||
tablet contains: | ||||
Ramipril IP ————-2.5 mg | ||||
Excipients —————-q.s. | ||||
Colour-Approved colour used. | ||||
Analgesic | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Diclofenac Gel IP | Composition: | IP | 1.16%w/w | Analgesic |
Diclofenac Dimethylamine | 1.0 %w/w | |||
equivalent to Diclofenac Sodium | q.s. | |||
Water soluble Gel Base | ||||
Lignocaine Cream | Composition | IP | 2.0 % w/w | Analgesic |
Lignocaine | q.s. | |||
Cream base | ||||
Lignocaine Cream | Composition | IP | 1.0 % w/w | Analgesic |
Lignocaine | q.s. | |||
Cream base | ||||
Aceclofenac Dispersible Tablets 100 mg | Each Uncoated Dispersible Tablet Contains:- | IP | 100 mg | Analgesic |
Aceclofenac | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Paracetamol Sustained Release Tablets | Each uncoated Bilayered Tablet Contains: | IP | 300 mg | Analgesic |
Paracetamol | ||||
(As Immediate Release) | IP | 700 mg | ||
Paracetamol | ||||
(As Sustained Release) | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Nimesulide Tablets BP | Each Uncoated Tablet Contains:- | Analgesic | ||
Nimesulide BP ——— 100 mg | ||||
Excipients—————–q.s | ||||
Colour-Approved colour used. | ||||
Paracetamol (SR) 1000 mg Tablets | Each Uncoated (SR) Tablet Contains:- | Analgesic | ||
Paracetamol IP ————————–1000 mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Aceclofenac Sustained Release Tablets | Each Film Coated Sustained Release Tablet Contains:- | Analgesic | ||
Aceclofenac IP ————— 200 mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Methyl salicylate Ointment IP 10%w/w | Composition: | IP | 10.0 % w/w | Analgesic |
Methyl salicylate | qs | |||
Ointment base | ||||
Antibacterial, Analgesic | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Nifedipine & Lignocaine Cream | Composition: | IP | 0.3%w/w | Antibacterial, Analgesic |
Nifedipine | IP | 1.5%w/w | ||
Lidocaine | q.s. | |||
Cream base | ||||
AntiInflammatory, Analgesic | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Etoricoxib, Linseed Oil, Methyl Salicylate & Menthol gel | Composition: | IP | 10 mg | AntiInflammatory, Analgesic |
Each gram contains | 30 mg | |||
Etoricoxib | BP | 100 mg | ||
Linseed Oil | IP | 50 mg | ||
Methyl Salicylate | IP | q.s. | ||
Menthol | ||||
Gel Base | ||||
Antispasmodic & analgesic | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Mefenamic Acid &Paracetamol Tablets | Each Uncoated Tablet Contains:- | Antispasmodic & analgesic | ||
Mefenamic Acid I.P. —————— 500 mg | ||||
Paracetamol IP ————————– 325 mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Muscle relaxant with anti-inflammatory and analgesic | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Thiocolchioside and Dexketoprofen Trometamol Tablets | Each Film Coated Tablets Contains:- | Muscle relaxant with anti-inflammatory and analgesic | ||
Thiocolchioside IP ————— 4 mg | ||||
Dexketoprofen Trometamol ——-25 mg | ||||
Excipients——————q.s. | ||||
Colour-Approved colour used. | ||||
Gastric Resistance & Anti Emetics & analgesic | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Rabeprazole (EC) Sodium & Diclofenac sodium Capsule(SR) | Each Hard Gelatin capsule contains | IP | 20mg | Gastric Resistance & Anti Emetics & analgesic |
Rabeprazole Sodium | ||||
(As enteric coated pellets) | IP | 100mg | ||
Diclofenac sodium | ||||
(as sustained release pellets) | ||||
Approved coloured used Empty hard Gelatin capsule shells. | ||||
Tranexamic Acid Tablets IP 250 mg | Each Film coated Tablet Contains:- | IP | 250 mg | Gastric Resistance, Antispasmodic & Anti Emetic |
Tranexamic Acid | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Eperisone HCl tablets 50 mg | Each Film coated Tablet Contains:- | IP | 50 mg | Gastric Resistance, Antispasmodic & Anti Emetic |
Eperisone HCl | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Flupirtine Maleate capsules | Each hard gelatin capsule contains:- | 100mg | Gastric Resistance, Antispasmodic & Anti Emetic | |
Flupirtine Maleate | q.s | |||
Excipients | ||||
Colour: Approved colours used un empty capsule shells. | ||||
Itopride Hydrochloride Sustained release capsules | Each hard gelatin capsule contains:- | 150mg | Gastric Resistance, | |
Itopride Hydrochloride | ||||
(As sustained release) | q.s. | |||
Excipients | ||||
Colour: Approved colours used in capsule shells & pellets. | ||||
Antiinflammatory | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Indomethacin Capsules IP | Each Hard Gelatin Capsule Contains: | IP | 25.0 mg | Antiinflammatory |
Indomethacin | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Piroxicam Capsules IP | Each Hard Gelatin Capsule Contains: | IP | 20.0 mg | Antiinflammatory |
Piroxicam | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Beclomethasone Dipropionate with salicyclic Acid Ointment | Composition: | IP | 0.025%w/w | Antiinflammatory |
Beclomethasone Dipropionate | IP | 3.00% | ||
Salicyclic Acid | q.s. | |||
Ointment base | ||||
Hydrocortisone Acetate cream IP | Composition: | IP | 1.0 %w/w | Antiinflammatory |
Hydrocortisone Acetate | q.s. | |||
cream base | ||||
Hydrocortisone Acetate cream IP | Composition: | IP | 2.5 %w/w | Antiinflammatory |
Hydrocortisone Acetate | q.s. | |||
cream base | ||||
White Soft Paraffin & Light Liquid Paraffin Cream | Composition : | IP | 13.2%w/w | Antiinflammatory |
White Soft Paraffin | IP | 10.2%w/w | ||
Light Liquid Paraffin | q.s | |||
Cream Base | ||||
Clindamycin Phosphate and benzoyl peroxide Gel | Composition:- | IP | 1.00% w/w | Anti-Inflammatory |
Clindamycin Phosphate | 2.50% w/w | |||
Equivalent to Clindamycin | IP | q.s. | ||
Benzoyl Peroxide (as Anhydrous) | ||||
Gel Base | ||||
Mometasone Furoate & Terbinafine Hydrochloride Cream | Composition:- | IP | 0.1% w/w | Anti-Inflammatory |
Mometasone Furoate | IP | 1% w/w | ||
Terbinafine Hydrochloride | q.s. | |||
Cream Base | ||||
Clomiphene Citrate Tablet IP 50 mg | Each uncoated Tablet Contains: – | Antiinflammatory | ||
Clomiphene Citrate IP ————–50.0 mg | ||||
Excipients……………q.s. | ||||
Colour : Approved Colour Used | ||||
Diacerein & Aceclofenac Tablets | Each Film coated tablet contains: | Antiinflammatory | ||
Diacerein IP ————50 mg | ||||
Aceclofenac IP ———–100 mg | ||||
Excipients……………q.s. | ||||
Colour-Approved colour used. | ||||
Diclofenac sodium (As enteric coated) & Misoprostol Capsules | Each hard gelatin capsule contains: | IP | 50.0 mg | Antinflammatory |
Diclofenac Sodium | ||||
(As sustained release pellets) | IP | 200 mcg | ||
Misoprostol | q.s. | |||
Excipients | ||||
Approved Colors Used. in Empty Shell & Pellet | ||||
Diclofenac sodium (As enteric coated) & Misoprostol Capsules | Each hard gelatin capsule contains: | IP | 75.0 mg | Antinflammatory |
Diclofenac Sodium | ||||
(As sustained release pellets) | IP | 200 mcg | ||
Misoprostol | q.s. | |||
Excipients | ||||
Approved Colors Used. in Empty Shell & Pellet | ||||
Hydrocortisone butyrate cream USP | Composition: | USP | 0.1%w/w | Anti-inflammatory |
Hydrocortisone butyrate | ||||
In hydrophilic | q.s. | |||
cream base | ||||
Fluocinolone Acetonide Cream IP | Composition : | IP | 0.025 %w/w | Anti-Inflammatory |
Fluocinolone Acetonide | q.s | |||
Cream Base | ||||
Dexamethasone Tablets IP | Each Uncoated Tablet Contains:- | Anti-inflammatory | ||
Dexamethasone Sodium Phosphate IP | ||||
Eq. to Dexamethasone ———— 0.5 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Analgesic & Antiinflammatory | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Diclofenac Potassium and Serratiopeptidase Tablets | Each Film Coated Tablet Contains:- | Analgesic & Antiinflammatory | ||
Diclofenac Potassium BP ——- 50 mg | ||||
Serratiopeptidase IP ———–10 mg | ||||
(20,000 units of Serratiopeptidase as enteric coated granules) | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Diclofenac Sodium, Paracetamol &Serratiopeptidase Tablets | Each Uncoated Tablet Contains:- | Analgesic & Antiinflammatory | ||
Diclofenac Sodium IP ——— 50 mg | ||||
Paracetamol IP ————–325 mg | ||||
Serratiopeptidase IP ———–10 mg | ||||
(20,000 units of Serratiopeptidase as enteric coated granules) | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Diclofenac Potassium, Paracetamol and Chlorzoxazone Tablets | Each Uncoated Tablet Contains:- | Analgesic & Antiinflammatory | ||
Diclofenac Potassium BP ——- 50 mg | ||||
Paracetamol IP ————–325 mg | ||||
Chlorzoxazone USP ——— 250 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Diclofenac Potassium Tablets | Each Film Coated Tablet Contains:- | Analgesic & Antiinflammatory | ||
Diclofenac Potassium BP ——- 50 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Diclofenac Potassium, Paracetamol and Chlorzoxazone Tablets | Each Film Coated Tablet Contains:- | Analgesic & Antiinflammatory | ||
Diclofenac Potassium BP ——- 50 mg | ||||
Paracetamol IP ————–325 mg | ||||
Chlorzoxazone USP ——— 250 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Aceclofenac, Paracetamol and Serratiopeptidase Tablets | Each Film Coated Tablet Contains:- | Analgesic & Antiinflammatory | ||
Aceclofenac IP —————- 100 mg | ||||
Paracetamol IP ————–325 mg | ||||
Serratiopeptidase IP ———–15 mg | ||||
(30,000 units of Serratiopeptidase as enteric coated granules) | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Diacerein Capsules I.P. | Each Hard Gelatin Capsule contains: | IP | 50.0 mg | Analgesic & Anti-Inflammatory |
Diacerein | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Thiocolchioside and Diclofenac sodium Capsules | Each Hard Gelatin Capsule Contains:- | IP | 4.0 mg | Analgesic & Anti-Inflammatory |
Thiocolchioside | IP | 50.0 mg | ||
Diclofenac sodium | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Thiocolchioside and Diclofenac sodium Capsules | Each Hard Gelatin Capsule Contains:- | IP | 16.0 mg | Analgesic & Anti-Inflammatory |
Thiocolchioside | IP | 100.0 mg | ||
Diclofenac sodium | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Thiocolchioside Capsules IP | Each Hard Gelatin Capsules Contains: | IP | 4.0 mg | Analgesic & Anti-Inflammatory |
Thiocolchioside | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Thiocolchioside Capsules IP | Each Hard Gelatin Capsules Contains: | IP | 8.0 mg | Analgesic & Anti-Inflammatory |
Thiocolchioside | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Oxaceprol Capsules | Each hard gelatin capsule contains: | 200 mg | Analgesic & Anti-Inflammatory | |
Oxaceprol | q.s. | |||
Excipients | ||||
Approved colors used in Hard Gelatin Capsule shell. | ||||
Aceclofenac along with Linseed oil Menthol, Methyl Salicylate & Capsaicin | Composition: | IP | 1.5 % w/w | Analgesic & Anti-Inflammatory |
Aceclofenac | BP | 3 % w/w | ||
Linseed oil | IP | 5.0 % w/w | ||
Menthol | IP | 10 % w/w | ||
Methyl Salicylate | USP | 0.01% | ||
Capsaicin | IP | 1% w/w | ||
Benzyl Alcohol | q.s. | |||
Gel Base | ||||
Diacerein & Glucosamine Sulphate Potassium Chloride Tablets | Each Film coated tablet contains: | Analgesic & Anti-Inflammatory | ||
Diacerein IP ————50.0 mg | ||||
Glucosamine Sulphate | ||||
Potassium Chloride IP ———–1500 mg | ||||
Excipients……………q.s. | ||||
Colour-Approved colour used. | ||||
Trypsin Chymotrypsin Tablet IP | Each Enteric coated Tablet Contains: – | |||
Trypsin Chymotrypsin IP ———(1,00,000 | ||||
Armour Units of enzymatic activity) | ||||
Excipients……………q.s. | ||||
Colour : Approved Colour Used. | ||||
Thiocolchicoside Capsule IP. | Each Hard gelatin capsule Contains: | IP | 4 mg | Analgesic & anti-inflammatory |
Thiocolchicoside | ||||
Approved colour used | ||||
Thiocolchicoside Capsule IP. | Each Hard gelatin capsule Contains: | IP | 8 mg | Analgesic & anti-inflammatory |
Thiocolchicoside | ||||
Approved colour used | ||||
Anti-Inflammatory Drug | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Apixaban Tablets 2.5 mg | Each Film coated Tablet Contains:- | 2.5 mg | Anti-Inflammatory Drug | |
Apixaban | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Apixaban Tablets 5 mg | Each Film coated Tablet Contains:- | 5 mg | Anti-Inflammatory Drug | |
Apixaban | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Anti-Inflammatory & Immuno Suppressant | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Deflazacort Tablets | Each Uncoated Tablet Contains:- | Anti-Inflammatory & Immuno Suppressant | ||
Deflazacort —————- 24 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Deflazacort Tablets | Each Uncoated Tablet Contains:- | Anti-Inflammatory & Immuno Suppressant | ||
Deflazacort —————- 18 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Deflazacort Tablets | Each Uncoated Tablet Contains:- | Anti-Inflammatory & Immuno Suppressant | ||
Deflazacort —————- 1 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Deflazacort Tablets | Each Uncoated Tablet Contains:- | Anti-Inflammatory & Immuno Suppressant | ||
Deflazacort —————- 30 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Deflazacort Tablets | Each Uncoated Tablet Contains:- | Anti-Inflammatory & Immuno Suppressant | ||
Deflazacort —————- 6 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Carisoprodol Tablets IP | Each Uncoated Tablet Contains:- | Antiinflamatory & Muscle relaxant | ||
Carisoprodol IP ————— 350 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Eperisone Hydrochloride (Sustained release) Capsule 150mg | Each hard gelatin capsule contains:- | 150mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | |
Eperisone Hydrochloride | ||||
(As sustained release pellets) | q.s. | |||
Excipients | ||||
Colour: Approved colours used in empty capsule shells & pellets. | ||||
Eperisone Hydrochloride (Sustained release) Capsule 150mg Diclofenac Sodium (Sustained Release) Capsules | Each hard gelatin capsule contains:- | IP | 150mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Eperisone Hydrochloride | ||||
(As sustained release pellets) | 100mg | |||
Diclofenac Sodium | ||||
(As sustained release pellets) | q.s. | |||
Excipients | ||||
Colour: Approved colours used in empty capsule shells & pellets. | ||||
Choline salicylate & Lignocaine Hydrochloride Gel | Composition: | BP | 8.7% w/w | Analgesic & Non-Steroidal Anti-Inflammatory |
Choline salicylate | IP | 2.0% w/w | ||
Lignocaine Hydrochloride | q.s. | |||
Water Soluble Gel Base in a purified water | ||||
Diclofenac Diethylamine, Linseed Oil, Methyl Salicylate & Menthol gel | Composition: | IP | 1.16% w/w | Analgesic & Non-Steroidal Anti-Inflammatory |
Diclofenac Diethylamine | 1.0% w/w | |||
eq. to Diclofenac sodium | IP | 3.0% w/w | ||
Linseed Oil | BP | 10.0% w/w | ||
Methyl Salicylate | IP | 5.0%w/w | ||
Menthol | IP | 1.0%w/w | ||
Benzyl Alcohol | IP | q.s. | ||
(as Preservative) | ||||
Gel Base | ||||
Virgin Linseed Oil, Diclofenac Diethylamine, Methyl Salicyclate, Menthol& Capsaicin Gel | Composition: | BP | 3.00%w/w | Analgesic & Non-Steroidal Anti-Inflammatory |
Virgin Linseed Oil | IP | 1.16%w/w | ||
Diclofenac Diethylamine | IP | 1.00%w/w | ||
Equ. to Diclofenac Sodium | IP | 10.00%w/w | ||
Methyl Salicylate | IP | 5.00%w/w | ||
Menthol | USP | 0.025%w/w | ||
Capsaicin | ||||
Preservative : | IP | 1.00%w/w | ||
Benzyl Alcohol | q.s. | |||
Gel Base | ||||
Choline Salicylate & Lignocaine Hydrochloride Gel | Composition : | BP | 8.7%w/w | Analgesic & Non-Steroidal Anti-Inflammatory |
Choline Salicylate Solution | ||||
Equ. to Choline Salicylate | IP | 2.0%w/w | ||
Lignocaine Hydrochloride | ||||
Preservative: | IP | 0.01%w/w | ||
Benzalkonium Chloride | q.s | |||
In Pleasant Flavoured Base | ||||
Etodolac Extended Release Tablets 200 mg | Each Film Coated Extended Release Tablet Contains:- | BP | 200 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Etodolac | q.s | |||
(As extended release) | ||||
Excipients. | ||||
Colour-Approved colour used. | ||||
Etodolac Extended Release Tablets 300 mg | Each Film Coated Extended Release Tablet Contains:- | BP | 300 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Etodolac(As extended release) | q.s | |||
Excipients. | ||||
Colour-Approved colour used. | ||||
Etodolac Extended Release Tablets 400 mg | Each Film Coated Extended Release Tablet Contains:- | BP | 400 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Etodolac | ||||
(As extended release) | q.s | |||
Excipients. | ||||
Colour-Approved colour used. | ||||
Allopurinol Tablets IP 100 mg | Each Film Coated Tablet Contains:- | IP | 100 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Allopurinol | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Lornoxicam Tablets | Each Film Coated Tablets Contains | 4 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | |
Lornoxicam | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Lornoxicam Tablets | Each Film Coated Tablets Contains | 8 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | |
Lornoxicam | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Lornoxicam and Paracetamol Tablets | Each Enteric Coated Tablets Contains | IP | 4 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Lornoxicam | 325 mg | |||
Paracetamol | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Aceclofenac, Paracetamol and Serratiopeptidase Tablets | Each Film Coated Tablet Contains:- | IP | 100 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Aceclofenac | IP | 325 mg | ||
Paracetamol | IP | 15 mg | ||
Serratiopeptidase | ||||
(30,000 units of Serratiopeptidase as enteric coated granules) | ||||
Excipients | q.s | |||
Colour-Approved colour used. | ||||
Promethazine Tablets IP 25 mg | Each Film Coated Tablets Contains | IP | 25 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Promethazine Hydrochloride | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Promethazine Tablets IP 50 mg | Each Film Coated Tablets Contains | IP | 50 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Promethazine Hydrochloride | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Nimesulide Phenylephrine Hydrochloride Cetirizine Dihydrochloride & Caffeine Tablets | Each Film Coated Tablet Contains:- | BP | 100 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Nimesulide | IP | 10 mg | ||
Phenylephrine Hydrochloride | IP | 5 mg | ||
Cetirizine Dihydrochloride | IP | 30 mg | ||
Caffeine | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Flavoxate Hydrochloride tablets IP 100 mg | Each Film coated Tablets contains: | IP | 100 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Flavoxate Hydrochloride | q.s | |||
Excipients | ||||
Colour: Approved Colour Used | ||||
Etoricoxib Tablets I.P. | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Etoricoxib I.P 60mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Etoricoxib Tablets I.P. | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Etoricoxib I.P 90mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Etoricoxib Tablets I.P. | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Etoricoxib I.P 120mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Etodolac Tablets I.P. | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Etodolac I.P —–200mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Etodolac Tablets I.P. | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Etodolac I.P —–300mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Etodolac Tablets I.P. | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Etodolac I.P —–400mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Thicolchicoside and Etoricoxib Tablets | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Thicolchicoside IP ———— 4 mg | ||||
Etoricoxib IP —————— 60 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Ketorolac Tromethamine Tablets IP | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Ketorolac Tromethamine IP———-10 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Piroxicam-Beta-Cyclodextrin Tablets | Each Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Piroxicam-Beta-Cyclodextrin | ||||
Eq. to Piroxicam IP ————- 20 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Aceclofenac and Thiocolchioside Tablets | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Aceclofenac IP ————— 100 mg | ||||
Thiocolchioside IP ———— –4 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Lornoxicam and Thiocolchioside Tablets | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Lornoxicam ——————- 4 mg | ||||
Thiocolchioside IP ———— –4 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Lornoxicam and Thiocolchioside Tablets | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Lornoxicam ——————- 4 mg | ||||
Thiocolchioside IP ———— –8 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Lornoxicam and Thiocolchioside Tablets | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Lornoxicam ——————- 8 mg | ||||
Thiocolchioside IP ———— –8 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Lornoxicam and Thiocolchioside Tablets | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Lornoxicam ——————- 16 mg | ||||
Thiocolchioside IP ———— –16 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Tolperisone Hydrochloride and Diclofenac Sodium Tablets IP | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Tolperisone Hydrochloride ———150 mg | ||||
Diclofenac Sodium —————-50 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Tolperisone Hydrochloride and Diclofenac Sodium Sustained Release Tablets IP | Each Sustained Release Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Tolperisone Hydrochloride ———450 mg | ||||
Diclofenac Sodium —————100 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Febuxostat Tablets | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Febuxostat —————- 80 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Febuxostat Tablets | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Febuxostat —————- 120 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Tadalafil Tablets IP | Each Uncoated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Tadalafil IP —————- 2.5 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Pirfenidone Tablets IP | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Pirfenidone IP ————— 200 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Pirfenidone Tablets IP | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Pirfenidone IP ————— 400 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Lornoxicam and Paracetamol Tablets | Each Enteric Coated Tablets Contains | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Lornoxicam —————– 4 mg | ||||
Paracetamol IP—————-325 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Lornoxicam and Paracetamol Tablets | Each Enteric Coated Tablets Contains | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Lornoxicam —————– 8 mg | ||||
Paracetamol IP—————-325 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Paracetamol, Phenylephrine Hydrochloride, Diphenhydramine& Caffeine Tablets | Each Uncoated tablet contains: | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Paracetamol IP ————— 500 mg | ||||
Phenylephrine Hydrochloride IP—— 5 mg | ||||
Diphenhydramine IP—————— 25 mg | ||||
Caffeine (Anhydrous) IP ————-30mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Diacerein, Glucosamine &Methylsulfonylmethane Tablets | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Diacerein IP —————– 50 mg | ||||
Glucosamine Sulphate Potassium Chloride USP –750 mg | ||||
Eq. to Glucosamine ———— 446 mg | ||||
Methylsulfonylmethane USP ——-250 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Etoricoxib & Paracetamol Tablets | Each Film Coated Tablet Contains:- | Analgesic & Non-Steroidal Anti-Inflammatory | ||
Etoricoxib IP —————— 60 mg | ||||
Paracetamol IP————– 325 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Aceclofenac and Thiocolchioside Tablets | Each Film Coated Tablet Contains:- | Analgesic & Non-Steroidal Anti-Inflammatory | ||
Aceclofenac IP ————— 100 mg | ||||
Thiocolchioside IP ———— — 8 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Aceclofenac and Drotaverine hydrochloride Tablets | Each Film Coated Tablet Contains:- | Analgesic & Non-Steroidal Anti-Inflammatory | ||
Aceclofenac IP ————— 100 mg | ||||
Drotaverine hydrochloride I.P.——-80 mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Aceclofenac Sustained Release Tablets | Each Film Coated Sustained Release Tablet Contains:- | Analgesic & Non-Steroidal Anti-Inflammatory | ||
Aceclofenac IP ————— 200 mg | ||||
(As Sustained Release) | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Trypsin, Bromelain, Rutoside Trihydrate & Diclofenac Sodium Tablets | Each Enteric Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Trypsin BP ———————–48 mg | ||||
Bromelain ————————90 mg | ||||
Rutoside Trihydrate BP ————-100 mg | ||||
Diclofenac Sodium IP————–50 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Paracetamol and Diclofenac Potassium Tablets IP | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Paracetamol IP —————– 325 mg | ||||
Diclofenac Potassium IP ——- 50 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Serratiopeptidase Tablets IP | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Serratiopeptidase IP ———–10 mg | ||||
(Eq. to Enzyme Activity 20,000 units of enteric coated granules) | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Ketoprofen and Thiocolchioside Tablets | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Ketoprofen IP ————— 50 mg | ||||
Thiocolchioside IP ————–4 mg | ||||
Excipients—————– q.s | ||||
Colour: Approved colour used | ||||
Ketoprofen and Thiocolchioside Tablets | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Ketoprofen IP ————— 100 mg | ||||
Thiocolchioside IP ———— –8 mg | ||||
Excipients—————– q.s | ||||
Colour: Approved colour used | ||||
Tolperisone Hydrochloride and paracetamol Tablets | Each Film Coated Tablet Contains:- | Analgesics, antipyretics, non-steroidal anti-inflammatory | ||
Tolperisone Hydrochloride ———150 mg | ||||
Paracetamol IP —————- 325 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Paracetamol and Thicolchicoside Tablets | Each Film Coated Tablet Contains:- | Analgesics, antipyretics, non-steroidal anti-inflammatory | ||
Paracetamol IP ————— 325 mg | ||||
Thiocolchioside IP ————–4 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Paracetamol and Thicolchicoside Tablets | Each Film Coated Tablet Contains:- | Analgesics, antipyretics, non-steroidal anti-inflammatory | ||
Paracetamol IP ————— 325 mg | ||||
Thicolchicoside IP ————–8 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Etodolac and Thicolchicoside Tablets | Each Film Coated Tablet Contains:- | Analgesics, antipyretics, non-steroidal anti-inflammatory | ||
Etodolac IP ————— 300 mg | ||||
Thicolchicoside IP ————-4.0 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Etodolac and Thicolchicoside Tablets | Each Film Coated Tablet Contains:- | Analgesics, antipyretics, non-steroidal anti-inflammatory | ||
Etodolac IP ————— 300 mg | ||||
Thicolchicoside IP ————-8.0 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Flavoxate Hydrochloride Tablet | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Flavoxate Hydrochloride IP ———– 200mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Diclofenac Potassium and Drotaverine Hydrochloride Tablets | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Diclofenac Potassium BP————- 50 mg | ||||
Drotaverine hydrochloride I.P.——-80 mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Tolperisone Tablets | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Tolperisone ————- 150 mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Aceclofenac, Paracetamol and Serratiopeptidase Tablets | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Aceclofenac IP —————- 100 mg | ||||
Paracetamol IP ————–325 mg | ||||
Serratiopeptidase IP ———–10 mg | ||||
(20,000 units of Serratiopeptidase as enteric coated granules) | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Thicolchicoside and Etoricoxib Tablets | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Thicolchicoside IP ———— 8 mg | ||||
Etoricoxib IP —————— 60 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Trypsin, Bromelain, &Rutoside Trihydrate Tablets | Each Enteric Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Trypsin BP ———————– 96 | ||||
Bromelain ———————— 180 mg | ||||
Rutoside Trihydrate ————– 200 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Trypsin, Bromelain, &Rutoside Trihydrate Tablets | Each Enteric Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Trypsin BP ———————– 48 mg | ||||
Bromelain BP ———————- 90 mg | ||||
Rutoside Trihydrate IP ————– 100 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Trypsin Chymotrypsin & Aceclofenac Tablet IP | Each Enteric coated Tablet Contains: – | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
50,000 Armour Units of enzymatic activity supplied by a purified concentrate which has specific Trypsin and Chymotrypsin Activity in a ratio of approximately six to one. | ||||
Aceclofenac IP ————————– 100 mg | ||||
Excipients……………q.s. | ||||
Colour : Approved Colour Used. | ||||
Phenylephrine Hydrochloride, Paracetamol, Dextromethorphan Hydrobromide & Cetirizine Hydrochloride Tablets | Each Uncoated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Phenylephrine Hydrochloride ——-5 mg | ||||
Paracetamol IP ———– 325 mg | ||||
Dextromethorphan Hydrobromide —- 10 mg | ||||
Cetirizine Dihydrochloride IP ——–5 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Drotaverine hydrochloride & Paracetamol Tablets | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Drotaverine hydrochloride I.P.——80 mg | ||||
Paracetamol IP ———– 325 mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Aceclofenac, Paracetamol and Chlorzoxazone Tablets | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Aceclofenac IP ——- 100 mg | ||||
Paracetamol IP ————–325 mg | ||||
Chlorzoxazone USP ——— 250 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Paracetamol, Phenylephrine Hydrochloride, Guaiphenesin, Cetirizine Dihydrochloride & Ambroxol Tablets IP | Each Uncoated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Paracetamol IP ———– 325 mg | ||||
Phenylephrine Hydrochloride ——-5 mg | ||||
Guaiphenesin IP ——————–50 mg | ||||
Cetirizine Dihydrochloride IP —— 5 mg | ||||
Ambroxol Hydrochloride IP ————-15 mg | ||||
Excipients—————–q.s | ||||
Colour-Approved colour used. | ||||
Paracetamol and Diclofenac Potassium Tablets | Each Uncoated bilayeredtablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Paracetamol …………………………IP 325mg | ||||
Diclofenac Potassium ………….BP 50mg | ||||
Excipients……………………………….q.s | ||||
Colour-Approved colour used. | ||||
Diclofenac Potassium & Paracetamol | Each uncoated tablet contains: | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Diclofenac Potassium………….BP 50mg | ||||
Paracetamol…………………………IP 325mg | ||||
Excipients ……………………………….q.s | ||||
Colour: Approved colour used. | ||||
Nimesulide & Paracetamol tablets | Each uncoated tablet contains: | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Nimesulide l…………………………BP 100mg | ||||
Paracetamol…………………………IP 325mg | ||||
Excipients ……………………………….q.s | ||||
Colour: Approved colour used. | ||||
Aceclofenac & Paracetamol tablets | Each uncoated tablet contains: | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Aceclofenac…………………………IP 100mg | ||||
Paracetamol…………………………IP 325mg | ||||
Excipients ……………………………….q.s | ||||
Colour: Approved colour used. | ||||
Nimesulide Phenylephrine Hydrochloride Cetirizine Dihydrochloride & Caffeine Tablets | Each uncoated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Nimesulide BP………………….………… 100 mg | ||||
Phenylephrine Hydrochloride IP…10 mg | ||||
Cetirizine Dihydrochloride IP………. 5 mg | ||||
Caffeine IP…………………..………………30 mg | ||||
Excipients ……………………………………..q. s. | ||||
Colour-Approved colour used. | ||||
Paracetamol, Phenylephrine Hydrochloride, Caffeine & Chlorpheniramine Maleate Tablets | Each Film Coated Tablet Contains:- | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Paracetamol IP………………………………………..325 mg | ||||
Phenylephrine Hydrochloride IP …………….12.5 mg | ||||
Caffeine IP ……………………………………………… 30 mg | ||||
Chlorpheniramine Maleate IP ………………..2 mg | ||||
Excipients………………………………………………..q.s. | ||||
Colour: Approved colours used. | ||||
Paracetamol, Chlorpheniramine Maleate & Phenylephrine Hydrochloride Tablets | Each uncoated tablet contains: | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Paracetamol IP………………………………………..500 mg | ||||
Chlorpheniramine Maleate IP ………………… 2 mg | ||||
Phenylephrine Hydrochloride IP ……………. 10 mg | ||||
Excipients ………………………………………………..q.s. | ||||
Colour-Approved colours used | ||||
Diclofenac Potassium, Paracetamol, Cetirizine hydrochloride & Magnesium Trisilicate Tablets | Each uncoated tablet contains: | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | ||
Diclofenac Potassium BP……………………….. 50 mg | ||||
Paracetamol IP ………………………………………325 mg | ||||
Cetirizine hydrochloride IP …………………… 5 mg | ||||
Magnesium Trisilicate IP ………………………. 100 mg | ||||
Excipients ……………………………………………….q.s. | ||||
Colour-Approved colours used | ||||
Diclofenac Potassium Paracetamol & Chlorzoxazone Tablets | Each Film Coated Tablet contains: | BP | 50 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Diclofenac Potassium | IP | 325 mg | ||
Paracetamol | USP | 250 mg | ||
Chlorzoxazone | q. s. | |||
Excipients | ||||
Thiocolchicoside and Dexketoprofen Trometamol Tablets | Each Film coated Tablet contains: | IP | 4 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Thiocolchicoside | 25 mg | |||
Dexketoprofen Trometamol | q. s. | |||
Excipients | ||||
Approved Colour used | ||||
Eperisone Hydrochloride 75 Sustained release | Each Hard gelatin capsule Contains: | 75mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory | |
Eperisone Hydrochloride | q. s. | |||
Excipients | ||||
Approved colour used | ||||
Nimesulide, Paracetamol, Phenylephrine Hydrochloride & Caffeine Tablets | Each Uncoated Tablet Contains:- | BP | 100 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Nimesulide | IP | 325 mg | ||
Paracetamol | IP | 10 mg | ||
Phenylephrine Hydrochloride | ||||
Caffeine (Anhydrous) | IP | 25 mg | ||
Excipients | q. s. | |||
Colour: Approved colours used. | ||||
Diclofenac Potassium, Paracetamol& Serratiopeptidase Tablets | Each film coated tablet contains:- | BP | 50 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Diclofenac Potassium | IP | 325 mg | ||
Paracetamol | IP | 10 mg | ||
Serratiopeptidase | ||||
(20,000 units of Serratiopeptidase) | ||||
Excipients | q.s. | |||
Approved colour used | ||||
Diclofenac potassium, Paracetamol & Serratiopeptidase Tablets | Each film coated tablet contains:- | BP | 50 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Diclofenac Potassium | IP | 325 mg | ||
Paracetamol | IP | 15 mg | ||
Serratiopeptidase | ||||
(As Enteric coated granules) | ||||
(Eq. to 30,000 Enzymatic Units of serratiopeptidase) | ||||
Excipients | ||||
Colour- Approved colour Used. | ||||
Paracetamol, Cetirizine Hydrochloride & Phenylephrine Hydrochloride Tablets | Each uncoated tablet contains:- | IP | 500 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Paracetamol | IP | 5 mg | ||
Phenylephrine Hydrochloride | IP | 5 mg | ||
Cetirizine Hydrochloride | q.s | |||
Excipients | ||||
Colour : Approved colour used. | ||||
Nimesulide & Paracetamol tablets | Each uncoated Bilayered tablet contains: | B.P. | 100mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Nimesulide | I.P. | 325mg | ||
Paracetamol | q.s | |||
Excipients. | ||||
Colour: Approved colour used. | ||||
Etodolac & Thiocolchicoside Tablets | Each film coated Tablets Contains: | I.P. | 400 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Etodolac | I.P. | 4 mg | ||
Thiocolchicoside | q.s. | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Paracetamol, Phenylephrine HCI, Chlorpheniramine Maleate & Caffeine Tablets | Each Uncoated Tablet Contains :- | I.P. | 500 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Paracetamol | I.P. | 5 mg | ||
Phenylephrine hydrochloride | I.P. | 2 mg | ||
Chlorpheniramine Maleate | I.P. | 16 mg | ||
Caffeine (Anhydrous) | q.s. | |||
Excipie nts | ||||
Colour-Approved colour used. | ||||
Trypsin, Bromelain, Rutoside Trihydrate & Aceclofenac Tablets | Each Enteric Coated Tablet Contains:- | B.P. | 48 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Trypsin | 90 mg | |||
Bromelain | B.P. | 100 mg | ||
Rutoside Trihydrate | ||||
Aceclofenac | I.P. | 100 mg | ||
Excipients | q. s. | |||
Colour-Approved colour used. | ||||
Aceclofenac, Paracetamol and Thiocolchicoside Tablets | Each film coated tablets contains: | I.P. | 100 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Aceclofenac | I.P. | 325 mg | ||
Paracetamol | I.P. | 4 mg | ||
Thiocolchicoside | q.s. | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Nimesulide, Paracetamol and Serratiopeptidase Tablets | Each Film Coated Tablet Contains:- | B.P. | 100 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Nimesulide | I.P. | 325 mg | ||
Paracetamol | I.P. | 15 mg | ||
Serratiopeptidase | ||||
(30,000 units of Serratiopeptidase as enteric coated granules) | ||||
Excipients | ||||
Colour-Approved colour used. | q.s. | |||
Diclofenac Sodium & Paracetamol Tablets I.P. | Each film coated tablet contains:- | I.P. | 50 mg | Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Diclofenac Sodium | I.P. | 325 mg | ||
Paracetamol | q.s. | |||
Excipients | ||||
Colour- Approved colour used. | ||||
Antiallergic | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Cinnarizine & Dimenhydrinate Tablets | Each Uncoated Sustained release Tablet Contains:- | IP | 20 mg | Antiallergic |
Cinnarizine | USP | 40 mg | ||
Dimenhydrinate | q.s | |||
Excipients. | ||||
Colour-Approved colour used. | ||||
Loratadine Dispersible Tablet | Each Uncoated Dispersible tablet contains: | USP | 10 mg | Antiallergic |
Loratadine | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Betahistine Tablets I.P. | Each Film Coated Tablet Contains:- | Antiallergic | ||
Betahistine Hydrochloride I.P.——8 mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Betahistine Tablets I.P. | Each Film Coated Tablet Contains:- | Antiallergic | ||
Betahistine Hydrochloride I.P.……16 mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Cetirizine Tablets | Each Film Coated Tablet Contains:- | Antiallergic | ||
Cetirizine Hydrochloride IP ———-20 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Fexofenadine Hydrochloride and Montelukast Tablets | Each Film Coated Tablet Contains:- | Antiallergic | ||
Fexofenadine Hydrochloride IP — 120 mg | ||||
Montelukast Sodium IP | ||||
Eq. to Montelukast —————10 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Levocetirizine Dihydrochloride Tablets IP | Each Uncoated Tablet Contains:- | Antiallergic | ||
Levocetirizine Dihydrochloride—— 5 mg | ||||
Excipients—————–q.s | ||||
Colour-Approved colour used. | ||||
Montelukast Sodium And Levocetirizine Dihydrochloride Tablets IP | Each Uncoated Tablet Contains:- | Antiallergic | ||
Montelukast Sodium I.P. | ||||
eq. to Montelukast 4mg | ||||
Levocetirizine Dihydrochloride I.P —2.5mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Montelukast Sodium And Levocetirizine Dihydrochloride Tablets IP | Each Uncoated Tablet Contains:- | Antiallergic | ||
Montelukast Sodium I.P. | ||||
eq. to Montelukast 10mg | ||||
Levocetirizine Dihydrochloride I.P — 5mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Betahistine Tablets I.P. | Each Film Coated Tablet Contains:- | Antiallergic | ||
Betahistine Hydrochloride I.P.——24 mg | ||||
Excipients q.s. | ||||
Colour: Approved colour used | ||||
Montelukast Sodium, Fexofenadine and Acebrophyline (SR) tablets | Each Film Coated Tablet Contains:- | Antiallergic | ||
Montelukast Sodium IP | ||||
Eq. to Montelukast —————10 mg | ||||
Fexofenadine Hydrochloride IP — 120 mg | ||||
Acebrophyline (SR)————– 200 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Cinnarizine & Dimenhydrinate Tablets | Each Uncoated Tablet Contains:- | Antiallergic | ||
Cinnarizine USP ————————– 20 mg | ||||
Dimenhydrinate ————————40 mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Montelukast Orally Disintegrating Tablets I.P. | Each Film Coated Tablet Contains:- | Antiallergic | ||
Montelukast Sodium I.P. | ||||
Eq.to Montelukast——— 4 mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Loratadine Tablet USP | Each film coated tablet contains: | Antiallergic | ||
Loratadine USP ———– 10 mg | ||||
Excipients—————–q.s | ||||
Colour-Approved colour used. | ||||
Domperidone & Cinnarizine Tablet | Each uncoated Tablet | IP | 20 mg | Antiallergic |
Cinnarizine | IP | 10 mg | ||
Domperidone | q. s. | |||
Excipients | ||||
Approved coloured used | ||||
Loratadine Tablets I.P. | Each uncoated tablet contains:- | I.P. | 10 mg | Antiallergic |
Loratadine | q.s. | |||
Excipients | ||||
Colour- Approved colour used. | ||||
antiallergic, antiasthamatic & mucolvtic | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Levocetirizine &Ambroxol Capsule | Each Hard Gelatin Capsule Contains: | IP | 5 mg | antiallergic, antiasthamatic & mucolvtic |
Levocetirizine Hydrochloride | ||||
Ambroxol Hydrochloride | IP | 75 mg | ||
(As Sustain Release) | q.s | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Hydroxyzine Hydrochloride tablet IP 25 mg | Each Film coated Tablets contains: | IP | 25 mg | Antiallergic, Antiasthamatic & Mucolvtic |
Hydroxyzine Hydrochloride | q.s. | |||
Excipients | ||||
Colour: Approved ColourUsed | ||||
Levocetirizine Hydrochloride, Phenylephrine Hydrochloride & Paracetamol Tablets | Each Film coated Tablet Contains:- | IP | 5 mg | Antiallergic, Antiasthamatic & Mucolvtic |
Levocetirizine Hydrochloride | IP | 5 mg | ||
Phenylephrine Hydrochloride | IP | 500 mg | ||
Paracetamol | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Cetirizine Tablets | Each Film Coated Tablet Contains:- | Antiallergic, Antiasthamatic & Mucolvtic | ||
Cetirizine Hydrochloride IP ———-10 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Hydroxyzine Hydrochloride Tablets IP | Each Uncoated Tablet Contains:- | Antiallergic, Antiasthamatic & Mucolvtic | ||
Hydroxyzine Hydrochloride IP | ||||
Eq. to Hydroxyzine ——— 10 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Hydroxyzine Hydrochloride Tablets IP | Each Uncoated Tablet Contains:- | Antiallergic, Antiasthamatic & Mucolvtic | ||
Hydroxyzine Hydrochloride IP | ||||
Eq. to Hydroxyzine ——— 25 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Antidiabetic | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Repaglinide Tablets IP 0.5 mg | Each Uncoated Tablet Contains:- | IP | 0.5 mg | Antidiabetic |
Repaglinide | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Repaglinide & Metformin Hydrochloride Tablets IP | Each Film coated Tablet Contains:- | IP | 1 mg | Antidiabetic |
Repaglinide | IP | 500 mg | ||
Metformin Hydrochloride | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Repaglinide & Metformin Hydrochloride Tablets IP | Each Film coated Tablet Contains:- | IP | 2 mg | Antidiabetic |
Repaglinide | IP | 500 mg | ||
Metformin Hydrochloride | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Empagliflozin Tablets 10 mg | Each Film Coated Tablet Contains:- | 10 mg | Antidiabetic | |
Empagliflozin | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Empagliflozin Tablets 25 mg | Each Film Coated Tablet Contains:- | 25 mg | Antidiabetic | |
Empagliflozin | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Gliclazide Tablets I.P. | Each Uncoated Modified Release Tablet Contains:- | Antidiabetic | ||
Gliclazide I.P—————80mg | ||||
Excipients——————-q.s. | ||||
Colour-Approved colour used. | ||||
Gliclazide and Metformin Hydrochloride Extended Release Tablets I.P. | Each Film Coated Extended Release Tablet Contains:- | Antidiabetic | ||
Gliclazide (MR) I.P—————30mg | ||||
Metformin Hydrochloride (ER) IP -500 mg | ||||
Excipients——————-q.s. | ||||
Colour-Approved colour used. | ||||
Gliclazide and Metformin Hydrochloride Extended Release Tablets I.P. | Each Film Coated Extended Release Tablet Contains:- | Antidiabetic | ||
Gliclazide (MR)I.P—————60mg | ||||
Metformin Hydrochloride (ER) IP -500 mg | ||||
Excipients——————-q.s. | ||||
Colour-Approved colour used. | ||||
Metformin Hydrochloride and Alpha Lipoic Acid Tablets | Each Film Coated Tablet Contains:- | Antidiabetic | ||
Metformin Hydrochloride I.P——–500mg | ||||
Alpha Lipoic Acid ————— 200 mg | ||||
Excipients——————-q.s. | ||||
Colour-Approved colour used. | ||||
Metformin Tablets IP | Each Film Coated Tablet Contains:- | Antidiabetic | ||
Metformin Hydrochloride IP ——500 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Metformin Tablets IP | Each Film Coated Tablet Contains:- | Antidiabetic | ||
Metformin Hydrochloride IP ——850 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Metformin Hydrochloride Sustained Release Tablets IP | Each Film Coated Sustained Release Tablet Contains:- | Antidiabetic | ||
Metformin Hydrochloride IP ——1000 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used | ||||
Metformin Hydrochloride Sustained Release Tablets IP | Each Film Coated Sustained Release Tablet Contains:- | Antidiabetic | ||
Metformin Hydrochloride IP ——500 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Metformin Hydrochloride (Prolonged Release) and Glimepiride Tablets I.P. | Each Uncoated Bilayer Tablet Contains:- | Antidiabetic | ||
Metformin Hydrochloride IP | ||||
(Prolonged Release) ———500 mg | ||||
Glimepiride IP ——————1 mg | ||||
Excipients——————-q.s. | ||||
Colour-Approved colour used. | ||||
Metformin Hydrochloride (Prolonged Release) and Glimepiride Tablets I.P. | Each Uncoated Bilayer Tablet Contains:- | Antidiabetic | ||
Metformin Hydrochloride IP | ||||
(Prolonged Release) ———500 mg | ||||
Glimepiride IP ——————2 mg | ||||
Excipients——————-q.s. | ||||
Colour-Approved colour used. | ||||
Metformin HCl (Extended Release) Fenofibrate Tablets IP | Each uncoated Bilayer Tablet Contains:- | Antidiabetic | ||
Metformin HCl (Extended Release) IP-500 mg | ||||
Fenofibrate IP ————- 80 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Metformin HCl (Extended Release) Fenofibrate Tablets IP | Each uncoated Bilayer Tablet Contains:- | Antidiabetic | ||
Metformin HCl (Extended Release) IP-500 mg | ||||
Fenofibrate IP ————- 160 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Metformin Hydrochloride (Prolonged Release) and Glimepiride Tablets I.P. | Each Uncoated Bilayer Tablet Contains:- | Antidiabetic | ||
Metformin Hydrochloride IP | ||||
(Prolonged Release) ———500 mg | ||||
Glimepiride IP —————— 0.5 mg | ||||
Excipients——————-q.s. | ||||
Colour-Approved colour used. | ||||
Metformin HCl (SR/ER/PR) Voglibose& Glimepiride Tablet | Each uncoated Bilayered tablet contains: | Antidiabetic | ||
Metformin HCl ————-500 mg | ||||
(SR/ER/PR) | ||||
Voglibose IP ————– 0.2 mg | ||||
Glimepiride IP —————1 mg | ||||
Excipients ——————-q.s. | ||||
Colour-Approved colour used | ||||
Metformin HCl (SR/ER/PR) Voglibose& Glimepiride Tablet | Each uncoated Bilayered tablet contains: | Antidiabetic | ||
Metformin HCl ————-500 mg | ||||
(SR/ER/PR) | ||||
Voglibose IP ————– 0.2 mg | ||||
Glimepiride IP ————— 2 mg | ||||
Excipients ——————-q.s. | ||||
Colour-Approved colour used | ||||
Glimepiride, Pioglitazone & Metformin Tablets | Each Uncoated Bilayered Tablet contains: | Antidiabetic | ||
Glimepiride IP ————– 1 mg | ||||
Pioglitazone IP ————— 15mg | ||||
Metformin Hydrochloride (ER) IP —-500 mg | ||||
Excipients ————— q.s. | ||||
Colour-Approved colour used. | ||||
Glimepiride, Pioglitazone & Metformin Tablets | Each Uncoated Bilayered Tablet contains: | Antidiabetic | ||
Glimepiride IP ————– 2 mg | ||||
Pioglitazone IP ————— 15mg | ||||
Metformin Hydrochloride (ER) IP—–500 mg | ||||
Excipients ————— q.s. | ||||
Colour-Approved colour used. | ||||
Metformin HCl (Sustained Release) Voglibose& Glimepiride Tablet | Each uncoated Bilayered tablet contains: | IP | 500 mg | Antidiabetic |
Metformin HCl | ||||
(As Sustained Release) | IP | 0.2 mg | ||
Voglibose | IP | 1 mg | ||
Glimepiride | q. s. | |||
Excipients | ||||
Colour-Approved colours used | ||||
Gliclazide & Metformin Hydrochloride Tablets | Each uncoated tablets contains: | I.P. | 80 mg | Antidiabetic |
Gliclazide | ||||
Metformin Hydrochloride | I.P. | 500 mg | ||
Excipients | q.s. | |||
Colour-Approved colour used. | ||||
Dapagliflozin Tablet | Each film coated tablet contains: | Antidiabetic | ||
Dapagliflozin propandiol monohydrate IH | ||||
eq. to Dapagliflozin—————10 mg | ||||
Excipients ————— q.s | ||||
Colour-Approved colour used. | ||||
Dapagliflozin Tablet | Each film coated tablet contains: | Antidiabetic | ||
Dapagliflozin propandiol monohydrate IH | ||||
q. to Dapagliflozin—————5.0 mg | ||||
Excipients ————— q.s | ||||
Colour-Approved colour used. | ||||
Metformin Hydrochloride (Prolonged Release) and Glimepiride Tablets I.P. | Each Uncoated Bilayer Tablet Contains:- | Antidiabetic | ||
Metformin Hydrochloride IP | ||||
(Prolonged Release) ———1000 mg | ||||
Glimepiride IP ——————1 mg | ||||
Excipients——————-q.s. | ||||
Colour-Approved colour used. | ||||
Metformin Hydrochloride (Prolonged Release) and Glimepiride Tablets I.P. | Each Uncoated Bilayer Tablet Contains:- | Antidiabetic | ||
Metformin Hydrochloride IP | ||||
(Prolonged Release) ———1000 mg | ||||
Glimepiride IP ——————2 mg | ||||
Excipients——————-q.s. | ||||
Colour-Approved colour used. | ||||
Glimepiride Tablet IP | Each uncoated tablet contains: | Antidiabetic | ||
Glimepiride IP —————-1 mg | ||||
Excipients——————-q.s. | ||||
Colour-approved colour used. | ||||
Glimepiride Tablet IP | Each uncoated tablet contains: | Antidiabetic | ||
Glimepiride IP —————-2 mg | ||||
Excipients——————-q.s. | ||||
Colour-approved colour used. | ||||
Glimepiride Tablet IP | Each uncoated tablet contains: | Antidiabetic | ||
Glimepiride IP —————-3 mg | ||||
Excipients——————-q.s. | ||||
Colour-approved colour used. | ||||
Glimepiride Tablet IP | Each uncoated tablet contains: | Antidiabetic | ||
Glimepiride IP —————-4 mg | ||||
Excipients——————-q.s. | ||||
Colour-approved colour used. | ||||
Pioglitazone HCl & Glimepiride tablets | Each Uncoated SR tablet contains: | Antidiabetic | ||
Pioglitazone HCl IP ————–15 mg | ||||
Glimepiride IP —————-1 mg | ||||
Excipients ——————-q.s. | ||||
Colour: Approved Colour Used | ||||
Vildagliptin Tablet | Each uncoated tablet contains: | Antidiabetic | ||
Vildagliptin IH ————– 50.0 mg | ||||
Excipients ——————-q.s. | ||||
Colour-Approved colour used. | ||||
Vildagliptin and Metformin HCL Tablets | Each film coated tablet contains: | Antidiabetic | ||
Vildagliptin IH ————– 50.0 mg | ||||
Metformin HCL IP ———- 500.0 mg | ||||
Excipients ——————-q.s. | ||||
Colour-Approved colour used. | ||||
Vildagliptin & Metformin SR Tablets. | Each uncoated Bilayer tablet contains: | Antidiabetic | ||
Vildagliptin IH ————– -50.0 mg | ||||
Metformin HCL IP ———- 1000.0 mg | ||||
Excipients ——————-q.s. | ||||
Colour-Approved colour used. | ||||
Sitagliptin tablet | Each film coated tablet Contains: | Antidiabetic | ||
Sitagliptin (As phosphate) IH — -50.0 mg | ||||
Excipients……………q.s. | ||||
Approved colour used. | ||||
Sitagliptin & Metformin tablets | Each film coated tablet Contains: | Antidiabetic | ||
Sitagliptin (As phosphate)IH— -50.0 mg | ||||
Metformin HCl IP — 500.0 mg | ||||
Excipients ——————-q.s. | ||||
Colour: Approved Colour Used | ||||
Sitagliptin & Metformin tablets | Each film coated tablet Contains: | Antidiabetic | ||
Sitagliptin (As phosphate)—– 50 mg | ||||
Metformin HCl IP———- 1000.0 mg | ||||
Excipients ——————-q.s. | ||||
Colour: Approved Colour Used | ||||
Teneligliptin tablets IP | Each uncoated Tablet Contains: | Antidiabetic | ||
Teneligliptin Hydrobromide Hydrate IP | ||||
eq. to. Teneligliptin— 20.0 mg | ||||
Excipients ——————-q.s. | ||||
Colour-Approved colour used | ||||
Tenegliptin Hydrobromide Hydrate & Metformin HCl Tablets | Each uncoated Tablet Contains: | Antidiabetic | ||
Tenegliptin Hydrobromide Hydrate IP | ||||
eq. to. Tenegliptin IP — 20.0 mg | ||||
Metformin HCl ————-500.0 mg | ||||
Excipients ——————-q.s. | ||||
Colour-Approved colour used | ||||
Tenegliptin Hydrobromide Hydrate & Metformin HCl Tablets | Each uncoated Tablet Contains: | Antidiabetic | ||
Tenegliptin Hydrobromide Hydrate IP | ||||
eq. to. Tenegliptin IP—– 20.0 mg | ||||
Metformin HCl ————-1000.0 mg | ||||
Excipients ——————-q.s. | ||||
Colour-Approved colour used | ||||
Voglibose Tablet IP | Each uncoated tablet contains: | Antidiabetic | ||
Voglibose IP ————- 0.3 mg | ||||
Excipients ——————-q.s. | ||||
Colour-Approved colour used | ||||
Voglibose Tablet IP | Each uncoated tablet contains: | Antidiabetic | ||
Voglibose IP ————- 0.2 mg | ||||
Excipients ——————-q.s. | ||||
Colour-Approved colour used | ||||
Voglibose& Metformin HCl Tablet | Each uncoated (SR) tablet contains: | Antidiabetic | ||
Voglibose IP ————– 0.2 mg | ||||
Metformin HCl (SR) ———500.0 mg | ||||
Excipients ——————-q.s. | ||||
Colour-Approved colour used | ||||
Voglibose& Metformin HCl Tablet | Each uncoated (SR) tablet contains: | Antidiabetic | ||
Voglibose IP————– 0.3 mg | ||||
Metformin HCl (SR) IP ———500.0 mg | ||||
Excipients ——————-q.s. | ||||
Colour-Approved colour used | ||||
Glibenclamide& Metformin HCl (SR) tablet | Each uncoated (SR) tablet contains: | Antidiabetic | ||
Glibenclamide ———2.5 mg | ||||
Metformin HCl (SR) IP ———500.0 mg | ||||
Excipients ——————-q.s. | ||||
Colour-Approved colour used. | ||||
Glibenclamide& Metformin HCl (SR) tablet | Each uncoated (SR) tablet contains: | Antidiabetic | ||
Glibenclamide ———5.0 mg | ||||
Metformin HCl (SR) IP ———500.0 mg | ||||
Excipients ——————-q.s. | ||||
Colour-Approved colour used. | ||||
Saxagliptin HCl tablet | Each Film coated tablet contains: | Antidiabetic | ||
Saxagliptin HCl eq. | ||||
to. Saxagliptin ——————-2.5 mg | ||||
Excipients ——————-q.s. | ||||
Colour-Approved colour used | ||||
Saxagliptin HCl tablet | Each Film coated tablet contains: | Antidiabetic | ||
Saxagliptin HCl eq. | ||||
to. Saxagliptin ——————-5.0 mg | ||||
Colour-Approved colour used | ||||
Saxagliptin HCl & Metformin tablet | Each Film coated tablet contains: | Antidiabetic | ||
Saxagliptin HCl eq. | ||||
to. Saxagliptin———-2.5 mg | ||||
Metformin HCl IP———1000.0 mg | ||||
Excipients ——————-q.s. | ||||
Colour-Approved colour used | ||||
Saxagliptin HCl & Metformin tablet | Each Film coated tablet contains: | Antidiabetic | ||
Saxagliptin HCl eq. | ||||
to. Saxagliptin———- 5.0 mg | ||||
Metformin HCl IP———500.0 mg | ||||
Excipients ——————-q.s. | ||||
Colour-Approved colour used | ||||
Metformin Hydrochloride Prolonged Release Tablets IP 850 mg | Each Uncoated Prolonged Release Tablet Contains:- | IP | 850 mg | Antidiabetic |
Metformin Hydrochloride | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Sitagliptin tablet IP | Each Uncoated tablet Contains: | Antidiabetic | ||
Sitagliptin phosphate IP | ||||
Eq. to Sitagliptin——- 25.0 mg | ||||
Excipients……………q.s. | ||||
Approved colour used. | ||||
Sitagliptin tablet IP | Each Uncoated tablet Contains: | Antidiabetic | ||
Sitagliptin phosphate IP | ||||
Eq. to Sitagliptin——- 50.0 mg | ||||
Excipients……………q.s. | ||||
Approved colour used. | ||||
Sitagliptin tablet IP | Each Uncoated tablet Contains: | Antidiabetic | ||
Sitagliptin phosphate IP | ||||
Eq. to Sitagliptin——- 100.0 mg | ||||
Excipients……………q.s. | ||||
Approved colour used. | ||||
Repaglinide Tablets IP 2 mg | Each Uncoated Tablet Contains:- | IP | 2 mg | Antidiabetic |
Repaglinide | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Voglibose Dispersible Tablet IP 0.2 mg | Each uncoated Dispersible tablet contains: | IP | 0.2 mg | Antidiabetic |
Voglibose | q.s | |||
Excipients . | ||||
Colour-Approved colour used | ||||
Voglibose Dispersible Tablet IP 0.3 mg | Each uncoated Dispersible tablet contains: | IP | 0.3 mg | Antidiabetic |
Voglibose | q.s | |||
Excipients . | ||||
Colour-Approved colour used | ||||
Empagliflozin and Linagliptin tablets | Each Film Coated Tablet Contains:- | 25 mg | Antidiabetics | |
Empagliflozin | 5 mg | |||
Linagliptin | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Empagliflozin and Metformin Hydrochloride tablets | Each Film Coated Tablet Contains:- | IP | 5 mg | Antidiabetic |
Empagliflozin | 500 mg | |||
Metformin Hydrochloride | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Empagliflozin and Metformin Hydrochloride tablets | Each Film Coated Tablet Contains:- | IP | 5 mg | Antidiabetic |
Empagliflozin | 850 mg | |||
Metformin Hydrochloride | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Empagliflozin and Metformin Hydrochloride tablets | Each Film Coated Tablet Contains:- | IP | 5 mg | Antidiabetic |
Empagliflozin | 1000 mg | |||
Metformin Hydrochloride | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Empagliflozin and Metformin Hydrochloride tablets | Each Film Coated Tablet Contains:- | IP | 12.5 mg | Antidiabetic |
Empagliflozin | 500 mg | |||
Metformin Hydrochloride | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Empagliflozin and Metformin Hydrochloride tablets | Each Film Coated Tablet Contains:- | IP | 12.5 mg | Antidiabetic |
Empagliflozin | 850 mg | |||
Metformin Hydrochloride | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Empagliflozin and Linagliptin tablets | Each Film Coated Tablet Contains:- | 10 mg | Antidiabetics | |
Empagliflozin | 5 mg | |||
Linagliptin | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Empagliflozin and Metformin Hydrochloride tablets | Each Film Coated Tablet Contains:- | IP | 12.5 mg | Antidiabetic |
Empagliflozin | 1000 mg | |||
Metformin Hydrochloride | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Metformin HCl (Sustained Release) Glimepiride &Voglibose Tablet | Each Film Coated tablet contains: | IP | 500 mg | Antidiabetic |
Metformin HCl | IP | 3 mg | ||
(As Sustained Release) | IP | 0.3 mg | ||
Glimepiride | q.s | |||
Voglibose | ||||
Excipients | ||||
Colour-Approved colour used | ||||
Dapagliflozin &Metformin Hydrochloride Tablet | Each film coated tablet contains: | IP | 10 mg | Antidiabetic |
Dapagliflozin | 500 mg | |||
Metformin Hydrochloride | q.s | |||
(Extended Release) | ||||
Excipients | ||||
Colour-Approved colour used. | ||||
Dapagliflozin &Metformin Hydrochloride Tablet | Each film coated tablet contains: | IP | 10 mg | Antidiabetic |
Dapagliflozin | 1000 mg | |||
Metformin Hydrochloride | q.s | |||
(Extended Release) | ||||
Excipients | ||||
Colour-Approved colour used. | ||||
Gliclazide and Metformin Hydrochloride Tablets | Each Film Coated Extended Release Tablet Contains:- | IP | 80 mg | Antidiabetic |
Gliclazide | IP | 500 mg | ||
Metformin Hydrochloride | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Gliclazide and Metformin Hydrochloride Tablets | Each Uncoated Tablet Contains:- | IP | 80 mg | Antidiabetic |
Gliclazide | IP | 500 mg | ||
Metformin Hydrochloride | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Repaglinide Tablets IP 1 mg | Each Uncoated Tablet Contains:- | IP | 1 mg | Antidiabetic |
Repaglinide | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Antiemetics | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Pantoprazole Sodium (Enteric Coated) & Itopride Hydrochloride (Sustained Release) Capsule | Each Hard Gelatin Capsule contain: | IP | 40 mg | Antiemetics |
Pantoprazole Sodium Sesquihydrate | ||||
Equivalent to Pantoprazole | ||||
(As enteric coated pellets) | 150 mg | |||
Itopride Hydrochloride | ||||
(As sustained release pellets) | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Palonosetron melt in mouth Tablets 0.5 mg | Each Uncoated Tablets contains: | 0.5 mg | antiemetics | |
Palonosetron Hydrochloride | q.s | |||
Eq. to Palonosetron | ||||
Excipients | ||||
Colour: Approved Colour Used | ||||
Ondansetron Orally Disintegrating Tablets IP | Each Uncoated Orally Disintegrating Tablet Contains:- | Antiemetic | ||
Ondansetron Hydrochloride IP | ||||
Eq. to Ondansetron ——— 4 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Ondansetron Orally Disintegrating Tablets IP | Each Uncoated Orally Disintegrating Tablet Contains:- | Antiemetic | ||
Ondansetron Hydrochloride IP | ||||
Eq. to Ondansetron ——— 8 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Metclopramide Hydrochloride Tablets IP | Each Uncoated Tablet Contains:- | Antiemetic | ||
Metclopramide Hydrochloride IP | ||||
Eq. to Metclopramide Anhydrous —- 10 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Cinnarizine & Domperidone Tablets | Each Uncoated Tablet Contains:- | Antiemetic | ||
Cinnarizine IP ————————– 20 mg | ||||
Domperidone IP ———————— 15 mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Gastric resistant Antiemetics | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Pantoprazole sodium & Domperidone capsule | Each hard gelatin capsule contains: | IP | 40 mg | Gastric resistant Antiemetics |
Pantoprazole sodium sesquihydrate | ||||
eq. to Pantoprazole | 10 mg | |||
(as enteric coated pellets) | IP | q.s. | ||
Domperidone | ||||
(As Sustained release) | ||||
Excipients | ||||
Approved colour used in | ||||
Empty capsule shells. | ||||
Omeprazole & Domperidone capsule IP | Each hard gelatin capsule contains | IP | 20 mg | Gastric resistant Antiemetics |
Omeprazole | ||||
(As Enteric coated pallets) | IP | 30 mg | ||
Domperidone | ||||
(As Sustain Release pallets) | q.s. | |||
Excipients | ||||
Approved colour used in empty capsule shell | ||||
Pantoprazole Sodium (EC) & Domperidone (SR)capsule IP | Each hard gelatin capsule contains | IP | 40 mg | Gastric resistant Antiemetics |
Pantoprazole Sodium | ||||
(As Enteric coated pallets) | IP | 30 mg | ||
Domperidone | ||||
(10 mg as immediate release & 20 mg As Sustain Release pallets) | q. s. | |||
Excipients | ||||
Approved colour used in empty capsule shell | ||||
Rabeprazole Sodium (EC)&Levosulpride (SR) Capsule | Each hard gelatin capsules contains: | IP | 20 mg | Gastric resistant Antiemetics |
Rabeprazole Sodium | ||||
(As enteric coated pellets) | IP | 75 mg | ||
Levosulpride | ||||
(As sustained release pellets) | q.s. | |||
Excipients | ||||
Approved Colours Used in Capsule Shell & Pellets | ||||
Rabeprazole Sodium (EC) & Domperidone (SR)capsules | Each hard gelatin capsule contains | IP | 20 mg | Gastric resistant Antiemetics |
Rabeprazole Sodium | ||||
(As Enteric coated pallets) | IP | 30 mg | ||
Domperidone | ||||
(As Sustained Release pallets) | q. s. | |||
Excipients | ||||
Approved colour used in empty capsule shell | ||||
Omeprazole Capsule IP | Each Hard gelatin capsule contains | IP | 20 mg | Gastric resistant Antiemetics |
Omeprazole | ||||
(As Enteric coated pallets) | q.s. | |||
Excipients | ||||
Approved colour used. in empty capsule shell | ||||
Esomeprazole & Itopride Capsules | Each hard gelatin capsule contains: | IP | 40 mg | Gastric resistant Antiemetics |
Esomeprazole magnesium | ||||
(As enteric Coated pellets) | 150 mg | |||
Itopride | q.s. | |||
(As SR pellets) | ||||
Excipients | ||||
Approved colour used in | ||||
empty capsule shells. | ||||
Esomeprazole (Enteric-coated) & Levosulpiride(Sustained-release) Capsules | Each hard gelatin Capsule contains : | IP | 40mg | Gastric resistant Antiemetics |
Esomeprazole Magnesium Trihydrate | ||||
Equ. to Esomeprazole | 75mg | |||
(as enteric coated pellets) | IP | |||
Levosulpiride | q.s | |||
(as sustained release pellets) | ||||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Omeprazole & Domperidone Capsules | Each hard gelatin capsule Contains: | IP | 20 mg | Gastric resistant Antiemetics |
Omeprazole | IP | 10 mg | ||
(Enteric Coated pellets) | q.s. | |||
Domperidone | ||||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Aceclofenac& Rabeprazole Capsule | Each hard gelatin Capsule contain: | IP | 200 mg | Gastric resistant Antiemetics |
Aceclofenac (SR) | IP | 10 mg | ||
Rabeprazole sodium | ||||
(As enteric coated pellets) | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Aceclofenac& Rabeprazole Capsule | Each hard gelatin Capsule contain: | IP | 200 mg | Gastric resistant Antiemetics |
Aceclofenac (SR) | IP | 20 mg | ||
Rabeprazole sodium | q.s. | |||
(As enteric coated pellets) | ||||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Pantoprazole Sodium (EC) &Itopride (ER) Capsules | Each hard gelatin capsule contains: | IH | 40 mg | Gastric resistant Antiemetics |
Pantoprazole Sodium (as EC pellets) | IP | 150 mg | ||
Itopride (ER pellets) | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Pantoprazole Sodium (EC) &Cinitapride (ER) Capsules | Each hard gelatin capsule contains: | IP | 40 mg | Gastric resistant Antiemetics |
Pantoprazole Sodium (as EC pellets) | IH | 3 mg | ||
Cinitapride (ER pellets) | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Omeprazole (EC) &Cinitapride (ER) Capsules | Each hard gelatin capsule contains: | IP | 20 mg | Gastric resistant Antiemetics |
Omeprazole (EC pellets) | IH | 3 mg | ||
Cinitapride (ER pellets) | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Pantoprazole sodium &Levosulpride capsule | Each hard gelatin capsule contains: | IP | 40 mg | Gastric resistant Antiemetics |
Pantoprazole sodium | ||||
eq. to Pantoprazole | 75 mg | |||
(as enteric coated pellets) | q.s. | |||
Levosulpride | ||||
(As Sustained release) | ||||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Rabeprazole sodium & Itopride Capsules | Each hard gelatin capsule contains: | IP | 20 mg | Gastric resistant Antiemetics |
Rabeprazole sodium | ||||
(As enteric Coated pellets) | 150 mg | |||
Itopride | ||||
(As SR pellets) | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Dexlansoprazole delayed release capsules | Each hard gelatin capsule contains: | IP | 30.0 mg | Gastric Resistance & Anti Emetics |
Dexlansoprazole | q.s. | |||
(As delayed release) | ||||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Dexlansoprazole delayed release capsules | Each hard gelatin capsule contains: | IP | 60.0 mg | Gastric Resistance & Anti Emetics |
Dexlansoprazole | q.s. | |||
(As delayed release) | ||||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Cinitapride Extended Release Tablets | Each Uncoated Extended Release Tablets contains: | 3 mg | Gastric Resistance & Anti Emetics | |
Cinitapride Hydrogen Tartarate | q.s | |||
Eq. to Cinitapride | ||||
Excipients | ||||
Colour: Approved Colour Used | ||||
Domperidone Tablets I.P. | Each Film Coated Tablet Contains:- | Gastric Resistance & Anti Emetics | ||
Domperidone Maleate I.P. | ||||
Eq. to Domperidone ———-10 mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Pantoprazole Gastro Resistant Tablets IP | Each Enteric Coated Tablet Contains:- | Gastric resistance & anti emetics | ||
Pantoprazole Sodium IP | ||||
Eq. to Pantoprazole ————–20 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Rabeprazole Sodium Gastro Resistant Tablets IP | Each Enteric Coated Tablet Contains:- | Gastric resistance & anti emetics | ||
Rabeprazole Sodium IP ——— 10 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Esomeprazole Gastro resistant Tablet IP | Each Enteric Coated Tablet Contains:- | Gastric resistance & anti emetics | ||
Esomeprazole magnesium Trihydrate IP | ||||
Eq. to Esomeprazole ———— 20 mg | ||||
Excipients———-q.s. | ||||
Colour-Approved colour used. | ||||
Esomeprazole Gastro resistant Tablet IP | Each Enteric Coated Tablet Contains:- | Gastric resistance & anti emetics | ||
Esomeprazole magnesium Trihydrate IP | ||||
Eq. to Esomeprazole ———— 30 mg | ||||
Excipients———-q.s. | ||||
Colour-Approved colour used. | ||||
Pantoprazole sodium& Ondansetron Tablets | Each Enteric Coated Tablet Contains:- | Gastric Resistance & Anti Emetics | ||
Pantoprazole sodium | ||||
Eq. to Pantoprazole…………………………IP 40mg | ||||
Ondansetron Hydrochloride | ||||
Eq. to Ondansetron…………………………IP 4mg | ||||
Excipients……………………………….q.s | ||||
Colour-Approved colour used. | ||||
Pantoprazole Sodium (EC) & Domperidone (SR)capsule IP | Each hard gelatin capsule contains:- | Gastric Resistance & Anti Emetics | ||
Pantoprazole Sodium IP—– 40 mg | ||||
(As Enteric coated pallets) | ||||
Domperidone IP ————-30 mg | ||||
(As Sustained Release pallets) | ||||
Excipients | ||||
Approved colour used in empty capsule shell | ||||
Lansoprazole capsule IP 30 mg | Each Hard Gelatin capsule contains: | IP | 30mg | Gastric Resistance & Anti Emetics |
Lansoprazole | q. s. | |||
Excipients | ||||
Approved colour used | ||||
Pantoprazole Sodium (Enteric Coated) & Domperidone (Sustained Release) Capsules | Each Hard Gelatin Capsule contains: | IP | 40 mg | Gastric Resistance & Anti Emetics |
Pantoprazole Sodium | ||||
eq. to Pantoprazole | ||||
(As Enteric Coated pellets) | 30 mg | |||
Domperidone | IP | |||
(As Sustained Release pellets) | ||||
Excipients | ||||
Approved colour used | ||||
Lansoprazole Gastro Resistant capsules IP | Each hard gelatin capsule contains: | IP | 30 mg | Gastric Resistance & Anti Emetics |
Lansoprazole | qs | |||
Excipients | ||||
Approved colour used | ||||
Lansoprazole Orally Disintegrating Tablets | Each uncoated orally disintegrating tablets contains: | I.P. | 30 mg | Gastric Resistance & Anti Emetics |
Lansoprazole | q.s. | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Omeprazole Gastro resistant Capsules IP | Each hard gelatin capsule contains:- | IP | 40mg | Gastic Resistance, & Anti Emetic |
Omeprazole | ||||
(As enteric coated pellets) | q.s. | |||
Excipients | ||||
Approved colours used in empty capsule shells & pellets. | ||||
Rabeprazole sodium &Itopride( SR) Capsules | Each hard gelatin capsule contains: | IP | 20 mg | Gastic Resistance, & Anti Emetic |
Rabeprazole sodium | ||||
(As enteric Coated pellets) | 150 mg | |||
Itopride (As SR pellets) | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Esomeprazole & domperidone Capsules | Each Hard Gelatin Capsule Contains:- | IP | 40 mg | Gastic Resistance, & Anti Emetic |
Esomeprazole Magnesium Trihydrate | 30.0 mg | |||
Eq. to Esomeprazole | IP | |||
( as enteric coated pellets ) | q.s. | |||
Domperidone | ||||
(as sustained release pellets ) | ||||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Esomeprazole & domperidone Capsules | Each Hard Gelatin Capsule Contains:- | IP | 20 mg | Gastic Resistance, & Anti Emetic |
Esomeprazole Magnesium Trihydrate | 30.0 mg | |||
Eq. to Esomeprazole | IP | |||
( as enteric coated pellets ) | q.s. | |||
Domperidone | ||||
(as sustained release pellets ) | ||||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Esomeprazole & Itopride Capsules | Each hard gelatin capsule contains: | IP | 20 mg | Gastic Resistance, & Anti Emetic |
Esomeprazole Magnesium Trihydrate | 150 mg | |||
Eq. to Esomeprazole | IP | q.s. | ||
( as enteric coated) | ||||
Itopride (As SR pellets) | ||||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Esomeprazole Gastro- Resistant Capsules IP | Each Hard Gelatin Capsule Contains: | IP | 20.0 mg | Gastric Resistance, & Anti Emetic |
Esomeprazole Magnesium Trihydrate | q.s. | |||
Eq. to Esomeprazole | ||||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell0 | ||||
Esomeprazole Gastro- Resistant Capsules IP | Each Hard Gelatin Capsule Contains: | IP | 40.0 mg | Gastic Resistance, & Anti Emetic |
Esomeprazole Magnesium Trihydrate | q.s. | |||
Eq. to Esomeprazole | ||||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Lansoprazole OrallyDisintegratingTablets | EachUncoatedorallyDisintegratingTabletContains:- | Gastric Resistance, Antispasmodic & Anti Emetic | ||
Lansoprazole IP———-15mg | ||||
Excipients q.s. | ||||
Colour-Approvedcolour used. | ||||
Tranexamic acid and Mefenamic Acid Tablets | Each Uncoated Tablet Contains: – | Gastric Resistance, Antispasmodic & Anti Emetic | ||
Tranexamic acid IP ———–500 mg | ||||
Mefenamic Acid IP ——– 250 mg | ||||
Excipients……………q.s. | ||||
Colour : Approved Colour Used | ||||
Sodium Bicarbonate IP | Each film Coated Tablet Contains: | Gastric Resistance, Antispasmodic & Anti Emetic | ||
Sodium Bicarbonate IP —————- 1000 mg | ||||
Excipients……………q.s. | ||||
Colour : Approved Colour Used | ||||
Lansoprazole Gastro- Resistant Capsules | Each Hard Gelatin Capsule Contains: | IP | 15.0 mg | Gastric Resistance, Antispasmodic & Anti Emetic |
Lansoprazole | q.s. | |||
(As Enteric Coated Granules) | ||||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Mefenamic Acid Capsules I.P. | Each Hard Gelatin Capsule Contains: | IP | 250 mg | Gastric Resistance, Antispasmodic & Anti Emetic |
Mefenamic Acid | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Mefenamic Acid Capsules I.P. | Each Hard Gelatin Capsule Contains: | IP | 500 mg | Gastric Resistance, Antispasmodic & Anti Emetic |
Mefenamic Acid | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Esomeprazole Gastro resistant Tablet IP | Each Enteric Coated Tablet Contains:- | Gastric Resistance, Antispasmodic & Anti Emetic | ||
Esomeprazole magnesium Trihydrate IP | ||||
Eq. to Esomeprazole ————40 mg | ||||
Excipients———-q.s. | ||||
Colour-Approved colour used. | ||||
Rabeprazole Gastro Resistant Tablets IP | Each Enteric Coated Tablet Contains:- | Gastric Resistance, Antispasmodic & Anti Emetic | ||
Rabeprazole Sodium IP ——— 20 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Rabeprazole and Domperidone Tablets | Each Enteric Coated Tablet Contains:- | Gastric Resistance, Antispasmodic & Anti Emetic | ||
Rabeprazole Sodium IP ——— 20 mg | ||||
Domperidone IP —————— 10 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Dicyclomine Tablets IP | Each Film Coated Tablet Contains:- | Gastric Resistance, Antispasmodic & Anti Emetic | ||
Dicyclomine Hydrochloride ——— 20 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Ondansetron Tablets IP | Each Film Coated Tablet Contains:- | Gastric Resistance, Antispasmodic & Anti Emetic | ||
Ondansetron Hydrochloride IP | ||||
Eq. to Ondansetron ——— 4 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Ondansetron Tablets IP | Each Film Coated Tablet Contains:- | Gastric Resistance, Antispasmodic & Anti Emetic | ||
Ondansetron Hydrochloride IP | ||||
Eq. to Ondansetron ——— 8 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Tranexamic Acid Tablets IP | Each Uncoated Tablet Contains:- | Gastric Resistance, Antispasmodic & Anti Emetic | ||
Tranexamic Acid IP ———— 500 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Cimetidine Tablets IP | Each Film Coated Tablet Contains:- | Gastric Resistance, Antispasmodic & Anti Emetic | ||
Cimetidine IP————- 400 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Famotidine Tablets IP | Each Film Coated Tablet Contains:- | Gastric Resistance, Antispasmodic & Anti Emetic | ||
Famotidine IP ——- 20 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Famotidine Tablets IP | Each Film Coated Tablet Contains:- | Gastric Resistance, Antispasmodic & Anti Emetic | ||
Famotidine IP ——- 40 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Solifenacin Succinate Tablets | Each Film Coated Tablet Contains:- | Gastric Resistance, Antispasmodic & Anti Emetic | ||
Solefenacin Succinate ——- 5 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Solefenacin Succinate Tablets | Each Film Coated Tablet Contains:- | Gastric Resistance, Antispasmodic & Anti Emetic | ||
Solefenacin Succinate ——- 10 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Analgesic & antiemetics | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Domperidone & Paracetamol Tablets | Each Enteric Coated Tablet Contains:- | Analgesic & antiemetics | ||
Domperidone IP —————— 10 mg | ||||
Paracetamol IP —————— 325 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Antiviral | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Aciclovir Cream IP | Compositions | IP | 5% w/w | Antiviral |
Aciclovir | q.s. | |||
In a cream base | ||||
Aciclovir Tablet IP 200 mg | Each uncoated tablet Contains | IP | 200 mg | Antiviral |
Aciclovir | q.s. | |||
Excipients | ||||
Colour: Approved Colour Used | ||||
Aciclovir Tablets IP 200 mg | Each Film Coated Tablet Contains:- | IP | 200mg | Antiviral |
Aciclovir | q.s | |||
Excipients. | ||||
Colour-Approved colour used. | ||||
Aciclovir Tablets IP 800 mg | Each Film Coated Tablet Contains:- | IP | 800mg | Antiviral |
Aciclovir | q.s | |||
Excipients. | ||||
Colour-Approved colour used. | ||||
Griseofulvin Tablets IP | Each Uncoated Tablet Contains:- | IP | 250 mg | Antiviral |
Griseofulvin | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Griseofulvin Tablets IP | Each Film Coated Tablet Contains:- | Antiviral | ||
Griseofulvin IP——— 125 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Griseofulvin Tablets IP | Each Film Coated Tablet Contains:- | Antiviral | ||
Griseofulvin IP——— 500 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Lopinavir and Ritonavir Tabl ets IP | Each Film Coated Tablet Contains:- | Antiviral | ||
Lopinavir IP —————200 mg | ||||
Ritonavir IP ————–50 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Lopinavir and Ritonavir Tablets IP | Each Film Coated Tablet Contains:- | Antiviral | ||
Lopinavir IP —————100 mg | ||||
Ritonavir IP ————– 25 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Aciclovir DispersibleTablets IP | Each Uncoated Dispersible Tablet Contains:- | Antiviral | ||
Aciclovir IP 200mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Aciclovir DispersibleTablets IP | Each Uncoated Dispersible Tablet Contains:- | Antiviral | ||
Aciclovir IP 400mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Aciclovir DispersibleTablets IP | Each Uncoated Dispersible Tablet Contains:- | Antiviral | ||
Aciclovir IP 800mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Rifaximin Tablets | Each Film Coated Tablet Contains:- | Antiviral | ||
Rifaximin BP ———– 200 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Rifaximin Tablets | Each Film Coated Tablet Contains:- | Antiviral | ||
Rifaximin BP ———– 400 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Rifaximin Tablets | Each Film Coated Tablet Contains:- | Antiviral | ||
Rifaximin BP ———– 550 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Rifaximin Dispersible Tablets | Each Uncoated Dispersible Tablet Contains:- | Antiviral | ||
Rifaximin BP ———– 200 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Valacyclovir Tablets | Each Film Coated Tablet Contains:- | Antiviral | ||
Valacyclovir Hydrochloride USP—1000 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Valacyclovir Tablets | Each Film Coated Tablet Contains:- | Antiviral | ||
Valacyclovir Hydrochloride USP—500 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Entecavir Tablet IP | Each Uncoated Tablet Contains:- | Antiviral | ||
Entecavir IP—————- 0.5 mg | ||||
(As monohydrate) | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Entecavir Tablet IP | Each Uncoated Tablet Contains:- | Antiviral | ||
Entecavir IP—————- 0.1 mg | ||||
(As monohydrate) | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Nitrofurantoin SR Tablets | Each Film Coated Sustained Release Tablet Contains:- | Antiviral | ||
Nitrofurantoin BP ————– 100 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Doxycycline Hyclate Tablet IP | Each film coated tablet contains: | Antiviral | ||
Doxycycline Hyclate | ||||
Eq. to Doxycycline——— 100 mg. | ||||
Excipients —————– q.s | ||||
Colour-approved colour used. | ||||
Tenofovir Disoproxil Fumarate tablet IP 300 mg | Each Film Coated Tablet contain: | Antiviral | ||
Tenofovir Disoproxil Fumarate IP—–300 mg | ||||
Excipients —————–q.s | ||||
Colour: approved colour used | ||||
Nitrofurantoin Tablets IP | Each Film Coated Tablet Contains:- | Antiviral | ||
Nitrofurantoin IP ————– 100 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Aciclovir Tablets IP | Each Uncoated Tablet Contains:- | Antiviral | ||
Aciclovir IP 200mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Aciclovir Tablets IP | Each Uncoated Tablet Contains:- | Antiviral | ||
Aciclovir IP 400mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Aciclovir Tablets IP | Each Uncoated Tablet Contains:- | Antiviral | ||
Aciclovir IP ——— 800mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Nitrofurantoin Tablets IP 50 mg | Each Uncoated Tablet Contains:- | IP | 50 mg | Antiviral |
Nitrofurantoin | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Nitrofurantoin Tablets IP 100 mg | Each Uncoated Tablet Contains:- | IP | 100 mg | Antiviral |
Nitrofurantoin | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Analgesics And Antipyretics | ||||
Ibuprofen Tablets IP 600 mg | Each Film Coated Tablet Contains:- | IP | 600 mg | Analgesics And Antipyretics |
Ibuprofen | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Ibuprofen and Paracetamol Tablets IP | Each Film Coated Tablet Contains:- | Analgesics And Antipyretics | ||
Ibuprofen IP ———— 400 mg | ||||
Paracetamol ————-325 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Ibuprofen Tablets IP | Each Film Coated Tablet Contains:- | Analgesics And Antipyretics | ||
Ibuprofen IP —————-400 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Ibuprofen Tablets IP | Each Film Coated Tablet Contains:- | Analgesics And Antipyretics | ||
Ibuprofen IP —————- 200 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Aceclofenac Tablets IP | Each Film Coated Tablet Contains:- | Analgesics And Antipyretics | ||
Aceclofenac IP ————— 100 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Aceclofenac And Paracetamol Tablets | Each Film Coated Tablet Contains:- | Analgesic & Antipyretic | ||
Aceclofenac IP —————- 100 mg | ||||
Paracetamol IP ————— 325 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Nimesulide and Paracetamol (Not for below 12 Years) | Each Film Coated Tablet Contains:- | Analgesic & Antipyretic | ||
Nimesulide BP ————-100 mg | ||||
Paracetamol IP ————–325 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Anticoagulant | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Dabigatran Etexilate capsule 150 mg | Each hard gelatin capsule contains: | IH | 150 mg | Anticoagulant |
Dabigatran etexilatemesilate | q.s. | |||
eq. to Dabigatran | ||||
Excipients | ||||
Approved colours used in Empty capsules shells. | ||||
Heparin Sodium , Benzyl nicotinate and Sorbic Acid ointment | Composition: | IP | 50 IU | Anticoagulant |
Heparin Sodium | IP | 2.0 mg | ||
Benzyl Nicotinate | 1.97 mg | |||
Sorbic Acid | q.s. | |||
Ointment base | ||||
Nicoumalone Tablets IP 2 mg | Each uncoated tablet Contains: | IP | 2 mg | Anticoagulant |
Nicoumalone | q.s. | |||
Excipients | ||||
Colour: Approved ColourUsed | ||||
Nicoumalone Tablets IP 4 mg | Each uncoated tablet Contains: | IP | 4 mg | Anticoagulant |
Nicoumalone | q.s. | |||
Excipients | ||||
Colour: Approved ColourUsed | ||||
Rivaroxaban Tablets 2.5 mg | Each Film coated Tablet Contains:- | 2.5 mg | Anticoagulant | |
Rivaroxaban | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Warfarin Tablets IP | Each Uncoated Tablet Contains:- | Anticoagulant | ||
Warfarin Sodium Clathrate IP | ||||
Eq. to Warfarin —————5 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Nicoumalone Tablets IP | Each uncoated Tablet Contains:- | Anticoagulant | ||
Nicoumalone IP ———— 2 mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Nicoumalone Tablets IP | Each uncoated Tablet Contains:- | Anticoagulant | ||
Nicoumalone IP ———— 4 mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Warfarin sodium tablet IP 5.0 mg | Each uncoated tablet contains: | Anti-Coagulants | ||
Wafarin sodium clathrate IP | ||||
Equivalent to Warfarin sodium—–5.0 mg | ||||
Excipients ————–q.s. | ||||
Colour: Approved colour used | ||||
Anticanvalsant | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Pregabalin &Methylcobalamin Capsule IP | Each hard gelatin capsule contains: | IP | 75 mg | Anticanvalsant |
Pregabalin | 750 mcg | |||
Methylcobalamin | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Pregabalin (Sustained Release) & Methylcobalamin Tablets | Each Film Coated Tablet Contains:- | Anticanvalsant | ||
Pregabalin IP | ||||
(As Sustained Release) ———-–75 mg | ||||
Methylcobalamin IP ————– 1500 mcg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Pregabalin, Nortriptyline & Methylcobalamin Tablets | Each Film Coated Tablet Contains:- | Anticanvalsant | ||
Pregabalin IP | ||||
(As Sustained Release) ———-–75 mg | ||||
Nortriptyline IP ———————- 10 mg | ||||
Methylcobalamin IP ————– 1500 mcg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Carbamazepine Tablets IP | Each Uncoated Tablet Contains:- | Anticonvulsants. | ||
Carbamazepine IP—– 200 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Phenobarbitone tablets IP | Each Uncoated Tablet Contains:- | Anticanvalsant | ||
Phenobarbitone IP—– 30 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Phenobarbitone tablets IP | Each Uncoated Tablet Contains:- | Anticanvalsant | ||
Phenobarbitone IP—– 60 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Nortriptyline IP Tablets | Each Film Coated Tablet Contains:- | Anticanvalsant | ||
Nortriptyline Hydrochloride | ||||
Eq. to Nortriptyline IP ————-25 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Sodium Valproate & Valproic Acid | Each Film Coated Tablet Contains:- | Anticanvalsant | ||
Sodium Valproate IP————- 333 mg | ||||
Valproic Acid IP ——————- 145 mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Oxcarbazepine Tablet | Each uncoated Tablet Contains:- | Anticanvalsant | ||
Oxcarbazepine ———— 300 mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Oxcarbazepine Tablet | Each uncoated Tablet Contains:- | Anticanvalsant | ||
Oxcarbazepine ———— 600 mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Piracetam with Citicoline Sodium Tablets | Each film coated tablet contains: | Anticanvalsant | ||
Citicoline Sodium IP | ||||
equivalent to Citicoline ———– 500 mg | ||||
Piracetam———– 800 mg | ||||
Excipients—————–q.s | ||||
Colour-Approved colour used. | ||||
Pregabalin & Nortriptyline Tablets | Each Film Coated Tablet Contains:- | Anticanvalsant | ||
Pregabalin IP —————–75 mg | ||||
Nortriptyline IP ———————- 10 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Gabapentin Tablets IP 100 mg | Each Film Coated Tablet Contains:- | Anticanvalsant | ||
Gabapentin…………………………IP 100mg | ||||
Excipients……………………………….q.s | ||||
Colour-Approved colour used. | ||||
Gabapentin & Nortriptyline Hydrochloride Tablets | Each Film Coated Tablet Contains:- | Anticanvalsant | ||
Gabapentin…………………………IP 100mg | ||||
Nortriptyline Hydrochloride | ||||
Eq. to Nortriptyline…………………………IP 10mg | ||||
Excipients……………………………….q.s | ||||
Colour-Approved colour used. | ||||
Sodium Picosulfate tablets 10 mg | Each uncoated Tablet Contains:- | BP | 10 mg | Anticanvalsant |
Sodium Picosulfate | q. s. | |||
Excipients | ||||
Colour-Approved colours used. | ||||
Sodium Valproate Controlled release tablets 200 mg | Each film coated controlled release tablet contains:- | IP | 133.5 mg | Anticanvalsant |
Sodium Valproate | IP | 58 mg | ||
Valproic Acid | ||||
(Both together corresponds to Sodium Valproate IP 200 mg) | ||||
Excipients | q. s. | |||
Colour-Approved colours used. | ||||
Sodium Valproate Controlled release tablets 300 mg | Each film coated controlled release tablet contains:- | IP | 200 mg | Anticanvalsant |
Sodium Valproate | IP | 87 mg | ||
Valproic Acid | ||||
(Both together corresponds to sodium valproate IP 300 mg) | ||||
Excipients | q. s. | |||
Colour-Approved colours used. | ||||
Sodium Valproate Controlled release tablets 500 mg | Each film coated controlled release tablet contains:- | IP | 133 mg | Anticanvalsant |
Sodium Valproate | IP | 145 mg | ||
Valproic Acid | ||||
(Both together corresponds to sodium valproate IP 500 mg) | ||||
Excipients | q. s. | |||
Colour-Approved colours used. | ||||
Pregabalin capsule IP | Each hard gelatin capsule contains: | IP | 75mg | Anticanvalsant |
Pregabalin | qs | |||
Excipients | ||||
Approved colour used | ||||
Pregabalin Capsules I.P. | Each hard gelatin capsule contains:- | I.P. | 300 mg | Anticanvalsant |
Pregabalin | q.s. | |||
Excipients | ||||
Colour – Approved colour used. | ||||
Gabapentin & Methylcobalamin Tablets | Each Film Coated Tablet Contains:- | Anticonvulsant | ||
Gabapentin IP —————– 300 mg | ||||
Methylcobalamin IP ————500 mcg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Divalproex Sodium Extended Release Tablets IP | Each Film Coated Extended Release Table Contains:- | Anticonvulsant | ||
Divalproex Sodium IP | ||||
Eq. to Valproic Acid ———- 250 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Divalproex Sodium Extended Release Tablets IP | Each Film Coated Extended Release Tablet Contains:- | Anticonvulsant | ||
Divalproex Sodium IP | ||||
Eq. to Valproic Acid ———- 500 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Phenytoin Sodium Tablet IP | Each Film Coated Tablet Contains:- | Anticonvulsant | ||
Phenytoin Sodium IP ——100 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Sodium Valproate Tablets IP | Each Film Coated Tablet Contains:- | Anticonvulsant | ||
Sodium Valproate IP ———– 100 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Sodium Valproate Tablets IP | Each Film Coated Tablet Contains:- | Anticonvulsant | ||
Sodium Valproate IP ———– 200 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Pregabalin Sustained Release Tablets | Each Film Coated Sustained Release Tablet Contains:- | Anticonvulsant | ||
Pregabalin IP ———– 75 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Gabapentin Tablets IP | Each Film Coated Tablet Contains:- | anticonvulsants | ||
Gabapentin IP ————— 300 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Gabapentin Tablets IP | Each Film Coated Tablet Contains:- | anticonvulsants | ||
Gabapentin IP ————— 400 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Gabapentin Tablets IP | Each Film Coated Tablet Contains:- | anticonvulsants | ||
Gabapentin IP ————— 800 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Gabapentin & Methylcobalamin Tablets | Each Film Coated Tablet Contains:- | Anticonvulsants | ||
Gabapentin IP —————– 100 mg | ||||
Methylcobalamin IP ————500 mcg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Perampanel Tablets 2 mg | Each Film coated Tablet Contains:- | 2 mg | Anticonvulsants | |
Perampanel | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Perampanel Tablets 4 mg | Each Film coated Tablet Contains:- | 4 mg | Anticonvulsants | |
Perampanel | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Perampanel Tablets 6 mg | Each Film coated Tablet Contains:- | 6 mg | Anticonvulsants | |
Perampanel | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Perampanel Tablets 10 mg | Each Film coated Tablet Contains:- | 10 mg | Anticonvulsants | |
Perampanel | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Perampanel Tablets 12 mg | Each Film coated Tablet Contains:- | 12 mg | Anticonvulsants | |
Perampanel | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Brivaracetam Tablets 50 mg | Each Film Coated Tablet Contains:- | 50 mg | Anticonvulsants | |
Brivaracetam | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Brivaracetam Tablets 75 mg | Each Film Coated Tablet Contains:- | 75 mg | Anticonvulsants | |
Brivaracetam | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Brivaracetam Tablets 100 mg | Each Film Coated Tablet Contains:- | 100 mg | Anticonvulsants | |
Brivaracetam | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Zonisamide Capsule IP 25mg | Each hard gelatin capsule contains:- | IP | 25mg | Anticonvulsants |
Zonisamide | q.s. | |||
Excipients | ||||
Colour: Approved colours used in empty capsule shells. | ||||
Zonisamide Capsule IP 50mg | Each hard gelatin capsule contains:- | IP | 50mg | Anticonvulsants |
Zonisamide | q.s. | |||
Excipients | ||||
Colour: Approved colours used in empty capsule shells. | ||||
Zonisamide Capsule IP 100mg | Each hard gelatin capsule contains:- | IP | 100mg | Anticonvulsants |
Zonisamide | q.s. | |||
Excipients | ||||
Colour: Approved colours used in empty capsule shells. | ||||
Antimigrain | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Propranolol & Flunarizine Capsules | Each Hard gelatin capsule contain: | IP | 40 mg | Antimigrain |
Propranolol HCl IP | IH | 5 mg | ||
Eq. to Propranolol (as SR pellets) | q.s. | |||
Flunarizine | ||||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Propranolol & Flunarizine Capsules | Each Hard gelatin capsule contain: | IP | 40 mg | Antimigrain |
Propranolol HCl IP | IH | 10 mg | ||
Eq. to Propranolol (as SR pellets) | q.s. | |||
Flunarizine | ||||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Naproxen Tablets IP | Each Film Coated Tablet Contains:- | Antimigrain | ||
Naproxen IP ———– 250 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Naproxen Tablets IP | Each Film Coated Tablet Contains:- | Antimigrain | ||
Naproxen IP ———– 500 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Flunarizine Tablets | Each uncoated tablet contains: | Antimigrain | ||
Flunarizine Dihydrochloride | ||||
Eq. to Flunarizine——————— 10 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Naproxen SR Tablets IP | Each Uncoated sustained Release Tablet Contains:- | Antimigrain | ||
Naproxen IP ———– 250 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Naproxen SR Tablets IP | Each Uncoated sustained Release Tablet Contains:- | Antimigrain | ||
Naproxen IP ———– 500 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Cinnarizine Tablet IP | Each Uncoated Tablet Contains:- | Antimigrain | ||
Cinnarizine IP ———– 25 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Naproxen Sodium & Domperidone Tablets | Each Film coated Tablet | Antimigrain | ||
Contains:- | ||||
Naproxen Sodium……………………… USP 500mg | ||||
Domperidone Maleate………………….IP | ||||
Eq. to Domperidone……………………….10mg | ||||
Excipients………………………………………..q.s | ||||
Colour-Approved colour used. | ||||
Naproxen Sodium & Domperidone Tablets | Each film coated tablet contains: | BP | 500 mg | Antimigrain |
Naproxen Sodium | IP | 10 mg | ||
Domperidone | q.s. | |||
Excipients | ||||
Approved colour used | ||||
Eletriptan Tablets 20 mg | Each Film Coated Tablet Contains:- | IP | 20 mg | Antimigraine |
Eletriptan Hydrobromide | q.s | |||
Eq. to Eletriptan | ||||
Excipients | ||||
Colour-Approved colour used. | ||||
Eletriptan Tablets 40 mg | Each Film Coated Tablet Contains:- | IP | 40 mg | Antimigraine |
Eletriptan Hydrobromide | q.s | |||
Eq. to Eletriptan | ||||
Excipients | ||||
Colour-Approved colour used. | ||||
Naproxen Sodium & Domperidone tablets | Each Film coated Tablet Contains:- | Antimigrain | ||
Naproxen Sodium ………………USP 250mg | ||||
Domperidone Maleate……………..IP | ||||
Eq. to Domperidone………………10mg | ||||
Excipients……………………………….q.s | ||||
Colour-Approved colour used. | ||||
Naproxen Prolonged – Release Tablets | Each Film Coated Prolonged – Release Tablets Contains:- | Antimirgrain | ||
Naproxen IP ————— 375 mg | ||||
Excipients——————q.s. | ||||
Colour-Approved colour used. | ||||
Propranolol (SR) & Flunarizine Tablets | Each uncoated Bilayered tablet contains: | anti-migraine | ||
Propranolol HCl | ||||
(in Sustained Release) IP ————–40 mg | ||||
Flunarizine Dihydrochloride BP | ||||
Eq. to Flunarizine——————— 10 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Antispasmodic | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Hyoscine Butylbromide Tablets 10 mg | Each Uncoated Tablet Contains:- | IP | 10 mg | Antispasmodic |
Hyoscine Butylbromide | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Drotaverine hydrochloride & Mefenamic Acid Tablets | Each Film Coated Tablet Contains:- | Antispasmodic | ||
Drotaverine hydrochloride I.P.——80 mg | ||||
Mefenamic Acid I.P. ………………250 mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Dicyclomine HCl and Mefenamic Acid Tablets IP | Each Film Coated Tablet Contains:- | Antispasmodic | ||
Dicyclomine HCl IP ——— 10 mg | ||||
Mefenamic Acid ————250 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Mefenamic Acid & Dicyclomine Hydrochloride Tablets IP | Each uncoated tablet Contains:- | Antispasmodic | ||
Mefenamic Acid…………………………IP 250mg | ||||
Dicyclomine Hydrochloride…………………………IP 10mg | ||||
Excipients……………………………….q.s | ||||
Colour-Approved colour used. | ||||
Mefenamic Acid & Drotaverine Hydrochloride Tablets | Each uncoated tablet contains: | I.P. | 250 mg | Antispasmodic |
Mefenamic Acid | I.P. | 80 mg | ||
Drotaverine Hydrochloride | q.s. | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Tamsulosin Hydrochloride (Modified Release) &Tolteridone Tartrate (Extended release) Capsules | Each hard gelatin capsule contains:- | IP | 0.4mg | Antispasmodic |
Tamsulosin Hydrochloride | ||||
(As Modified release pellets) | IP | 2mg | ||
Tolteridone Tartrate(As Extended release pellets) | ||||
Excipients | q.s. | |||
Colour: Approved colours used in empty capsule shells & Pellets. | ||||
Tamsulosin Hydrochloride (Modified Release) &Tolteridone Tartrate (Extended release) Capsules | Each hard gelatin capsule contains:- | IP | 0.4mg | Antispasmodic |
Tamsulosin Hydrochloride | ||||
(As Modified release pellets) | IP | 4mg | ||
Tolteridone Tartrate | ||||
(As Extended release pellets) | q.s. | |||
Excipients | ||||
Colour: Approved colours used in empty capsule shells & Pellets. | ||||
Tamsulosin Hydrochloride (Prolonged Release) & Dutasteride Capsules IP | Each hard gelatin capsule contains:- | IP | 0.4mg | Antispasmodic |
Tamsulosin Hydrochloride | ||||
(As Prolonged release pellets) | IP | 0.5mg | ||
Dutasteride | q.s. | |||
Excipients | ||||
Colour: Approved colours used in empty capsule shells & Pellets. | ||||
Mirabegron Extended Release Tablets 25 mg | Each Film Coated Extended Release Tablet Contains:- | 25 mg | Antispasmodics | |
Mirabegron | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Pinaverium Bromide Tablets 50 mg | Each Film Coated Tablet Contains:- | 50 mg | Antispasmodic agents | |
Pinaverium Bromide | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Antiameanic | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Ferrous Ascorbate & Folic Acid Ta blets | Each Film Coated Tablet Contains:- | Antiameanic | ||
Ferrous Ascorbate | ||||
Eq. to Elemental Iron ———– 100 mg | ||||
Folic Acid IP ——————– 1.5 mg | ||||
Excipients—————– q.s. | ||||
Colour-Approved colour used. | ||||
Ferrous Ascorbate, Folic Acid & Zinc Tablets | Each Film Coated Tablet Contains:- | Antiameanic | ||
Ferrous Ascorbate | ||||
Eq. to Elemental Iron ———– 100 mg | ||||
Folic Acid IP ——————– 1.5 mg | ||||
Zinc Sulphate Monohydrate IP | ||||
Eq. to elemental Zinc———- 22.5 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Anthelmintic | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Diethylcarbamazine Tablets IP | Each Uncoated Tablet Contains:- | Anthelmintic | ||
Diethylcarbamazine Citrate IP—– 50 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Diethylcarbamazine Tablets IP | Each Uncoated Tablet Contains:- | Anthelmintic | ||
Diethylcarbamazine Citrate IP—- 100 mg | ||||
Excipients—————–q.s | ||||
Colour-Approved colour used. | ||||
Albendazole chewable Tablets IP | Each Film Coated Tablet Contains:- | Anthelmintic | ||
Albendazole IP ———— 400 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Albendazole Tablets IP | Each uncoated chewable tablet Contains:- | Anthelmintic | ||
Albendazole …………………………IP 400mg | ||||
Excipients……………………………….q.s | ||||
Colour-Approved colour used. | ||||
Albendazole Tablets IP | Each Uncoated Tablet Contains:- | Anthelmintic | ||
Albendazole IP ———— 400 mg | ||||
Excipients—————– q.s | ||||
Albendazole and Ivermectin Tablets IP | Each Uncoated Tablet Contains:- | Anthelmintic | ||
Albendazole IP ———— 400 mg | ||||
Ivermectin ————— 6 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Ivermectin tablet | Each uncoated dispersible tablet contains: | Anthelmintics | ||
Ivermectin IP———–12.0 mg | ||||
Excipients ————–q.s. | ||||
Colour: Approved colour used | ||||
Antiamaemic | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Folic acid, Mecobalamin, Pyridoxine HCl, Docosahexaenoic acid Capsule | Each Hard Gelatin Capsule Contains: | IP | 5 mg | Antiamaemic |
Folic acid | IP | 1500 mcg | ||
Mecobalamin | IP | 1.5 mg | ||
Pyridoxine HCl | IH | 200 mg | ||
Docosahexaenoic acid | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Ferrous Ascorbate & Folic Acid Tablets I.P. | Each Film Coated Tablet Contains:- | I.P. | 100 mg | Antiamaemic |
Ferrous Ascorbate | ||||
Eq. to Elemental Iron | I.P. | 1.5 mg | ||
Folic Acid | q.s. | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Ferrous Bisglycinate, Zinc Bisglycinate, Folic Acid & Methylcobalamin Tablets | Each Film Coated Tablet Contains:- | IP | 60 mg | Antiamaemic |
Ferrous Bisglycinate | IP | |||
Eq. to elemental Iron | 15 mg | |||
Zinc Bisglycinate | 1 mg | |||
Eq. to elemental Zinc | 500 mcg | |||
Folic Acid | q.s | |||
Methylcobalamin | ||||
Excipients | ||||
Colour-Approved colour used. | ||||
Ferrous Ascorbate, Folic Acid & Zinc Tablets | Each film coated tablet contains: | IP | 100 mg | Antiamaenic |
Ferrous Ascorbate | IP | 1.5 mg | ||
Folic Acid | IP | 61.8 mg | ||
Zinc Sulphate Monohydrate | 22.5 mg | |||
Eq. to Elemental Zinc | q.s. | |||
Excipients | ||||
Approved colour used | ||||
Carbonyl Iron, folic acid & Zinc Capsules | Each hard gelatin capsule contain: | IP | 50 mg | Antiamaenic |
Carbonyl Iron | 0.5 mg | |||
Equivalent to Elemental Iron | IP | |||
Folic acid | IP | 61.8 mg | ||
Zinc sulphate monohydrate | 22.5 mg | |||
Equivalent to elemental zinc | ||||
Excipients | ||||
Approved colour used | q.s. | |||
Ferrous Ascorbate & Folic Acid Tablets | Each Film Coated Tablet Contains:- | Antianaemia | ||
Ferric Ascorbate | ||||
Eq. to Elemental Iron ————– 100 mg | ||||
Folic Acid IP ———————- 1.5 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Ferrous Ascorbate, Folic Acid & Zinc Tablets | Each Film Coated Tablet Contains:- | Antianaemia | ||
Ferric Ascorbate | ||||
Eq. to Elemental Iron ————– 100 mg | ||||
Folic Acid IP ———————- 1.5 mg | ||||
Zinc Sulphate Monohydrate IP | ||||
Eq. to elemental Zinc———— 22.5 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Antihistaminic, Cough Suppressant & Sympathomimetic | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Paracetamol Tablets IP | Each Uncoated Tablet Contains:- | Antihistaminic, Cough Suppressant & Sympathomimetic | ||
Paracetamol —————- 500 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Paracetamol Tablets IP | Each Uncoated Tablet Contains:- | Antihistaminic, Cough Suppressant & Sympathomimetic | ||
Paracetamol —————- 650 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Levocetirizine Hcl& Montelukast tablets IP | Each Film Coated Tablet Contains:- | Antihistaminic, Cough Suppressant & Sympathomimetic | ||
Levocetirizine Hcl…………………………IP 5mg | ||||
Montelukast Sodium IP | ||||
Eq. to Montelukast ………………………… 10mg | ||||
Excipients ……………………………….q.s | ||||
Colour: Approved colour used. | ||||
Levocetirizine Dihydrochloride tablets IP | Each Film Coated Tablet Contains:- | Antihistaminic, Cough Suppressant & Sympathomimetic | ||
Levocetirizine Dihydrochloride…………………………IP 5mg | ||||
Excipients ……………………………….q.s | ||||
Colour: Approved colour used. | ||||
Levocetirizine Dihydrochloride Tablets IP | Each Film Coated Tablet Contains:- | Antihistaminic, Cough Suppressant & Sympathomimetic | ||
Levocetirizine Dihydrochloride…………………………IP 10mg | ||||
Excipients…………………………………………………………………q.s | ||||
Colour-Approved colour used. | ||||
Paracetamol, Phenylephrine Hcl, Caffeine & Diphenhydramine Hcl Tablets | Each uncoated tablet contains: | Antihistaminic, Cough Suppressant & Svmpathomimetic | ||
Paracetamol…………………………IP 325mg | ||||
Phenylephrine Hcl l………………………… IP 5mg | ||||
Caffeine (Anhydrous) l…………………………IP 30mg | ||||
Diphenhydramine Hcl l…………………………IP 25mg | ||||
Excipients ……………………………….q.s | ||||
Colour: Approved colour used. | ||||
Levocetirizine Dihydrochloride and Ambroxol Hydrochloride Tablets IP | Each Film coated Tablet Contains:- | Antihistaminic, Cough Suppressant & Svmpathomimetic | ||
Levocetirizine Dihydrochloride IP —— 5 mg | ||||
Ambroxol Hydrochloride IP ————- 60 mg | ||||
Excipients—————–q.s | ||||
Colour-Approved colour used. | ||||
Levocetirizine, Phenylephrine, Ambroxol and Paracetamol Tablets IP | Each Uncoated Tablet Contains:- | Antihistaminic, Cough Suppressant & Svmpathomimetic | ||
Levocetirizine Dihydrochloride IP —— 5 mg | ||||
Phenylephrine Hydrochloride ——-5 mg | ||||
Ambroxol Hydrochloride IP ————- 30 mg | ||||
Paracetamol IP ———– 325 mg | ||||
Excipients—————–q.s | ||||
Colour-Approved colour used. | ||||
Acebrophylline& Acetylcysteine Tablets | Each Film Coated Bilayered Tablet Contains:- | BP | 100 mg | Antihistaminic, Cough Suppressant & Svmpathomimetic |
Acebrophylline | 600 mg | |||
Acetylcysteine | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Terbutaline Tablets IP | Each Film Coated Tablet Contains:- | Antihistaminic, Cough Suppressant & Svmpathomimetic | ||
Terbutaline Sulphate IP ———— 2.5 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Paracetamol, Cetirizine Dihydrochloride & Phenylephrine Hydrochloride Tablets | Each Film Coated Tablet Contains:- | Antihistaminic, Cough Suppressant & Svmpathomimetic | ||
Paracetamol IP ———– 325 mg | ||||
Cetirizine Dihydrochloride IP ——–5 mg | ||||
Phenylephrine Hydrochloride ——-5 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Paracetamol, Phenylephrine &Cetirizine Tablets | Each Uncoated Tablet Contains:- | Antihistaminic, Cough Suppressant & Svmpathomimetic | ||
Paracetamol IP ———– 325 mg | ||||
Phenylephrine IP ——- 10 mg | ||||
Cetirizine IP ——– 5 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Paracetamol, Phenlephrine Hydrochloride & Chlopheniramine Maleate Tablets | Each Uncoated Tablets Contains : | Antihistaminic, Cough Suppressant & Svmpathomimetic | ||
Paracetamol IP—————–500 mg | ||||
Phenlephrine Hydrochloride—– 10 mg | ||||
Chlopheniramine Maleate ——-2 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Paracetamol, Phenylephrine Hydrochloride & Chlopheniramine Maleate Tablets | Each Uncoated Tablets Contains : | Antihistaminic, Cough Suppressant & Svmpathomimetic | ||
Paracetamol IP—————–325 mg | ||||
Phenylephrine Hydrochloride—– 5 mg | ||||
Chlopheniramine Maleate ——-2 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Levofloxacin & Ambroxol (Sustained Release) Tablets | Each Film Coated Tablet Contains:- | IP | 500 mg | Antihistaminic, Cough Suppressant & Svmpathomimetic |
Levofloxacin Hemihydrate | 75 mg | |||
Eq. to Levofloxacin | IP | q.s | ||
Ambroxol Hydrochloride | ||||
(Sustained Release) | ||||
Excipients | ||||
Colour-Approved colour used. | ||||
Acebrophyline (Sustained Release) & Montelukast Sodium, tablets | Each Film Coated Bilayered Tablet Contains:- | 200 mg | Antihistaminic, Cough Suppressant & Svmpathomimetic | |
Acebrophyline (Sustained Release) | IP | |||
Montelukast Sodium | 10 mg | |||
Eq. to Montelukast | q.s | |||
Excipients | ||||
Colour: Approved Colour Used | ||||
antimalarials | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Melfloquine Tablets IP | Each Film Coated Tablet Contains:- | antimalarials | ||
Melfloquine Hydrochloride IP ——- 250mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Pyrimethamine and Sulphadoxine Tablets IP | Each Film Coated Tablet Contains:- | antimalarials | ||
Pyrimethamine IP ——- 25mg | ||||
Sulphadoxine IP ——–500 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Artmether and Lumefantrine Tablets IP | Each Film Coated Tablet Contains:- | Antimalarials | ||
Artmether IP —————20 mg | ||||
Lumefantrine IP ————– 120 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Hydroxychloroquine Tablets IP | Each Film Coated Tablet Contains:- | Antimalarial | ||
Hydroxychloroquine IP——— 200 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Artmether and Lumefantrine Tablets IP | Each Film Coated Tablet Contains:- | Antimalarial | ||
Artmether IP ————— 80 mg | ||||
Lumefantrine IP ————– 480 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Artmether and Lumefantrine Dispersible Tablets IP | Each Uncoated Dispersible Tablet Contains:- | antimalarials | ||
Artmether IP ————— 40 mg | ||||
Lumefantrine IP ————– 480 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Hydroquinone,Tretinoin & Allantoin Gel | Composition: | Antimalarial | ||
Hydroquinone USP2.0%w/w | ||||
Tretinoin USP0.025%w/w | ||||
Allantoin USP1.0% w/w | ||||
GelBase q.s | ||||
Quinine Bisulphate Tablets IP | Each Film Coated Tablet Contains:- | Antimalaria | ||
Quinine Bisulphate IP ————— 300 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Antidepressant | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Doxepin capsules IP | Each hard gelatin capsule contains:- | IP | 10mg | Antidepressant |
Doxepin HCl | q.s. | |||
Eq. to Doxepin | ||||
Excipients | ||||
Colour: Approved colours used in empty capsule shells. | ||||
Doxepin capsules IP | Each hard gelatin capsule contains:- | IP | 25mg | Antidepressant |
Doxepin HCl | q.s. | |||
Eq. to Doxepin | ||||
Excipients | ||||
Colour: Approved colours used in empty capsule shells. | ||||
Amitriptyline Hydrochloride & Methylcobalamin Tablets | Each Film Coated Tablet Contains:- | IP | 5 mg | Antidepressant |
Amitriptyline Hydrochloride | IP | 1500 mcg | ||
Methylcobalamin | q.s | |||
Excipients | ||||
Colour: Approved colour used | ||||
Amitriptyline Hydrochloride & Methylcobalamin Tablets | Each Film Coated Bilayered Tablet Contains:- | IP | 10 mg | Antidepressant |
Amitriptyline Hydrochloride | IP | 1500 mcg | ||
Methylcobalamin | ||||
(As Sustained Release) | q.s | |||
Excipients | ||||
Colour: Approved colour used | ||||
Sertraline Tablets IP 25 mg | Each Film Coated Tablet Contains:- | IP | 25 mg | Antidepressant |
Sertraline Hydrochloride | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Gabapentin & Nortriptyline Hydrochloride Tablets | Each Film Coated Tablet Contains:- | Antidepressant | ||
Gabapentin IP ———— 400 mg | ||||
Nortriptyline Hydrochloride | ||||
Eq. to Nortriptyline IP ————-10 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Fluoxetine Tablets IP | Each Film Coated Tablet Contains:- | Antidepressant | ||
Fluoxetine Hydrochloride IP | ||||
Eq. to Fluoxetine ————— 20 mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Citicoline Sodium Tablet IP | Each film coated tablet contains: | Antidepressant | ||
Citicoline Sodium IP | ||||
equivalent to Citicoline———– 500 mg | ||||
Excipients—————–q.s | ||||
Colour-Approved colour used. | ||||
Piracetam with Citicoline Tablets | Each film coated tablet contains: | Antidepressant | ||
Citicoline Sodium IP | ||||
equivalent to Citicoline ———– 500 mg | ||||
Piracetam———– 400 mg | ||||
Excipients—————–q.s | ||||
Colour-Approved colour used. | ||||
Venlafaxine Tablets | Each uncoated Tablet Contains:- | Antidepressant | ||
Venlafaxine Hydrochloride BP ——– 20 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Citicoline Sodium (PR) Tablet IP | Each film coated prolonged release tablet contains: | Antidepressant | ||
Citicoline Sodium IP | ||||
equivalent to Citicoline———– 1000 mg | ||||
Excipients—————–q.s | ||||
Colour-Approved colour used. | ||||
Sertraline Tablets IP 50 mg | Each Film Coated Tablet Contains:- | Antidepressant | ||
Sertraline Hydrochloride IP | ||||
Eq. to Sertraline……………………………….. 50 mg | ||||
Excipients ……………………………………………q.s. | ||||
Colour-Approved colours used. | ||||
Sertraline Tablets IP 100 mg | Each Film Coated Tablet Contains:- | Antidepressant | ||
Sertraline Hydrochloride IP | ||||
Eq. to Sertraline………………………………. 100 mg | ||||
Excipients ………………………………………….q.s. | ||||
Colour-Approved colours used. | ||||
Propranolol(SR) & Flunarizine capsule | Each Hard gelatin capsule Contains: | IP | 40 mg | Antidepressant |
Propranolol Hydrochloride | 10 mg | |||
Eq to Propranolol(SR pellets) | ||||
Flunarizine | ||||
Approved colour used | ||||
Antidiarrheal | ||||
Loperamide Capsules IP | Each Hard Gelatin Capsule Contains:- | IP | 2.0 mg | Antidiarrheal |
Loperamide Hydrochloride | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Loperamide Tablets IP | Each Film Coated Tablet Contains:- | Antidiarrheal | ||
Loperamide Hydrochloride IP ——2 mg | ||||
Excipients——————q.s. | ||||
Colour-Approved colour used. | ||||
Rececadotril capsules IP100. | Each Hard Gelatin capsule contains | IP | 100mg | Antidiarrheal |
Rececadotril | q. s. | |||
Excipients | ||||
Approved colour used | ||||
Antacid, Anti Ulcer And Antispasmodic | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Calcium Carbonate and Simethicone Chewable Tablets | Each Film Coated Tablet Contains:- | Antacid, Anti Ulcer And Antispasmodic | ||
Calcium Carbonate IP ————- 600 mg | ||||
Simethicone IP ———————80 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Dicyclomine Tablets IP | Each Film coated Tablet contains: | IP | 20 mg | Antacid, Anti Ulcer And Antispasmodic |
Dicyclomine Hydrochloride | q. s. | |||
Excipients | ||||
White Soft Paraffin & Liquid Paraffin Cream | Composition: | IP | 15.0%w/w | Antacid, Anti Ulcer And Antispasmodic |
White Soft Paraffin | IP | 6.0%w/w | ||
Liquid Paraffin | q.s | |||
Cream Base | ||||
Antiseptic, Antiulcer | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Povidone Iodine, & Sucralfate Ointment | Composition: | IP | 5.0 % w/w | Antiseptic, Antiulcer |
Povidone Iodine (available iodine 1.0% w/w) | IP | 7.0 % w/w | ||
Sucralfate | q.s. | |||
Ointment base | ||||
Povidone-Iodine, Ointment USP | Composition: | IP | 5.0% w/w | Antiseptic |
Povidone-Iodine (available iodine 0.5% w/w) | ||||
Water Soluble Ointment base | q.s. | |||
Silver Nitrate, Chlorhexidine Gluconate, Aloevera& Allantoin Cream | Composition : | IP | 0.2%w/w | Antiseptic |
Silver Nitrate | IP | 0.2%w/w | ||
Chlorhexidine Gluconate Solution | 0.1%w/w | |||
Allantoin | IP | 15.0%w/w | ||
Aloe Vera extract | ||||
Preservatives: | IP | 0.1%w/w | ||
Chlorocresol | q.s | |||
Cream Base | ||||
Povidone-Iodine, Ointment USP | Composition: | IP | 5.0% w/w | Antiseptic |
Povidone-Iodine (available iodine 0.5% w/w) | ||||
Water Soluble Ointment base | q.s. | |||
Povidone-Iodine, Ointment USP | Composition: | IP | 10.0% w/w | Antiseptic |
Povidone-Iodine (available iodine 1.0% w/w) | q.s. | |||
Ointment base | ||||
Povidone-Iodine solution IP | Composition: | IP | 10.0% w/v | Antiseptic |
Povidone-Iodine (available iodine 1.0% w/w) | q.s. | |||
Ointment base | ||||
Zinc oxide cream IP | Composition: | IP | 32.00% | Antiseptic |
Zinc oxide | q.s. | |||
Cream Base | ||||
Misoprostol Tablets IP | Each Film Coated Tablet Contains:- | Antiulcer | ||
Misoprostol IP ———–200 mcg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Ranitidine Tablets IP | Each Film Coated Tablet Contains:- | Antiulcer | ||
Ranitidine Hydrochloride IP | ||||
Eq. to Ranitidine —————150 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Pantoprazole and Domperidone Tablets | Each Enteric Coated Tablet Contains:- | Antiulcer | ||
Pantoprazole Sodium (Sesquihydrate) IP | ||||
Eq. to Pantoprazole ————– 40 mg | ||||
Domperidone IP —————— 10 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Calcium Carbonate Tablets IP | Each Film Coated Tablet Contains:- | Antiulcer | ||
Calcium Carbonate IP | ||||
Eq. to Elemental Calcium———–400 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Calcium Carbonate Tablets IP | Each Film Coated Tablet Contains:- | Antiulcer | ||
Calcium Carbonate IP | ||||
Eq. to Elemental Calcium———–500 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Calcium Carbonate Tablets IP | Each Film Coated Tablet Contains:- | Antiulcer | ||
Calcium Carbonate IP | ||||
Eq. to Elemental Calcium———–625 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Calcium Carbonate Tablets IP | Each Film Coated Tablet Contains:- | Antiulcer | ||
Calcium Carbonate IP | ||||
Eq. to Elemental Calcium———-1000 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Ranitidine Tablets IP | Each Film Coated Tablet Contains:- | Antiulcer | ||
Ranitidine Hydrochloride IP | ||||
Eq. to Ranitidine —————300 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Chlorhexidine Gluconate sodium Fluoride & Zinc chloride mouth wash. | Composition: | IP | 0.2%w/v | Antiulcer |
Each 100 ml contains: | ||||
Chlorhexidine Gluconate | IP | 0.05%w/v | ||
( As Chlorhexidine Gluconate solution IP) | IP | 0.09%w/v | ||
Sodium Fluoride | IP | qs | ||
Zinc chloride | ||||
Colour Approved colour used | ||||
Antihistamines | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Desloratadine Tablet | Each film coated tablet contains: | Antihistamines | ||
Desloratadine BP ———– 5 mg | ||||
Excipients—————–q.s | ||||
Colour-Approved colour used. | ||||
Desloratadine & Montelukast Tablet | Each film coated tablet contains: | Antihistamines | ||
Desloratadine BP ———– 5 mg | ||||
Montelukast Sodium IP | ||||
eq. to Montelukast ————- 10 mg | ||||
Excipients—————–q.s | ||||
Colour-Approved colour used. | ||||
Doxylamine Succinate, Pyridoxine Hydrochloride & Folic Acid Tablet | Each Film Coated Tablet Contains:- | Antihistamines | ||
Doxylamine Succinate USP —- 10 mg | ||||
Pyridoxine Hydrochloride IP —— 10 mg | ||||
Folic Acid IP —————————- 2.5 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Fexofenadine Hydrochloride Tablets IP 30 mg | Each Film coated Tablet contains: | IP | 30 mg | antihistamines |
Fexofenadine Hydrochloride | q. s. | |||
Excipients | ||||
Approved Colour used | ||||
Fexofenadine Hydrochloride Tablets IP 60 mg | Each Film coated Tablet contains: | IP | 60 mg | antihistamines |
Fexofenadine Hydrochloride | q. s. | |||
Excipients | ||||
Approved Colour used | ||||
Doxylamine Succinate, Pyridoxine Hydrochloride & Folic Acid Tablets | Each Enteric Coated Tablet Contains:- | B.P. | 10 mg | Antihistamines |
Doxylamine Succinate | I.P. | 10 mg | ||
Pyridoxine Hydrochloride | I.P. | 2.5 mg | ||
Folic Acid | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Fexofenadine Hydrochloride Tablet I.P. | Each Film Coated Tablet Contains:- | Antihistamine | ||
Fexofenadine Hydrochloride I.P——-120mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Fexofenadine Hydrochloride Tablet I.P. | Each Film Coated Tablet Contains:- | Antihistamine | ||
Fexofenadine Hydrochloride I.P——180mg | ||||
Excipients—————————q.s. | ||||
Colour-Approved colour used. | ||||
Chlorpheniramine Tablets I.P. | Each Film Coated Tablet Contains:- | Antihistamine | ||
Chlorpheniramine Maleate I.P. ———4mg | ||||
Excipients—————————-q.s. | ||||
Colour-Approved colour used. | ||||
Chlorpheniramine Tablets I.P. | Each Film Coated Tablet Contains:- | Antihistamine | ||
Chlorpheniramine Maleate I.P———8mg | ||||
Excipients————————–q.s. | ||||
Colour-Approved colour used. | ||||
antimuscarinics | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Trihexyphenidyl Hydrochloride Tablets IP | Each Uncoated Tablet Contains:- | Antimuscarinics | ||
Trihexyphenidyl Hydrochloride IP—- 1 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Solifenacin Succinate Tablets | Each Film coated Tablet Contain: | IP | 10 mg | antimuscarinics. |
Solifenacin Succinate | q. s. | |||
Excipients | ||||
Antifibrotic | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Silymarin Tablets | Each Film Coated Tablet Contains:- | Antifibrotic | ||
Silymarin ————– 200 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
SilymarinTablets | Each Film Coated Tablet contains: | IP | 140 mg | Antifibrotic |
Silymarin | q. s. | |||
Excipients | ||||
Antipsychotic | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Quetiapine Fumarate Tablets IP 25 mg | Each Film Coated Tablets Contains | IP | 25 mg | Antipsychotics |
Quetiapine Fumarate | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Quetiapine Fumarate Tablets IP 50 mg | Each Film Coated Tablets Contains | IP | 50 mg | Antipsychotics |
Quetiapine Fumarate | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Flupentixol Tablets BP 1 mg | Each Film Coated Tablet Contains:- | BP | 1 mg | antipsychotic |
Flupentixol Dihydrochloride | q.s | |||
Eq. to Flupentixol | ||||
Excipients | ||||
Colour-Approved colour used. | ||||
Flupentixol Tablets BP 3 mg | Each Film Coated Tablet Contains:- | BP | 3 mg | antipsychotic |
Flupentixol Dihydrochloride | q.s | |||
Eq. to Flupentixol | ||||
Excipients | ||||
Colour-Approved colour used. | ||||
Chlorpromiazine Hydrochloride, Trifluoperazine And Trihexyphenidyl Hydrochloride Tablets | Each Film Coated Tablet Contains:- | Antipsychotic | ||
ChlorpromiazineHydrochloride I.P–50mg | ||||
Trifluoperazine Hydrochloride I.P. | ||||
Eq. to Trifluoperazine 5mg | ||||
Trihexyphenidyl Hydrochloride I.P…—2mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Olanzapine Tablets IP | Each uncoated Tablet Contains:- | Antipsychotics | ||
Olanzapine IP ———————-2.5 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Olanzapine Tablets IP | Each uncoated Tablet Contains:- | Antipsychotics | ||
Olanzapine IP ———————-5.0 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Olanzapine Tablets IP | Each uncoated Tablet Contains:- | Antipsychotics | ||
Olanzapine IP ———————-10 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Levosulpiride Tablets | Each Film Coated Tablet Contains:- | Antipsychotic | ||
Levosulpiride ——————– 75 mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Levosulpiride Tablets | Each Film Coated Tablet Contains:- | Antipsychotic | ||
Levosulpiride ——————– 150 mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Levosulpiride Tablets | Each Film Coated Tablet Contains:- | antipsychotic | ||
Levosulpiride ——————– 200 mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Haloperidol Tablets | Each Film Coated Tablet Contains:- | Antipsychotics | ||
Haloperidol IP ———– 20 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Prochlorperazine Maleate Mouth Dissolving Tablet | Each uncoated mouth | Antipsychotic | ||
dissolving tablet Contains: | ||||
Prochlorperazine Maleate…………..IP 5mg | ||||
Excipients…………………………………….q.s | ||||
Colour-Approved colour used. | ||||
Antianginal | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Nitroglycerine Sustained Release Tablets (Glyceryl Trinitrate Controlled Release Tablets | Each Film Coated Sustained Release Tablet Contains:- | Antianginal | ||
Nitroglycerine IP——– 2.6 mg | ||||
(As Diluted Nitroglycerine IP) | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Nifedipine Prolonged Release Tablets IP ( Nifedipine Sustained release Tablets IP) | Each Film Coated Prolonged Release Tablet Contains:- | Antianginal | ||
Nifedipine IP—————— 10 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Nifedipine Prolonged Release Tablets IP ( Nifedipine Sustained release Tablets IP) | Each Film Coated Prolonged Release Tablet Contains:- | Antianginal | ||
Nifedipine IP—————— 20 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Verapamil Tablets IP | Each Film Coated Tablet Contains:- | Antianginal | ||
Verapamil Hydrochloride IP ——– 40 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Verapamil Tablets IP | Each Film Coated Tablet Contains:- | Antianginal | ||
Verapamil Hydrochloride IP ——– 80 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Verapamil Tablets IP | Each Film Coated Tablet Contains:- | Antianginal | ||
Verapamil Hydrochloride IP —— 120 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Verapamil Tablets IP | Each Film Coated Tablet Contains:- | Antianginal | ||
Verapamil Hydrochloride IP —— 160 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Ivabradine Hydrochloride Tablets | Each Film Coated Tablet Contains:- | Antianginal | ||
Ivabradine Hydrochloride ———- 5 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Ivabradine Hydrochloride Tablets | Each Film Coated Tablet Contains:- | Antianginal | ||
Ivabradine Hydrochloride ———7.5 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Isosorbide Mononitrate Tablets IP. | Each Film Coated Tablet Contains:- | Anti-Anginal | ||
Diluted Isosorbide Dinitrate I.P.—-20mg | ||||
Excipients—————————q.s. | ||||
Colour-Approved colour used. | ||||
Anti-spasmodic | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Benzhexol Tablets IP (Trihexyphenidyl Hydrochloride Tablets IP) | Each Film Coated Tablet Contains:- | Anti-spasmodic | ||
Benzhexol Hydrochloride IP——– 2 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Benzhexol Tablets IP (Trihexyphenidyl Hydrochloride Tablets IP) | Each Film Coated Tablet Contains:- | Anti-spasmodic | ||
Benzhexol Hydrochloride IP——–5 mg | ||||
Excipients—————–q.s | ||||
Colour-Approved colour used. | ||||
Hyoscine Butylbromide Tablets IP | Each Sugar Coated Tablet Contains:- | Antisapsmodic | ||
Hyoscine Butylbromide IP ——10 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Anti-Rheumatic | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Azathioprine tablets IP 50 mg | Each Uncoated Tablet Contains:- | IP | 50 mg | Anti-Rheumatic |
Azathioprine | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Azathioprine tablets IP 50 mg | Each Uncoated Tablet Contains:- | IP | 50 mg | Anti-Rheumatic |
Azathioprine | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Hydroxychloroquine Tablets IP | Each Film Coated Tablet Contains:- | Anti-Rheumatic | ||
Hydroxychloroquine IP——— 200 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Anti Gallstones | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Ursodeoxycholic Acid Tablets I.P | Each film coated tablet contains: | Anti Gallstones | ||
Ursodeoxycholic Acid I.P———–450 mg | ||||
Excipients————————–q.s | ||||
Colour-Approved colour used. | ||||
Ursodeoxycholic Acid Tablets I.P | Each film coated tablet contains: | Anti Gallstones | ||
Ursodeoxycholic Acid I.P———–300 mg | ||||
Excipients————————–q.s | ||||
Colour-Approved colour used. | ||||
Ursodeoxycholic Acid Tablets I.P | Each film coated tablet contains: | Anti Gallstones | ||
Ursodeoxycholic Acid I.P———- 150 mg | ||||
Excipients————————–q.s | ||||
Colour-Approved colour used. | ||||
Ursodeoxycholic Acid Sustained Release Tablets I.P | Each Sustained Release Tablet contains: | Anti Gallstones | ||
Ursodeoxycholic Acid I.P———–300 mg | ||||
Excipients————————–q.s | ||||
Colour-Approved colour used. | ||||
Ursodeoxycholic Acid Sustained Release Tablets I.P | Each Sustained Release Tablet contains: | Anti Gallstones | ||
Ursodeoxycholic Acid I.P———–600 mg | ||||
Excipients————————–q.s | ||||
Colour-Approved colour used. | ||||
Anticold | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Pheniramine Tablets I.P. | Each Film Coated Tablet Contains:- | Anticold | ||
Pheniramine Maleate I.P 25mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Pheniramine Tablets I.P. | Each Film Coated Tablet Contains:- | Anticold | ||
Pheniramine Maleate I.P 50mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Antiparkinsonism agents | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Pramipexol Dihydrochloride Tablets 0.125 mg | Each Uncoated Tablets contains: | USP | 0.125 mg | Antiparkinsonism agents |
Pramipexol Dihydrochloride Monohydrate | q.s | |||
Excipients | ||||
Colour: Approved Colour Used | ||||
Pramipexol Dihydrochloride Tablets 0.25 mg | Each Uncoated Tablets contains: | USP | 0.25 mg | Antiparkinsonism agents |
Pramipexol Dihydrochloride Monohydrate | q.s | |||
Excipients | ||||
Colour: Approved Colour Used | ||||
Pramipexol Dihydrochloride Tablets 0.5 mg | Each Uncoated Tablets contains: | USP | 0.5 mg | Antiparkinsonism agents |
Pramipexol Dihydrochloride Monohydrate | q.s | |||
Excipients | ||||
Colour: Approved Colour Used | ||||
Pramipexol Dihydrochloride Tablets 1 mg | Each Uncoated Tablets contains: | USP | 1 mg | Antiparkinsonism agents |
Pramipexol Dihydrochloride Monohydrate | q.s | |||
Excipients | ||||
Colour: Approved Colour Used | ||||
Pramipexol Dihydrochloride Tablets 1.5 mg | Each Uncoated Tablets contains: | USP | 1.5 mg | Antiparkinsonism agents |
Pramipexol Dihydrochloride Monohydrate | q.s | |||
Excipients | ||||
Colour: Approved Colour Used | ||||
Pramipexol Dihydrochloride Extended Release Tablets 0.375 mg | Each Uncoated extended release Tablets contains: | USP | 0.375 mg | Antiparkinsonism agents |
Pramipexol Dihydrochloride Monohydrate | q.s | |||
Excipients | ||||
Colour: Approved Colour Used | ||||
Pramipexol Dihydrochloride Extended Release Tablets 0.75 mg | Each Uncoated extended release Tablets contains: | USP | 0.75 mg | Antiparkinsonism agents |
Pramipexol Dihydrochloride Monohydrate | q.s | |||
Excipients | ||||
Colour: Approved Colour Used | ||||
Pramipexol Dihydrochloride Extended Release Tablets 1.5 mg | Each Uncoated extended release Tablets contains: | USP | 1.5 mg | Antiparkinsonism agents |
Pramipexol Dihydrochloride Monohydrate | q.s | |||
Excipients | ||||
Colour: Approved Colour Used | ||||
Pramipexol Dihydrochloride Extended Release Tablets 3 mg | Each Uncoated extended release Tablets contains: | USP | 3 mg | Antiparkinsonism agents |
Pramipexol Dihydrochloride Monohydrate | q.s | |||
Excipients | ||||
Colour: Approved Colour Used | ||||
Pramipexol Dihydrochloride Extended Release Tablets 4.5 mg | Each Uncoated extended release Tablets contains: | USP | 4.5 mg | Antiparkinsonism agents |
Pramipexol Dihydrochloride Monohydrate | q.s | |||
Excipients | ||||
Colour: Approved Colour Used | ||||
Febuxotat Tablet 40 mg | Each Film coated Tablets contains: | IH | 40 mg | Antihyperuricemic agents |
Febuxotat | q.s. | |||
Excipients | ||||
Colour: Approved Colour Used | ||||
Amantadine hydrochloride Capsules IP | Each hard gelatin capsule Contains: | IP | 100 mg | Antiparkinson agent |
Amantadine Hydrochloride | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Piribedil (SR) Tablets | Each Sustained Release Tablets Contains | 50 mg | Antiparkinsonian agent | |
Piribedil | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Antiarrhythmics | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Amiodarone HCl Tablets IP 100 mg | Each Uncoated Tablet Contains:- | IP | 100 mg | Antiarrhythmic |
Amiodarone HCl | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Amiodarone HCl Tablets IP 200 mg | Each Uncoated Tablet Contains:- | IP | 200 mg | Antiarrhythmic |
Amiodarone HCl | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Mexiletine Hydrochloride Capsules IP | Each hard gelatin capsule contains: | IP | 50 mg | Antiarrhythmics |
Mexiletine Hydrochloride | q.s. | |||
Excipients | ||||
Approved colors used in Hard Gelatin Capsule shell. | ||||
Mexiletine Hydrochloride Capsules IP | Each hard gelatin capsule contains: | IP | 150 mg | Antiarrhythmics |
Mexiletine Hydrochloride | q.s. | |||
Excipients | ||||
Approved colors used in Hard Gelatin Capsule shell. | ||||
Digoxin tablet IP 250 µg | Each uncoated tablet contains | IP | 250 µg | Antiarrhythmics |
Digoxin | q.s. | |||
Excipients | ||||
Colour: Approved Colour used | ||||
Antidepresant | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Fluoxetine Tablets IP 10 mg | Each Film Coated Tablet Contains:- | IP | 10 mg | Antidepresant |
Fluoxetine Hydrochloride | ||||
Eq. to Fluoxetine | q.s | |||
Excipients. | ||||
Colour-Approved colour used. | ||||
Citicoline Tablet IP 250 mg | Each film coated tablet contains: | IP | 250 mg | Antidepresant |
Citicoline Sodium | ||||
equivalent to Citicoline | ||||
Excipients | ||||
Colour-Approved colour used. | ||||
Mirtazapine Tablets IP 15 mg | Each Film Tablet Contains:- | IP | 15 mg | Antideprresant |
Mirtazapine | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Mirtazapine Tablets IP 30 mg | Each Film Tablet Contains:- | IP | 30 mg | Antidepresant |
Mirtazapine | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Cyclobenzaprine Extended Release capsules | Each hard gelatin capsule contains: | IP | 15 mg | Antidepressants |
Cyclobenzaprine | ||||
(As sustained release pellets) | q.s. | |||
Excipients | ||||
Approved Colors Used. in Empty Shell & Pellet | ||||
Cyclobenzaprine Extended Release capsules | Each hard gelatin capsule contains: | IP | 30 mg | Antidepressants |
Cyclobenzaprine | ||||
(As sustained release pellets) | q.s. | |||
Excipients | ||||
Approved Colors Used. in Empty Shell & Pellet | ||||
Trazodone Hydrochloride Tablets USP 50 mg | Each Uncoated Tablets contains: | USP | 50 mg | Antideprresant |
Trazodone Hydrochloride | q.s | |||
Excipients | ||||
Colour: Approved Colour Used | ||||
Trazodone Hydrochloride Tablets USP 100 mg | Each Uncoated Tablets contains: | USP | 100 mg | Antideprresant |
Trazodone Hydrochloride | q.s | |||
Excipients | ||||
Colour: Approved Colour Used | ||||
Trazodone Hydrochloride Tablets USP 25 mg | Each Uncoated Tablets contains: | USP | 25 mg | Antideprresant |
Trazodone Hydrochloride | q.s | |||
Excipients | ||||
Colour: Approved Colour Used | ||||
Antianeamic | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Folic Acid Tablets IP 10 mg | Each Uncoated Tablet Contains:- | IP | 10 mg | Antianeamic |
Folic Acid | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Folic Acid Tablets IP 5 mg | Each Uncoated Tablet Contains:- | IP | 5 mg | Antianeamic |
Folic Acid | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Ferrous Ascorbate, Folic Acid and Methylcobalamin Tablets | Each Film Coated Tablet Contains:- | Antianeamic | ||
Ferrous Ascorbate | ||||
Eq. to Elemental Iron————–100 mg | ||||
Folic Acid IP————————-1.5 mg | ||||
Zinc Sulphate USP | ||||
Eq. to Elemental Zinc ————–22.5 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Ferrous Ascorbate, Folic Acid, Cyanocobalamin & Zinc Sulphate Tablets | Each Film Coated Tablet Contains:- | Antianeamic | ||
Ferrous Ascorbate | ||||
Eq. to elemental Iron ————– 100 mg | ||||
Folic Acid IP ——————— 1.5 mg | ||||
Cyanocobalamin IP —————-15 mcg | ||||
Zinc Sulphate monohydrate IP | ||||
Eq. to Elemental Zinc ————–22.5 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Ferrous Ascorbate, Folic Acid and Methylcobalamin Tablets | Each Film Coated Tablet Contains:- | Antianeamic | ||
Ferrous Ascorbate IP | ||||
eq. to elemental Iron—————- 100 mg | ||||
Folic Acid IP ——————- 1.5mg | ||||
Methylcobalamin IP ————– 1500 mcg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Ferrous Bisglycinate, Folic Acid, Zinc Bisglycinate&Methylcobalamin Tablets | Each Film Coated Tablet Contains:- | IP | 60 mg | Anti-anemic |
Ferrous Bisglycinate | 1 mg | |||
Folic Acid | 15 mg | |||
Zinc Bisglycinate | IP | 500 mcg | ||
Methylcobalamin | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Antioxidant | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Ascorbic Acid Tablets IP | Each UncoatedChewableTablet Contains:- | Antioxidant | ||
Ascorbic Acid IP ———– 500 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Ascorbic Acid Tablets IP 100 mg | Each Chewable Tablet Contains : | IP | 100 mg | Antioxidants |
Ascorbic Acid | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Vitamin C Tablets IP | Each Uncoated Tablet Contains:- | Antioxidants | ||
Vitamin C IP ————— 100 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Vitamin C Tablets IP | Each Uncoated Tablet Contains:- | Antioxidants | ||
Vitamin C IP ————— 50 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Antipsoriatic | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Acitretin Capsules IP. | Each Hard Gelatin Capsule Contains: | IP | 25mg | Antipsoriatic |
Acitretin | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Acitretin Capsules I.P. | Each Hard Gelatin Capsule Contains: | IP | 10mg | Antipsoriatic |
Acitretin | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Antiepileptic | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Gabapentin Capsules IP | Each Hard Gelatin Capsule Contains: | IP | 100.0 mg | Antiepileptic |
Gabapentin | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Gabapentin Capsules IP | Each Hard Gelatin Capsule Contains: | IP | 300.0 mg | Antiepileptic |
Gabapentin | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Gabapentin Capsules IP | Each Hard Gelatin Capsule Contains: | IP | 400.0 mg | Antiepileptic |
Gabapentin | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Gabapentin Tablets IP | Each Film Coated Tablet Contains:- | Antiepileptic | ||
Gabapentin IP ———— 600 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Levetiracetam Tablet IP 750 mg | Each film Coated Tablet Contains: | anticonvulsants/antiepileptics | ||
Levetiracetam IP ——————-750 mg | ||||
Excipients……………q.s. | ||||
Colour : Approved Colour Used | ||||
Levetiracetam Tablet IP 1000 mg | Each film Coated Tablet Contains: | anticonvulsants/antiepileptics | ||
Levetiracetam IP ——————-1000 mg | ||||
Excipients……………q.s. | ||||
Colour : Approved Colour Used | ||||
Levetiracetam Sustained Release Tablets | Each Sustained Release Tablet Contains:- | Anticonvulsants/Antiepileptics | ||
Levetiracetam USP ————1000 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Levetiracetam Tablet IP 500 mg | Each film Coated Tablet Contains: | Anticonvulsants/Antiepileptics | ||
Levetiracetam IP ——————-500 mg | ||||
Excipients……………q.s. | ||||
Colour : Approved Colour Used | ||||
Antihistamins | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Diphenhydramine Capsules IP | Each Hard Gelatin Capsules Contains: | IP | 25.0 mg | Antihistamins |
Diphenhydramine Hydrochloride | q.s. | |||
Excipients q.s | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Diphenhydramine Capsules IP | Each Hard Gelatin Capsules Contains: | IP | 50.0 mg | Antihistamins |
Diphenhydramine Hydrochloride | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Antineoplastics | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Isotretinoin Capsule USP | Each Hard Gelatin Capsule contains: | IP | 20 mg | Antineoplastics |
Isotretinoin | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Anti Scabies | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Permethrin Cream | Composition : | 5.0%w/w | Anti Scabies | |
Permethrin | q.s | |||
Cream Base | ||||
Alzheimer’s disease | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Donepzil Hydrochloride &Memantadine Hydrochloride Tablets | Each Film coated Tablets contains: | IP | 5 mg | Alzheimer’s disease |
Donepzil Hydrochloride | IP | 5 mg | ||
Memantadine Hydrochloride | q.s | |||
Excipients | ||||
Colour: Approved Colour Used | ||||
Donepzil Hydrochloride &Memantadine Hydrochloride Tablets | Each Film coated Tablets contains: | IP | 5 mg | Alzheimer’s disease |
Donepzil Hydrochloride | IP | 10 mg | ||
Memantadine Hydrochloride | q.s | |||
Excipients | ||||
Colour: Approved Colour Used | ||||
Antiparkinson | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Levodopa And Carbidopa Tablets I.P. | Each Film Coated Tablet Contains:- | Antiparkinson | ||
Levodopa I.P ——————– 250mg | ||||
Carbidopa IP 25mg | ||||
Excipients——————q.s. | ||||
Colour-Approved colour used. | ||||
Levodopa And Carbidopa Tablets I.P. | Each Film Coated Tablet Contains:- | AntiParkinson | ||
Levodopa I.P ——————– 100mg | ||||
Carbidopa IP 25mg | ||||
Excipients——————q.s. | ||||
Colour-Approved colour used. | ||||
Levodopa And Carbidopa Tablets I.P. | Each Film Coated Tablet Contains:- | AntiParkinson | ||
Levodopa I.P ——————– 100mg | ||||
Carbidopa IP 10mg | ||||
Excipients——————q.s. | ||||
Colour-Approved colour used. | ||||
Antiaginal | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Isosorbide Dinitrate Tablets IP. | Each Film Coated Tablet Contains:- | Antiaginal | ||
Diluted Isosorbide Dinitrate I.P. | ||||
Eq. to Isosorbide Dinitrate———-20mg | ||||
Excipients—————————q.s. | ||||
Colour-Approved colour used. | ||||
Antidiuretic | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Furosemide Tablets IP | Each Uncoated Tablet Contains:- | Antidiuretic | ||
Furosemide IP ————— 20 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Furosemide Tablets IP | Each Uncoated Tablet Contains:- | Antidiuretic | ||
Furosemide IP ————— 40 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Antidotes | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Calcium Gluconate Tablets IP | Each Uncoated Tablet Contains:- | Antidotes | ||
Calcium Gluconate IP ————500 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Calcium Gluconate Tablets IP | Each Uncoated Tablet Contains:- | Antidotes | ||
Calcium Gluconate IP ————325 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Calcium Gluconate Tablets IP | Each Uncoated Tablet Contains:- | Antidotes | ||
Calcium Gluconate IP ————650 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Antacids | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Pantoprazole Gastro Resistant Tablets IP | Each Enteric Coated Tablet Contains:- | Antacids | ||
Pantoprazole Sodium IP | ||||
Eq. to Pantoprazole ————– 40 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Alcohol Antagonist | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Disulfiram Tablets IP 200 mg | Each Uncoated Tablet Contains: – | Alcohol Antagonist | ||
Disulfiram IP———————-200 mg | ||||
Excipients……………q.s. | ||||
Colour : Approved Colour Used | ||||
Anti-Fibrinolytic Agents | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Ethamsylate& Tranexamic acid Tablets | Each Uncoated Tablet Contains: – | Anti-Fibrinolytic Agents | ||
Ethamsylate BP ————– 250.0 mg | ||||
Tranexamic acid IP ———–250.0 mg | ||||
Excipients……………q.s. | ||||
Colour : Approved Colour Used | ||||
Antihemorrhagic | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Ethamsylate Tablets | Each Uncoated Tablet Contains: – | Antihemorrhagic | ||
Ethamsylate BP ————– 250 mg | ||||
Excipients……………q.s. | ||||
Colour : Approved colour used | ||||
Ethamsylate Tablets | Each Uncoated Tablet Contains: – | Antihemorrhagic | ||
Ethamsylate BP ————– 500 mg | ||||
Excipients……………q.s. | ||||
Colour : Approved Colour Used | ||||
Antigout agents | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Probenecid Tablets IP | Each Film Coated Tablet Contains:- | Antigout agents | ||
Probenecid IP ————— 500 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Antiglaucoma | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Acetazolamide Tablets IP | Each Uncoated Tablet Contains:- | Antiglaucoma | ||
Acetazolamide IP—– 250 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Antidysrhythmics | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Digoxin Tablet IP | Each uncoated Tablet Contains:- | |||
Digoxin IP ———— 250 µg | ||||
Excipients —————— q.s. | ||||
Colour-Approved colour used. | ||||
antiplatelet | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Cilostazole Tablet IP | Each uncoated tablet contains: | antiplatelet | ||
Cilostazole IP —————— 50.0 mg | ||||
Excipients ——————-q.s. | ||||
Colour-Approved colour used. | ||||
Cilostazole Tablet IP | Each uncoated tablet contains: | antiplatelet | ||
Cilostazole IP —————— 200.0 mg | ||||
Excipients ——————-q.s. | ||||
Colour-Approved colour used. | ||||
Benign Prostatic Hyperplasia | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Silodosin Capsules | Each hard gelatin capsules contain: | IH | 4 mg | Benign Prostatic Hyperplasia |
Silodosin | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Silodosin Capsules | Each hard gelatin capsules contain: | IH | 8 mg | Benign Prostatic Hyperplasia |
Silodosin | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Dutasteride Capsules IP | Each hard gelatin capsule contains: | IP | 0.5 mg | Benign Prostatic Hyperplasia |
Dutasteride | q.s. | |||
Excipients | ||||
Approved colors used in Hard Gelatin Capsule shell. | ||||
Silodosin & Dutasteride Capsules | Each hard gelatin capsules contain: | IH | 8 mg | Benign Prostatic Hyperplasia |
Silodosin ( as pellets ) | IP | 0.5 mg | ||
Dutasteride( as pellets ) | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Tamsulosin HCl Prolonged release | Each hard gelatin capsule contains:- | IP | 200mcg | Benign Prostatic Hyperplasia |
Capsules IP | Tamsulosin HCl | |||
(As prolonged release pellets) | q.s. | |||
Excipients | ||||
Colour: Approved colours used in empty capsule shells & pellets. | ||||
Tamsulosin HCl Prolonged release | Each hard gelatin capsule contains:- | IP | 400mcg | Benign Prostatic Hyperplasia |
Capsules IP | Tamsulosin HCl | |||
(As prolonged release pellets) | q.s. | |||
Excipients | ||||
Colour: Approved colours used in empty capsule shells & pellets. | ||||
Tamsulosin HCl (Sustained Release) and Deflazacort tablets | Each Film Coated Bilayered Tablet Contains:- | IP | 0.4 mg | Benign Prostatic Hyperplasia |
Tamsulosin HCl | ||||
(As Sustained Release) | 30 mg | |||
Deflazacort | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Tamsulosin HCl and Dutasteride tablets | Each Film Coated Tablet Contains:- | Benign Prostatic Hyperplasia | ||
Tamsulosin HCl IP————- 0.4 mg | ||||
Dutasteride IP ——————- 0.5 mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Bronchodilator | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Acebrophylline Capsules | Each Hard Gelatin Capsules Contains: | 100.0 mg | Bronchodilator | |
Acebrophylline | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Theophylline Prolonged – release Tablets IP | Each Film Coated Tablet Contains:- | Bronchodilator | ||
Theophylline IP ——- 400 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Acebrophylline Sustained Release Tablets | Each Film Coated Sustained Release Tablet Contains:- | Broncodilator | ||
Acebrophylline ——————- 200 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Salbutamol Tablets IP | Each Film Coated Tablet Contains:- | Bromcholdialtor | ||
Salbutamol Sulphate IP | ||||
Eq. to Salbutamol ————— 4 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Etofylline & Theophylline Tablets | Each Uncoated Sustained Release Tablet Contains:- | Bromcholdialtor | ||
Etofylline —————– 231 mg | ||||
Theophylline —————— 69 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Calcium & Vitamins | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Methylcobalamin, Calcium carbonate, Calcitriol, folic acid and Pyridoxin Hydrochloride Capsules | Each Hard Gelatin Capsule contains: | IP | 1500 mcg | Calcium & Vitamins |
Methylcobalamin | ||||
Calcium carbonate equivalent to elemental Calcium | IP | 200 mg | ||
Calcitriol | IP | 0.25 mcg | ||
Folic Acid | IP | 1.5 mg | ||
Pyridoxine Hydrochloride | IP | 3.0 mg | ||
Excipients | q.s. | |||
Approved colored used in Hard Gelatin Capsule shell | ||||
Methylcobalamin, Alpha lipoic Acid, Inositol, Folic acid, Chromium Polynicotinate, Selenium Dioxide and Benfotiamine Capsules | Each hard gelatin Capsules contains: | IP | 1500mcg | Calcium & Vitamins drug |
Methylcobalamin | USP | 100mg | ||
Alpha Lipoic Acid | BP | 100mg | ||
Inositol | IP | 1.5mg | ||
Folic Acid | USP | 200mcg | ||
Chromium Polynicotinate | USP | 55mcg | ||
Selenium Dioxide | 150mg | |||
Benfotiamine | q.s | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Calcium, Magnesium, Vitamin D3 and Zinc Sulphate | Each Uncoated Tablet Contains:- | Calcium & Vitamins | ||
Calcium citrate USP | ||||
Eq. to Elemental calcium———— 200mg | ||||
Vitamin D3 Granules | ||||
Eq. to Vitamin D3 IP—————– 200 IU | ||||
Magnesium Hydroxide IP | ||||
Eq. to Elemental Magnesium ———50mg | ||||
Zinc Sulphate Monohydrate IP | ||||
Eq. to elemental Zinc—————–4 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Vitamin K2-7, Calcitriol, Calcium, Zinc and Magnesium Tablets | Each Film Coated Tablet Contains:- | Calcium & Vitamins | ||
Vitamin K2-7 ———————– 50 mcg | ||||
Calcium Carbonate IP | ||||
Eq. to Elemental calcium———— 500mg | ||||
Calcitriol IP ———————- 0.25 mcg | ||||
Zinc Sulphate Monohydrate IP | ||||
Eq. to elemental Zinc—————7.5 mg | ||||
Magnesium Sulphate IP | ||||
Eq. to elemental Magnesium ——- 50 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Calcium Citrate, Magnesium, Zinc with Vitamin D3 Tablets | Each Film Coated Tablet Contains:- | Calcium & vitamins | ||
Calcium citrate USP ————1000mg | ||||
Magnesium Hydroxide IP——– 100mg | ||||
Zinc Sulphate Monohydrate IP | ||||
Eq. to elemental Zinc—————–4 mg | ||||
Vitamin D3 IP—————– 200 IU | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Calcium and Vitamin D3 Tablets IP | Each Film Coated Tablet Contains:- | Calcium & vitamins | ||
Calcium Carbonate IP | ||||
Eq. to Elemental Calcium———-500mg | ||||
Vitamin D3 IP—————– 250 IU | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Zinc & Vitamin C Chewable Tablet | Each uncoated chewable tablet contains: – | Calcium & vitamins | ||
Zinc Gluconate 87.1 mg | ||||
eq. to. Elemental zinc 12.5 mg) | ||||
Ascorbic acid 100 mg + Sodium Ascorbate 170 mg | ||||
eq. to ascorbic acid 150 mg | ||||
Excipients —————–q.s. | ||||
Colour:- Approved colour used | ||||
Calcium, Calcitriol, Vitamin K2-7 Tablets | Each Film Coated Tablet Contains:- | Calcium & Vitamins | ||
Calcium Carbonate IP | ||||
Eq. to Elemental calcium———— 500mg | ||||
Calcitriol IP ———————- 0.25 mcg | ||||
Vitamin K2-7 ———————– 1000 mcg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Calcium Carbonate and Vitamin D3 Tablets IP | Each Film Coated Tablet Contains:- | Calcium & Vitamins | ||
Calcium Carbonate IP | ||||
Eq. to Elemental Calcium———- 250mg | ||||
Vitamin D3 IP—————– 125 IU | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Calcium and Vitamin D3 Tablets IP | Each Film Coated Tablet Contains:- | Calcium & vitamins | ||
Calcium Carbonate 1.25 gm IP | ||||
Eq. to elemental calcium (Derived From an Organic source oyster shell) ———- 500mg | ||||
Vitamin D3 IP—————– 500 IU | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Calcium Citrate Maleate, Magnesium, Zinc, Vit. D3, Methylcobalamin, L- Methyl Folate & Pyridoxal Phosphate | Each Film Coated Tablet contains: | Calcium & Vitamin | ||
Calcium Citrate Maleate USP 12.50 mg | ||||
Eq. to elemental Calcium ———- 250 mg | ||||
Magnesium Hydroxide IP———- 100 mg | ||||
Zinc Sulphate Monohydrate IP | ||||
Eq. to Elemental Zinc —————- 10 mg | ||||
Vitamin D3 ———————————- 2000 IU | ||||
Methylcobalamin IP —————–1500 mcg | ||||
L- Methyl Folate IP —————— 1 mg | ||||
Pyridoxal Phosphate IP —————– 20 mg | ||||
Excipients ——————- q.s. | ||||
Colour-Approved colour used. | ||||
Calcium Citrate, Vitamin D3 &Zinc Tablets | Each Uncoated Tablet Contains:- | Calcium & Vitamin | ||
Calcitriol Citrate USP————-1000 mg | ||||
Vitamin D3 IP ——————200 IU | ||||
Zinc Sulphate Monohydrate IP | ||||
Eq. to elemental Zinc————– 4 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Calcium, Magnesium Vitamin D3 &Zinc Tablets | Each Uncoated Tablet Contains:- | Calcium & Vitamins | ||
Calcium Citrate USP————-1000 mg | ||||
Vitamin D3 IP ——————200 IU | ||||
Magnesium Hydroxide IP | ||||
Eq. to Elemental Magnesium ——-100 mg | ||||
Zinc Sulphate Monohydrate IP | ||||
Eq. to elemental Zinc————– 4 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Calcium citrate, Vitamin D3, Magnesium Hydroxide and Zinc Sulphate | Each Film Coated Tablet Contains:- | Calcium & Vitamins | ||
Calcium citrate USP | ||||
Eq. to Elemental calcium———— 1000mg | ||||
Vitamin D3 Granules | ||||
Eq. to Vitamin D3 IP—————– 400 IU | ||||
Magnesium Hydroxide IP | ||||
Eq. to Elemental Magnesium ———100mg | ||||
Zinc Sulphate Monohydrate IP | ||||
Eq. to elemental Zinc—————–4 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Calcium Pantothenate Tablets IP 100 mg | Each Film Coated Tablet Contains:- | IP | 100 mg | Calcium & Vitamin |
D- Calcium Pantothenate | q.s | |||
Excipients | ||||
Colour-Approved colour used | ||||
Calcium Carbonate, Vitamin D3, Methylcobalamin, L- Methyl Folate Calcium & Pyridoxal 5 Phosphate | Each Film Coated Tablet contains: | IP | 1250 mg | Calcium & Vitamin |
Calcium Carbonate | ||||
Eq. to Elemental Calcium | IP | 2000 IU | ||
Vitamin D3 | IP | 1500 mcg | ||
Methylcobalamin | 1 mg | |||
L- Methyl Folate | 20 mg | |||
Pyridoxal 5 Phosphate | ||||
Excipients . | q.s | |||
Colour-Approved colour used. | ||||
Calcium Dobesilate capsules | Each Hard Gelatin Capsule contains: | IP | 500 mg | Calcium & Vitamins |
Calcium dobesilate Monohydrate | q.s. | |||
Excipients | ||||
Approved colored used in Hard Gelatin Capsule shell | ||||
Cholecalciferol Tablets IP | Each Film Coated Tablet Contains:- | Calcium & Vitamin | ||
Cholecalciferol IP ———–60000 IU | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Cholinesterase inhibitor | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Rivastigmine Capsules USP | Each hard gelatin capsule contains:- | USP | 1.5mg | Cholinesterase inhibitor. |
Rivastigmine Tartrate | q.s. | |||
Eq. to Rivastigmine | ||||
Excipients | ||||
Colour: Approved colours used in empty capsule shells. | ||||
Rivastigmine Capsules USP | Each hard gelatin capsule contains:- | USP | 3mg | Cholinesterase inhibitor. |
Rivastigmine Tartrate | q.s. | |||
Eq. to Rivastigmine | ||||
Excipients | ||||
Colour: Approved colours used in empty capsule shells. | ||||
Corticosteroid & Bronchodilator | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Doxofylline MR Tablets 650 mg | Each Uncoated Modified Release Tablet Contains:- | IP | 650 mg | Corticosteroid & Bronchodilator |
Doxofylline | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Deflazacort Tablets 12 mg | Each Uncoated Tablet Contains:- | 12 mg | Corticosteroid & Bronchodilator | |
Deflazacort | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Montelukast And Olopatadine Hydrochloride Tablets | Each Film Coated Tablet Contains:- | Corticosteroid & Bronchodilator | ||
Montelukast Sodium I.P. | ||||
eq. to Montelukast 10mg | ||||
Olopatadine Hydrochloride I.P—-5mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Montelukast Tablets I.P. | Each Film Coated Tablet Contains:- | Corticosteroid & Bronchodilator | ||
Montelukast Sodium I.P. | ||||
Eq.to Montelukast——— 5mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Montelukast Tablets I.P. | Each Film Coated Tablet Contains:- | Corticosteroid & Bronchodilator | ||
Montelukast Sodium I.P. | ||||
Eq.to Montelukast———- 10mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Ambroxol Hydrochloride And Olopatadine Hydrochloride Tablets | Each Film Coated Tablet Contains:- | Corticosteroid & Bronchodilator | ||
Ambroxol Hydrochloride I.P——-30mg | ||||
Olopatadine Hydrochloride USP—-5mg | ||||
Excipients————————q.s. | ||||
Colour-Approved colour used. | ||||
Prednisolone Tablets I.P | Each film coated tablet contains: | Corticosteroid & Bronchodilator | ||
Prednisolone Acid I.P———– 5 mg | ||||
Excipients————————–q.s | ||||
Colour-Approved colour used. | ||||
Prednisolone Tablets I.P | Each film coated tablet contains: | Corticosteroid & Bronchodilator | ||
Prednisolone Acid I.P———– 10 mg | ||||
Excipients————————–q.s | ||||
Colour-Approved colour used. | ||||
Prednisolone Tablets I.P | Each film coated tablet contains: | Corticosteroid & Bronchodilator | ||
Prednisolone Acid I.P———– 20 mg | ||||
Excipients————————–q.s | ||||
Colour-Approved colour used. | ||||
Doxofylline Tablets IP | Each Film Coated Tablet Contains:- | Corticosteroid & Bronchodilator | ||
Doxofylline IP ——— 400 mg | ||||
Excipients—————– q.s | ||||
Methylprednisolone Tablets IP | Each Uncoated Tablet Contains:- | Corticosteroid & Bronchodilator | ||
Methylprednisolone 4mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Methylprednisolone Tablets IP | Each Uncoated Tablet Contains:- | Corticosteroid & Bronchodilator | ||
Methylprednisolone 2mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Methylprednisolone Tablets IP | Each Uncoated Tablet Contains:- | Corticosteroid & Bronchodilator | ||
Methylprednisolone 16mg | ||||
Excipients q.s. | ||||
MethylprednisoloneTablets IP | Each Uncoated Tablet Contains:- | Corticosteroid & Bronchodilator | ||
Methylprednisolone 8.0mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Calcium supplement | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Cholecalciferol Chewable tablets 60,000 I.U. | Each uncoated chewable tablet contains: | IP | 60,000 IU | Calcium supplement |
Cholecalciferol (As Stabilized) | q. s. | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Alfacalcidol, Calcium Carbonate and Betacarotene Tablets | Each Film Coated Tablet Contains:- | Calcium supplement | ||
Alfacalcidol I.P.————– 0.25 mcg | ||||
Calcium Carbonate IP 625 mg | ||||
(From an Organic Source Oyster Shell) | ||||
Eq. to Elemental Calcium —- 250 mg | ||||
Betacarotene (30%)————– 2500 IU | ||||
Excipients—————————q.s. | ||||
Colour-Approved colour used. | ||||
Diagestive enzyme | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Pancreatin and Activated Dimethicone Tablets | Each Enteric Coated Tablets Contains | Diagestive enzyme | ||
Pancreatin IP ———— 170 mg | ||||
Activated Dimethicone IP —–80 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Erectile Dysfunction | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Tadalafil Tablets IP | Each Uncoated Tablet Contains:- | Erectile Dysfunction | ||
Tadalafil IP —————- 5.0 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Tadalafil Tablets IP | Each Uncoated Tablet Contains:- | Erectile Dysfunction | ||
Tadalafil IP —————- 10 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Tadalafil Tablets IP | Each Uncoated Tablet Contains:- | Erectile Dysfunction | ||
Tadalafil IP —————- 20 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Labeltalol Hydrochloride Tablets IP | Each Film Coated Tablet Contains:- | Erectile Dysfunction | ||
Labeltalol Hydrochloride IP ——-50 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Labeltalol Hydrochloride Tablets IP | Each Film Coated Tablet Contains:- | Erectile Dysfunction | ||
Labeltalol Hydrochloride IP ——-100 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Labeltalol Hydrochloride Tablets IP | Each Film Coated Tablet Contains:- | Erectile Dysfunction | ||
Labeltalol Hydrochloride IP ——-200 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Labeltalol Hydrochloride Tablets IP | Each Film Coated Tablet Contains:- | Erectile Dysfunction | ||
Labeltalol Hydrochloride IP ——- 400 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Sildenafil Citrate Tablets IP | Each Film Coated Tablet Contains:- | Erectile dysfunction | ||
Sildenafil Citrate IP | ||||
Eq. to Sildenafil ————— 50 mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Sildenafil Citrate Tablets IP | Each Film Coated Tablet Contains:- | Erectile dysfunction | ||
Sildenafil Citrate IP | ||||
Eq. to Sildenafil ————— 100 mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Gastrointestinal Agent | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Acotiamide Hydrochloride Hydrate Tablets 100 mg | Each Film coated Tablets contains: | 100 mg | Gastrointestinal Agent | |
Acotiamide Hydrochloride Hydrate Excipients | q.s | |||
Colour: Approved Colour Used | ||||
Hydrating agent | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Urea, Lactic acid, Propylene Glycol & Liquid Paraffin Cream | Composition : | IP | 10%w/w | Hydrating agent |
Urea | IP | 10%w/w | ||
Lactic Acid | IP | 10%w/w | ||
Propylene Glycol | IP | 10%w/w | ||
Liquid Paraffin | ||||
Preservatives: | IP | 0.16%w/w | ||
Methyl Paraben | IP | 0.04%w/w | ||
Propyl Paraben | q.s | |||
Cream Base | ||||
Histamine Hl-Receptor Antagonist | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Cyproheptadine Hydrochloride 4 mg IP | Each uncoated tablet contains : – | Histamine Hl-Receptor Antagonist | ||
Cyproheptadine Hydrochloride IP ——4.0 mg | ||||
Excipients……………q.s. | ||||
Colour : Approved Colour Used | ||||
Hypothyroidism | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Thyroxine Tablets | Each uncoated Tablet Contains:- | Hypothyroidism | ||
Thyroxine Sodium IP ————- 12.5 mcg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Thyroxine Tablets | Each uncoated Tablet Contains:- | Hypothyroidism | ||
Thyroxine Sodium IP ————- 100 mcg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Thyroxine Tablets | Each uncoated Tablet Contains:- | Hypothyroidism | ||
Thyroxine Sodium IP ————- 25 mcg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Thyroxine Tablets | Each uncoated Tablet Contains:- | Hypothyroidism | ||
Thyroxine Sodium IP ————- 50 mcg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Thyroxine Tablets | Each uncoated Tablet Contains:- | Hypothyroidism | ||
Thyroxine Sodium IP ————- 75 mcg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Levothyroxine Tablets | Each uncoated Tablet Contains:- | Hypothyroidism | ||
Levothyroxine Sodium IP | ||||
Eq. to Levothyroxine ————- 25 mcg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Immunosuppresant | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Tacrolimus Capsules IP | Each Hard Gelatin Capsule Contains: | IP | 0.5 mg | Immunosuppresant |
Tacrolimus | q.s. | |||
Eq. to Anhydrous Tacrolimus | ||||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Tacrolimus Capsules IP | Each Hard Gelatin Capsule Contains: | IP | 1.0 mg | Immunosuppresant |
Tacrolimus | q.s. | |||
Eq. to Anhydrous Tacrolimus | ||||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Cyclosporine Capsules IP | Each Hard Gelatin Capsule Contains: | IP | 25.0 mg | Immunosuppresant |
Cyclosporine | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Cyclosporine Capsules IP | Each Hard Gelatin Capsule Contains: | IP | 50.0 mg | Immunosuppresant |
Cyclosporine | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Cyclosporine Capsules IP | Each Hard Gelatin Capsule Contains: | IP | 250.0 mg | Immunosuppresant |
Cyclosporine | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Mycophenolate Mofetil Tablets IP | Each Film Coated Tablet Contains:- | Immunosuppressants | ||
Mycophenolate Mofetil IP——— 250 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Mycophenolate Mofetil Tablets IP | Each Film Coated Tablet Contains:- | Immunosuppressants | ||
Mycophenolate Mofetil IP——— 360 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Mycophenolate Mofetil Tablets IP | Each Film Coated Tablet Contains:- | Immunosuppressants | ||
Mycophenolate Mofetil IP——— 500 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Mycophenolate Mofetil Tablets IP | Each Film Coated Tablet Contains:- | Immunosuppressants | ||
Mycophenolate Mofetil IP——— 750 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Tacrolimus ointment 0.1% w/w | Composition: | U.S.P. | 0.1%w/w | Immunosuppressive |
Tacrolimus | q.s | |||
Ointment Base | ||||
Tacrolimus Ointment | Composition:- | IP | 0.03%w/w | Immunosuppressive Agents |
Tacrolimus | q.s. | |||
Excipients | ||||
Iron, Calcium & Vitamin | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Zinc Acetate Tablets | Each Film coated Tablet Contains:- | USP | 50 mg | Iron, Calcium & Vitamin |
Zinc Acetate (As Dihydrate) | q.s | |||
Eq. to. Zinc | ||||
Excipients | ||||
Colour-Approved colour used. | ||||
Zinc Sulphate Dispersible Tablets IP | Each Uncoated Dispersible Tablet Contains:- | IRON, CALCIUM & VITAMIN D | ||
Zinc Sulphate Monohydrate IP | ||||
Eq. to Elemental Zinc ———— 20 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Zinc Sulphate Dispersible Tablets IP | Each Uncoated Dispersible Tablet Contains:- | IRON, CALCIUM & VITAMIN D | ||
Zinc Sulphate Monohydrate IP | ||||
Eq. to Elemental Zinc ———— 10 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Laxative | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Prucalopride Tablet 1 mg | Each Film coated Tablet Contains:- | 1 mg | Laxative | |
Prucalopride Succinate | q.s | |||
Eq. to Prucalopride | ||||
Excipients | ||||
Colour-Approved colour used. | ||||
Prucalopride Tablet 2 mg | Each Film coated Tablet Contains:- | 2 mg | Laxative | |
Prucalopride Succinate | q.s | |||
Eq. to Prucalopride | ||||
Excipients | ||||
Colour-Approved colour used. | ||||
Activated Dimethicone, Magnesium Hydroxide, Dried Aluminium Hydroxide Gel and Magnesium Aluminum Silicate Hydrate Tablets | Each Uncoated chewable tablet Contains:- | laxatives | ||
Activated Dimethicone IP ——50 mg | ||||
Magnesium Hydroxide IP ——— 250 mg | ||||
Dried Aluminium Hydroxide Gel IP —250 mg | ||||
Magnesium Aluminum Silicate Hydrate —————————————- 250 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Multivitamins | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Carbonyl Iron, folic acid, Vitamin B12 and Zinc Sulphate Capsules | Each hard gelatin capsule contain: | IP | 100 mg | Multivitamins |
Carbonyl Iron | 1.5 mg | |||
Equivalent to Elemental Iron | IP | 15 mcg | ||
Folic acid | IP | 61.8 mg | ||
Vitamin B12 | IP | 22.5 mg | ||
Zinc sulphate monohydrate | q.s. | |||
Equivalent to elemental zinc | ||||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Multivatamin, Multiminerals with lycopene Capsules | Each Hard Gelatin capsule contains: | USP | 5 mg | Multivatamin |
Lycopene 6 % | USP | 6 mg | ||
Lutien 8 % | USP | 10 mg | ||
Beta carotene (10 % Dispersion) | IP | 5 mcg | ||
Vitamin B6 | IP | 200 IU | ||
Vitamin B12 | IP | |||
Vitamin D3 | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Alpha Lipoic acid, Methylcobalamin, Vitamin B6, Folic acid, Benfotiamine ,Biotin, Chromium Picolinate Capsules | Each Hard Gelatin capsule contains: | USP | 100 mg | Mutivitamins |
Alpha Lipoic Acid | IP | 1500mcg | ||
Methylcobalamin | IP | 3 mg | ||
Vitamin B6 | IP | 1.5 mg | ||
Folic acid | IH | 50 mg | ||
Benfotiamine | USP | 5 mg | ||
Biotin | USP | 200 mcg | ||
Chromium Picolinate USP | q.s. | |||
Eq. to Chromium | ||||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Methylcobalamin, Alpha lipoic acid, Benzothiazine, Vit B6, calcium Pantothenate, Nicotinamide & Folic acid capsule | Each Hard gelatin capsule contain: | IP | 750 mcg | Multivitamin |
Methylcobalamin | USP | 100 mg | ||
Alpha lipoic acid | IH | 7.5 mg | ||
Benfothiamine | IP | 1.5 mg | ||
Vit B6 | IP | 25 mg | ||
Calcium Pantothenate | IP | 50 mg | ||
Nicotinamide | IP | 0.75 mg | ||
Folic acid | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Mecobalamin, Vitamin B1, B6, Alpha lipoic Acid & Folic Acid Capsule | Each hard gelatin capsule contains: | IP | 1500 mcg | Multivitamin |
Mecobalamin | IP | 10 mg | ||
Vitamin B1(Thiamine Mononitrate) | IP | 3 mg | ||
Vitamin B6(Pyridoxine HCL) | USP | 100 mg | ||
Alpha Lipoic Acid | IP | 1.5 mg | ||
Folic Acid | q. s | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Alpha lipoic Acid &Methylcobalamin capsules | Each Hard gelatin Capsule contains: | IP | 1500 mcg | Multivitamins |
Methylcobalamin | IP | 300 mg | ||
Alphalipoic Acid | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Methylcobalamin, Folic Acid, Alpha Lipoic Acid Vitamin B1 & vitamin B6 | Each Hard Gelatin Capsule Contains: | IP | 500 mcg | Mutivitamins |
Methylcobalamin | IP | 1.5 mg | ||
Folic Acid | USP | 100 mg | ||
Alpha Lipoic Acid | IP | 10.0 mcg | ||
Vitamin B1 Mononitrate | IP | 3.0 mg | ||
Vitamin B6 HCl | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Alpha Lipoic acid, Pyridoxine HCl, Methylcobalamin, Folic acid, Benfothiamine, Biotin & Chromium Capsules | Each hard gelatin capsule contains:- | USP | 100mg | Mutlivitamin |
Alpha Lipoic Acid | IP | 3mg | ||
Pyridoxine Hydrochloride | IP | 1500mcg | ||
Methylcobalamin | IH | 50mg | ||
Benfothiamine | USP | 5mg | ||
Biotin | IP | 1.5mg | ||
Folic Acid | USP | |||
Chromium Picolinate | 200mcg | |||
Eq. to Chromium | q.s. | |||
Excipients | ||||
Approved colours used in empty capsule shells. | ||||
Methylcobalamin, Pregabalin, Vitamin B6, Folic Acid &Benfothiamine Capsules | Each hard gelatin capsule contains: | IP | 750 mcg | Multivitamin |
Methylcobalamin | IP | 75 mg | ||
Pregabalin | IP | 1.5 mg | ||
Vitamin B6 | IP | 0.75 mg | ||
Folic Acid | IH | 7.5 mg | ||
Benfothiamine | q.s. | |||
Excipients | ||||
Approved colours used in empty capsule shells. | ||||
Sodium Feredetate, Folic Acid & Vitamin B12 Tablets | Each Film Coated Tablet Contains:- | BP | 231 mg | Mutivitamin |
Sodium Feredetate | 33 mg | |||
Eq. to Elemental Iron | 1.5 mg | |||
Folic Acid | 15 mcg | |||
Vitamin B12 | q.s. | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Vitamin C, Sodium Ascorbate & Zinc Citrate Tablets | Each Uncoated Tablet Contains:- | IP | 100 mg | Mutivitamin |
Ascorbic Acid | IP | |||
Sodium Ascorbate (450 mg) | 400 mg | |||
Eq. to Ascorbic Acid | IP | |||
Zinc Citrate | 5 mg | |||
Eq. to Elemental Zinc | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Methylcobalamin, L- Methylfolate, Pyridoxal Phosphate, Vitamin D3 & DHA Tablets | Each Film coated Tablet Contains:- | IP | 1500 mcg | Multivitamin |
Methylcobalamin | 1 mg | |||
L- Methylfolate | 0.5 mg | |||
Pyridoxal Phosphate | 1000 IU | |||
Vitamin D3 | 100 mg | |||
Doscosahexaneoic Acid (DHA ) | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
L- Methylfolate, Pyridoxal 5 Phosphate & Methylcobalamin Tablets | Each Film coated Tablet Contains:- | IP | 5 mg | Multivitamin |
L- Methylfolate | 3 mg | |||
Pyridoxal 5 Phosphate | 1500 mcg | |||
Methylcobalamin | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Methylcobalamin, L- Methyl Folate Calcium, & Pyridoxal-5 Phosphate Tablets | Each Film Coated Tablet contains: | Mutivitamin | ||
Methylcobalamin IP —————–1500 mcg | ||||
L- Methyl Folate Calcium ———- 1 mg | ||||
Pyridoxal-5 Phosphate —————– 0.5 mg | ||||
Excipients ——————- q.s. | ||||
Colour-Approved colour used. | ||||
Calcium Citrate Malate, Calcitriol, Vitamin K2-7 Tablets | Each Film Coated Tablet Contains:- | Mutivitamin | ||
Calcium Citrate Malate IP | ||||
Eq. to Elemental calcium———— 250mg | ||||
Calcitriol ————————— 0.25 mcg | ||||
Vitamin K2-7 ———————– 50 mcg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Antioxidant Multivitamins &Multiminerals Tablets | Each Film Coated Tablet Contains:- | Multivitamin | ||
Vitamin A Acetate IP ————— 5000 IU | ||||
Vitamin E Acetate IP —————- 25 IU | ||||
Ascorbic Acid IP ——————- 100 mg | ||||
Thiamine Monohydrate IP ——– 10 mg | ||||
Riboflavin IP ————————–10 mg | ||||
Pyridoxine Hydrochloride IP —— 3 mg | ||||
Cyanocobalamin IP—————— 5 mcg | ||||
Niacinamide IP ———————— 50 mg | ||||
Folic Acid IP —————————–1 mg | ||||
Calcium Pantothenate IP ————12.5 mg | ||||
Zinc Oxide IP | ||||
Eq. to Elemental Zinc ————– 15 mg | ||||
Cupric Oxide USP | ||||
Eq. to Elemental Cupric ————– 2.5 mg | ||||
Sodium Selenate BP | ||||
Eq. to Elemental Sodium ————– 60 mcg | ||||
Magnesium Chloride USP | ||||
Eq. to Magnesium ——————-1.5 mg | ||||
Chromium Chloride USP | ||||
Eq. to Elemental Chromium ——— 65 mcg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used | ||||
Adenosylcobalamin, Iron, Folic Acid and Zinc Tablets | Each Film Coated Tablet Contains:- | Mutivitamin | ||
Adenosylcobalamin ———- 15 mcg | ||||
Ferrous Ascorbate | ||||
Eq. to Elemental Iron————–100 mg | ||||
Folic Acid IP————————-1.5 mg | ||||
Zinc Sulphate USP | ||||
Eq. to Elemental Zinc —————-22.5 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Sodium Feredetate, Folic Acid and Vitamin B12 Tablets | Each Film Coated Tablet Contains:- | Multivitamins | ||
Sodium Feredetate BP ————- 231mg | ||||
(Eq. to 33 mg. Elemental Iron) | ||||
Folic Acid IP ———————– 1.5 mg | ||||
Vitamin B12 IP ——————- 15 mcg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Methylcobalamin, Alpha Lipoic Acid, Vitamin D3, Pyridoxine Hydrochloride, Folic Acid Tablets | Each Film Coated Tablet Contains:- | Mutivitamins | ||
Methylcobalamin IP ————– 1500 mcg | ||||
Alpha Lipoic Acid USP ————- 100 mg | ||||
Vitamin D3 IP—————– —1000 IU | ||||
Pyridoxine Hydrochloride IP —— 3 mg | ||||
Folic Acid IP ——————- 1.5mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Methylcobalamin, Alpha Lipoic Acid, Gabapentin & Pyridoxine Hydrochloride Tablets | Each Film Coated Tablet Contains:- | Mutivitamins | ||
Methylcobalamin IP ————– 750 mcg | ||||
Alpha Lipoic Acid USP ————- 100 mg | ||||
Gabapentin IP——————— 300 mg | ||||
Pyridoxine Hydrochloride IP —— 3 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Methylcobalamin, Alpha Lipoic Acid, Vitamin B6, Folic Acid, Zinc, Chromium, Selenium, Biotin & Inositol Tablets | Each Film Coated Tablet Contains:- | Multivitamin | ||
Methylcobalamin IP ————– 1500 mcg | ||||
Alpha Lipoic Acid USP ————- 100 mg | ||||
Vitamin B6 ——————– 3 mg | ||||
Folic Acid IP ——————- 1.5mg | ||||
Zinc ——————————– 15 mg | ||||
Chromium ———————– 60 mcg | ||||
Selenium ————————- 65 mcg | ||||
Biotin —————————– 100 mcg | ||||
Inositol ————————- 2 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Biotin Tablets | Each Film Coated Tablet Contains:- | Multivitamin | ||
Biotin USP ————————— 5 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Muscle Relaxant | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Baclofen Extended Release Capsules | Each hard gelatin capsule contains: | IP | 30 mg | Muscle Relaxant |
Baclofen | ||||
( As extended Release pellets ) | q.s. | |||
Excipients | ||||
Approved colours used in empty capsule shells & pellets. | ||||
Alfuzosin HCl (ER) and Dutasteride Tablets | Each Film Coated Tablet Contains :- | Muscle Relaxant | ||
Alfuzosin Hydrochloride I.P—— 10mg | ||||
Dutasteride I.P. — 0.5mg | ||||
Excipients——————-q.s. | ||||
Colour-Approved colour used. | ||||
Drotaverine Tablets IP | Each film coated tablet contains: | Muscle Relaxant | ||
Drotaverine Hydrochloride IP——40mg | ||||
Excipients—————————-q.s. | ||||
Colour-Approved colour used. | ||||
Drotaverine Tablets IP | Each film coated tablet contains: | Muscle Relaxant | ||
Drotaverine Hydrochloride IP——-80mg | ||||
Excipients————————–q.s. | ||||
Colour-Approved colour used. | ||||
Carisoprodol Tablets USP 500 mg | Each Uncoated Tablets contains: | USP | 500 mg | Skeletal Muscle Relaxants |
Carisoprodol | q.s | |||
Excipients | ||||
Colour: Approved Colour Used. | ||||
Baclofen Tablets IP 10 mg | Each Uncoated Tablets contains: | IP | 10 mg | Skeletal Muscle Relaxants |
Baclofen | q.s | |||
Excipients | ||||
Colour: Approved Colour Used | ||||
Baclofen Tablets IP 25 mg | Each Uncoated Tablets contains: | IP | 25 mg | Skeletal Muscle Relaxants |
Baclofen | q.s | |||
Excipients | ||||
Colour: Approved Colour Used | ||||
Pancreatic Enzymes | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Pancreatin 300 mg Capsule | Each Hard Gelatin capsule contains: | IP | 300 mg | Pancreatic Enzymes |
Pancreatin (Enteric coated pellets) | q.s. | |||
Eq. to. Pancreatin | ||||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
L-Ornithine L-Aspartate and Pancreatin Tablets | Each Enteric Coated Tablets Contains | Pancreatic Enzymes | ||
L-Ornithine L-Aspartate——– 150 mg | ||||
Pancreatin IP——————- 100 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Pancreatin Tablets | Each Enteric Coated Tablets Contains | Pancreatin Enzyme Deficiency | ||
Pancreatin IP ———— 212.5 mg | ||||
Eq. to Lipase activity ———-6000 FIP units | ||||
Amylase Activity ————4500 FIP units | ||||
Protease Activity —— 300 FIP units | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Protease Inhibitors | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Ritonavir Capsules IP | Each Hard Gelatin Capsule Contains: | IP | 10.0 mg | Protease Inhibitors |
Ritonavir | q.s. | |||
Excipients | ||||
Approved colour used in empty hard gelatin capsule shell | ||||
Skin lightening agent | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Hydroquinone | Composition: | USP | 4.0% w/w | Skin lightening agent |
Cream USP | Hydroquinone | q.s. | ||
In a Cream Base | ||||
Sedative | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Melatonin Tablets 3 mg | Each Uncoated Tablets contains: | 3 mg | Sedative | |
Melatonin | q.s | |||
Excipients | ||||
Colour: Approved Colour Used | ||||
Treatment osteoporosis | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Ibandronic Acid Tablets 150 mg | Each Film coated Tablets contains: | Treatment osteoporosis | ||
Ibandronic Acid monosodium Monohydrate | ||||
Eq. to Ibandronic Acid 150 mg | ||||
Excipients q.s | ||||
Colour: Approved Colour Used | ||||
Alendronic Acid Tablets USP | Each Film Coated Tablet Contains:- | Treatment osteoporosis | ||
Alendronate Sodium USP | ||||
Eq.to Alendronic Acid 10 mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Treat iron overload | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Deferasirox Dispersible Tablets | Each Uncoated Dispersible Tablet Contains:- | Treat iron overload | ||
Deferasirox 500mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Deferasirox Dispersible Tablets | Each Uncoated Dispersible Tablet Contains:- | Treat iron overload | ||
Deferasirox 250mg | ||||
Excipients q.s. | ||||
Colour-Approved colour used. | ||||
Transfusional hemosiderosis | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Deferasirox Dispersible Tablets | Each Uncoated Dispersible Tablet Contains:- | Transfusional hemosiderosis | ||
Deferasirox———–500mg | ||||
Excipients————————-q.s. | ||||
Colour-Approved colour used. | ||||
Treatment vitamin B6 deficiency | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Pyridoxine Tablets IP | Each Film Coated Tablet Contains:- | Treatment vitamin B6 deficiency | ||
Pyridoxine Hydrochloride IP——– 5 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
uterine relaxants | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Ritodrine Hydrochloride Tablets IP 10 mg | Each Film Coated Tablet Contains:- | IP | 10 mg | uterine relaxants |
Ritodrine Hydrochloride | q.s | |||
Excipients. | ||||
Colour-Approved colour used. | ||||
Uricosuric Agent | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Allopurinol Tablets IP | Each Film Coated Tablet Contains:- | Uricosuric Agent | ||
Allopurinol IP ———— 300 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Vitamins | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Methylcobalamin Tablets | Each Film Coated Tablet Contains:- | Vitamins | ||
Methylcobalamin IP —————-500 mcg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Methylcobalamin Tablets | Each Film Coated Tablet Contains:- | Vitamins | ||
Methylcobalamin IP —————-1000 mcg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Methylcobalamin Tablets | Each Film Coated Tablet Contains:- | Vitamins | ||
Methylcobalamin IP —————-1500 mcg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Biotin Tablets USP | Each Film Coated Tablet Contains: | U.S.P. | 5 mg | Vitamin Supplement |
Biotin | q.s. | |||
Excipients | ||||
Colour-Approved colour used | ||||
Vasodilator | ||||
Generic Name | Composition | Ph. Ref. | Str. | Category |
Isoxsuprine HCl Sustained Release Tablets 40 mg | Each Uncoated Sustained release Tablet Contains:- | IP | 40 mg | Vasodilator |
Isoxsuprine Hydrochloride | q.s | |||
Excipients | ||||
Colour-Approved colour used. | ||||
Isoxsuprine Tablets IP | Each Film Coated Tablet Contains:- | vasodilators | ||
Isoxsuprine IP———20 mg | ||||
Excipients—————– q.s | ||||
Colour-Approved colour used. | ||||
Hydroquinoine, Octyl Methoxycinnamate & Oxybenzone Cream | Composition : | USP | 2.0 %w/w | |
Hydroquinoine | USP | 5.0 %w/w | ||
Octyl Methoxycinnamate | USP | 3.0 %w/w | ||
Oxybenzone | q.s. | |||
Cream base | ||||
Doxofylline Tablets IP | Each Uncoated Tablet | |||
Contains:- | ||||
Doxofylline………………………….IP 400mg | ||||
Excipients | ||||
Colour-Approved colour used…………..q.s | ||||
Mefenamic Acid and Paracetamol Tablets | Each Uncoated Tablet Contains:- | I.P. | 250 mg | |
Mefenamic Acid | I.P. | 325 mg | ||
Paracetamol | q.s | |||
Excipients . | ||||
Colour-Approved colour used. |
[/vc_column_text][/vc_column][/vc_row]